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Abstract&!Estrogen! drives! the! growth! and! development! of! estrogen! receptor! alpha! (ERα)!positive!breast!cancer!and!ERα!is!the!target!for!hormonal!therapies!that!inhibit! its!activity.! A! substantial! proportion! of! patients! become! resistant! to! these! therapies,!demonstrating!a!need!for!new!therapies.!!!Gene!expression!microarray!studies!have!been!performed!with!a!view!to!identifying!potential!novel!therapeutic!targets,!biomarkers!or!forming!the!basis!of!identifying!a!molecular! signature! for! endocrine! resistance.! These! studies! have! identified!candidate! genes! whose! expression! is! altered! in! models! of! endocrine! resistance.!Investigation! of! the! molecular! pathways! particularly! highlights! cell! survival! and!regulation! of! apoptosis! and! indicates! that! these! pathways! play! a! key! role! in! the!development!of!resistance.!!Microarray!analysis!also!identified!the!liver!receptor!homolog!1!(LRHI1,!NR5A2),!a!member!of!the!nuclear!receptor!superfamily!of!transcription!factors,!as!an!estrogen!regulated! gene! in! MCF7! cells.! Functional! analysis! showed! that! LRHI1! regulates!breast! cancer! cell! growth,! acting! in! part! by! regulating! ERα! expression.! Gene!expression! profiling! of! MCFI7! cells! following! RNAi! for! LRHI1! identified! LRHI1!regulated! genes.! LRHI1! is! known! to! regulate! expression!of! CYP19A1! (aromatase),!responsible! for! estrogen! biosynthesis! through! the! aromatisation! of! aromatase.!Together,! our! findings! identify! LRHI1! as! a! potential! therapeutic! target! for! breast!cancer!treatment.!Results!of!screening!for!small!molecule!inhibitors!of!LRHI1!will!be!presented,! together!with!analysis!of!gene!expression!profiling! for!LRHI1!regulated!genes.!!
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1.&Introduction&Breast! cancer! is! the! most! common! cancer! diagnosed! in! women! in! the! Western!World.!There!were!130!age!adjusted!new!cases!per!100,000!people!in!UK!in!2008,!a!prevalence! of! 297,769! on! 31st! December! 2006! and! a! lifetime! risk! for! developing!breast!cancer!of!1!in!8,!for!women!in!the!UK!(Sasieni!et!al.,!2011).!Worldwide!there!were!1.38!million!new!cases!!and!458,400!deaths!in!2008!(Figure!1.1)!(Jemal!et!al.,!2011).!The! importance! of! estrogen! on! breast! cancer! development! and! progression! have!long! been! established.! In! the! 1870s,! Alfred! Schinzinger! noted! that! the! permanent!cessation! of! menstruation,! the! menopause,! led! to! breast! atrophy! and! proposed!oopherectomy!as!a!possible!means!to!treat!breast!cancer!(Ali!and!Coombes,!2002).!In!1896,!George!Beatson!published! the!successful!use!of!oophorectomy!to!achieve!tumour!regression!in!a!preImenopausal!woman!with!breast!cancer!(Beatson,!1896).!Stanley!Boyd!reported!on! this! case!and! forty!others! in! the!British!Medical! Journal!(Boyd,! 1900).! The! identification! of! the! ovaries! as! the! source! of! the! hormone!estrogen! led! to! the! proposal! by! Antoine! Lacassagne! of! the! concept! of! synthetic!estrogen! antagonists! that! could! be! used! in! the! prevention! of! breast! cancer!(Lacassagne,! 1936).! However! the! actual! discovery! of! synthetic! antagonists! and!subsequently! the! estrogen! receptor! did! not! occur! until! the! 1950/60s! (MacGregor!and!Jordan,!1998)!and!has!since!led!to!a!paradigm!shift!in!individualizing!the!care!of!patients! with! breast! cancer! at! a! molecular! level.! The! importance! of! estrogen! in!regulating! breast! cancer! growth! is! now! abundantly! clear! and! drugs! that! inhibit!estrogen!biosynthesis,!or!those!that!bind!competitively!to!estrogen!receptors,!have!become!very!important!agents!in!the!treatment!of!breast!cancer.!Estrogenic!actions!are! mediated! by! the! estrogen! receptors,! ERα! and! ERß.! The! first! important! antiIestrogen!was!Tamoxifen,!a!selective!estrogen!receptor!modulator!(SERM),!approved!by! the! Food! and! Drug! Administration! (USA)! in! 1977! for! use! in! management! of!metastatic!breast!cancer!and!subsequently!in!an!adjuvant!setting!(Osborne,!1998).!!
Figure' 1.1' Global' age' standardised' incidence' and'mortality' rates'
for'cancer'in'women.'Data$obtained$from$the$International$Agency$for$Research$ on$Cancer$ $ GLOBOCAN$2012$ (http://globocan.iarc.fr/Pages/fact_sheets_population.aspx)$
































The!therapeutic!use!of!antiIestrogens!such!as!tamoxifen!for!five!years!has!increased!overall! survival! in! the! postIoperative! adjuvant! setting! (Lewis,! 2007),! with! low!toxicities!compared!to!cytotoxic!treatment,! in!ERα!positive!patients.!The!discovery!of! aromatase,! the! enzyme! involved! in! the! conversion! pathway! of! androgens! to!estrogens!(Figure!1.2),!has!now!led!to!the!development!of!aromatase!inhibitors!such!as!letrozole!and!anastrozole,!which!act!via!competitive!inhibition!of!aromatase,!and!exemestane,!which!acts!via!an!irreversible!inactivation!of!aromatase!(Johnston!and!Dowsett,! 2003).! Clinical! trials! with! aromatase! inhibitors! show! significant!improvements!in!overall!survival!in!both!the!adjuvant,!neoIadjuvant!and!metastatic!settings! in!postImenopausal!ERαIpositive!patients! (Cuzick,! 2008)! (Coombes! et! al.,!2007;! Ellis! et! al.,! 2001).! Recent! metaIanalyses! confirm! that! aromatase! inhibitors!significantly! lower! recurrence! rates! in! initial! adjuvant! administration! and!significantly! decrease! mortality! (0.7%! and! 1.6%! for! three! and! six! years! from!treatment! divergence,! respectively)! in! a! ‘switch’! setting! following! 2I3! years! of!tamoxifen!(Dowsett!et!al.,!2010;!J.!Ingle,!2008).!This!phasing!of!adjuvant!endocrine!therapies!is!increasingly!becoming!the!standard!of!care!in!clinical!practice.!
Figure' 1.2' ' The' mechanisms' of' action' of' anti;estrogens' and'








1.1&Endocrine&Resistance!Although! it! remains!one!of! the!greatest!advances! in!cancer! therapeutics,!hormone!therapy! is! not!without! problems.! An! important! clinical! issue! is! that! of! resistance,!both! de$ novo! and! acquired! resistance! to! tamoxifen,! as! well! as! to! aromatase!inhibitors.!Many!patients!presenting!with! localized!disease!progress!on! tamoxifen,!or! relapse! following! initial! response.! In! the!metastatic! setting! all! patients! treated!with!tamoxifen!relapse!(Ali!and!Coombes,!2002).!Published!data!have!shown!that!in!the! majority! of! cases! ERα! expression! is! maintained! (Johnston! et! al.,! 1995)! and!approximately!20%!of!patients!who!relapse!on!tamoxifen!will!respond!to!second!or!third!line!endocrine!treatments!(Howell!et!al.,!2002;!Osborne!et!al.,!2002),!indicating!that! ERα! continues! to! be! important! in! the! growth! of! endocrine! resistant! breast!cancer.! Despite! this! knowledge,! definitive!molecular! causes! of! resistance! are! still!uncertain;!however!it!is!these!findings!that!have!led!to!the!idea!of!phasing!endocrine!treatments! as! a! means! of! reducing! the! development! of! endocrine! resistance!(Coombes!et!al.,!2007).!!!The! increasing! use! of! aromatase! inhibitors! as! neoadjuvant! treatment,! phasing! of!adjuvant! treatment! (i.e.! pre! or! post! tamoxifen)! and! in! the! metastatic! setting! is!leading! to! a! different! molecular! scenario! to! tamoxifen! resistance,! as! aromatase!inhibitors! act! by! decreasing! systemic! estrogen! biosynthesis! in! contrast! to! acting!directly! on! the! estrogen! receptor.! We! might! assume! that! the! clinical! scenario! of!estrogen!deprivation!is!a!different!model!to!that!of!tamoxifen!resistance.!!The! incidence! and! mortality! of! breast! cancer! in! some! Western! countries! has!decreased! since! 2000,! but! there! has! been! an! increase! in!many! Asian! and! African!countries!and!breast!cancer!remains!the!most!commonly!diagnosed!cancer!and!the!leading!cause!of!cancer!death,!in!!women,!worldwide!(Jemal!et!al.,!2011).!!!
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The! efficacy! and! availability! of! hormonal! therapies! such! as! SERMs,! faslodex! and!aromatase! inhibitors,! the! convenience! of! administration! and! cost! effectiveness!means!that!we!can!expect!use!to!continue!to!rise.!This!has!provided!the!impetus!for!further! efforts! to! determine! the! mechanisms! underlying! resistance! to! hormonal!therapies.!!






















1.2.1&ERα&Structure&&The!human!ERα!gene!codes!for!a!6.3!kb!mRNA,!which!is!translated!to!generate!a!595!amino! acid! polypeptide.! The! ERα!polypeptide! can! be! functionally! divided! into! six!distinct! regions,!on! the!basis!of!homology,!when!comparing!protein!sequences! for!ERα,! and! other!members! of! the! nuclear! receptor! family,! across! different! species.!Following! on! from! these! analyses! and! functional! characterization! the!most! highly!conserved! domains! in! the! ERα! protein! across! different! species! are! region! C,!encoding!the!DNA!binding!domain!(DBD),!comprised!of!two!zinc!finger!motifs!and!responsible!for!specific!binding!to!estrogen!response!elements!in!regulatory!regions!of!estrogenIresponsive!genes,!and!the!ligand!binding!domain!(LBD,!region!E),!which!binds!estrogen!and!antiIestrogens!(Ali!and!Coombes,!2002).!The!LBD!also!encodes!an! intrinsic! transcription! activation! function! AF2,! whose! action! requires! ligand!binding.!NIterminal! to! the!DBD!is! transcription!activation! function!AF1,!which!can!act! in! a! ligandIindependent! manner,! at! least! when! separated! from! the! ERα! LBD!(Ring!and!Dowsett,!2004).!AF1!activity! is! regulated!by!growth! factors!and!protein!kinases! causing! phosphorylation! at! several! sites,! leading! to! stimulation! of! ERα!activity,!often!in!a!ligandIindependent!manner.!AF1!phosphorylation!is!mediated!by!ERK1/2!MAPK!(at!serines,!104,!106!and!118),!by!CDK7!(serine!118),!by!the!MAPKIregulated!p90RSK!(at!serine!167)!and!by!AKT!(also!at!serine!167)!(Ali!and!Coombes,!2002).! AF1! phosphorylation! and! consequent! ERα! activation! by! ERK1/2! and! AKT!provides!a!potential! for!crosstalk!between!ERα!and!cell! surface!receptors,! such!as!EGFR!and!HER2,!which!have!been! implicated! in! resistance! to! endocrine! therapies!(Martin!et!al.,!2005;!Moy!and!Goss,!2006;!Nicholson!et!al.,!2007).!!!Estrogens!regulate!the!growth!of!breast!cancer!cells!by!binding!to!the!ERα!LBD!and!promoting! dissociation! from! heat! shock! proteins! and! leading! to! receptor!dimerisation! and! localization! in! the! nucleus.! The! ERα/estrogen! complex! binds! to!estrogen!response!elements!(EREs)!in!the!regulatory!(promoter,!enhancer)!regions!
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1.2.2&ERα&Cofactors&At! least! 285! transcriptional! cofactors! (coIregulators)! have! been! identified!mainly!through! screens! for! genes! that! promote! or! repress! nuclear! receptor! activities!(Lonard! et! al.,! 2007).! Transcriptional! cofactors! were! initially! noted! to! be! of!importance! through! their! role! in! the! interaction! with! DNAIbinding! transcription!factors,! creating! a! bridge! to! the! general! transcription! machinery,! to! promote!transcription! initiation.! Since! then! they! have! also! been! found! to! have! enzymatic!roles,! to! promote! chromatin! remodelling! and! modification,! as! well! as! including!factors! that! have! enzymatic! roles! in! regulating! transcriptional! elongation,! RNA!splicing!and!mRNA!transport.!!!The! dysregulation! of! transcriptional! coIfactors! in! cancer! is! being! increasingly!recognized.! A! review! on! nuclear! receptor! coIfactors! (coIactivators! and! coIrepressors),! using! the! Oncomine! database! in! 2007,! reported! that! 60%! of!transcriptional! coIregulators! are! overIexpressed! in! lung! cancer,! 38%! in! breast!cancer!and!43%!in!prostate!cancer!(Lonard!et!al.,!2007).!!An! example! of! an! ERα! coIactivator! that! is! frequently! amplified! and/or! overIexpressed! in! breast! cancer! is! AIB1! (Amplified! in! breast! cancer! 1)! (Anzick! et! al!1997).! Transgenic! mice! overIexpressing! AIB1! in! the! mammary! gland! develop!malignant!mammary! tumours! (TorresIArzayus! et! al.,! 2004;! TorresIArzayus! et! al.,!2010),!directly!implicating!AIB1!in!breast!cancer!initiation!and!progression.!!!The!majority!of! identified!nuclear! receptor! cofactors!bind!at! the!AF2!binding! site.!Other!coIactivators!bind!to!the!DBD,!for!example,!Ciz1!binds!to!the!DBD!of!ERα!(den!Hollander! et! al.,! 2006),! PGC1Iα! that! binds! to! the! hinge! region,! as!well! as! the!AF2!(Tcherepanova! et! al.,! 2000)! and! p68! RNA! helicase,! which! binds! to! the! ERα! AF1!(Endoh!et!al.,!1999),!have!been!described.!!
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From! various! studies,! three! classes! of! coIactivator! peptides! have! been! identified,!based! on! the! flanking! sequences! of! the! common,! signature! nuclear! receptor! LBD!binding!motif,! LXXLL! (NR! binding! box)!where! L! is! leucine! and! X! any! amino! acid!(Chang!et!al.,!1999;!Darimont!et!al.,!1998;!Heery!et!al.,!1997;!Nolte!et!al.,!1998;!Shiau!et!al.,!1998).!The!steroid!receptor!coIactivators!(SRCs),!which!include!AIB1!(SRC3)!are! an! important! group! of! coIactivators! with! mostly! class! 1! or! 2! LXXLL! binding!motifs.!They!share!common!functional!domains!including!an!N!terminal!basic!helixIloopIhelixIPer/ARNT/Sim! (bHLHIPAS)! domain! (required! for! proteinIprotein!interactions),! a! flanking! serine/threonine! rich! domain,! an! NR! interaction! domain!containing!multiple! LXXLL!binding!motifs,! CIterminal! to!which! are! transcriptional!activation!domain!1!(AD1),!the!interaction!site!for!CREBIbinding!protein!and!p300)!and!transcription!activation!domain!2!(AD2),!the!latter!being!a!site!of!interaction!for!histone!methyltransferases)!(Moore!et!al.,!2010).!The!binding!of!the!coactivator!to!NRs!occurs!within!the!hydrophobic!pocket!of!H12!and!coIcrystalization!studies!have!shown!that!they!are!stabilised!by!the!leucine!residues!of!the!LXXLL!motif!with!the!hydrophobic! pocket! and! by! hydrogen! bonding! between! an! H3! lysine! and! a!glutamate!within!the!LXXLL!motif!(Johnson!and!O'Malley,!2012).!!Transcriptional! corepressors! act! as! abrogaters! of! agonist! activity! or! to! repress!target! gene! activity! for! the! ligand! bound! NR! in! the! absence! of! a! ligand,! e.g.! for!RARα/RXR!heterodimers.!The!related!coIrepressors,!SMRT!and!NCOR,!bind!to!ERα!in!the!presence!of!antagonists,!rather!than!in!the!unliganded!state,!and!in$vitro!data!show! that!mutations! in!αIhelices!H3!and!H5,! inhibit! this! interaction! (Huang!et!al.,!2002).! NCOR! and! SMRT! are! able! to! sit! in! the! same! AF2! binding! pocket! as! coIactivators! due! to! displacement! of! the!H12! αIhelix! by! antagonists! (Madauss! et! al.,!2007;! Xu! et! al.,! 2002).! Blocking! the! actions! of! NCOR! and! SMRT! with! specific!antibodies! promotes! the! agonist! action! of! the! active! form! of! tamoxifen! (4Ihydroxytamoxifen! (4HT))! (Lavinsky! et! al.,! 1998)! and! 4HT! acts! as! an! agonist! in!fibroblasts! developed! from! NCOR! null! mice! (Jepsen! et! al.,! 2000).! Similarly! when!NCOR! and! SMRT! are! overIexpressed! in! HEPG2! cells,! where! agonism!with! 4HT! is!
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usually! seen,! the!agonist!action!of!4HT! is! reduced.!The!effects!of! coIrepressors!on!the! ligand! independent! activity! (AF1,! DBD)! are! less! clear! (Jackson! et! al.,! 1997;!Jepsen!et!al.,!2000;!Smith!et!al.,!1997).!!NCOR! and! SMRT! interact! with! nuclear! receptors! at! the! AF2! binding! site! via! an!elongated!αIhelix,!with! the! consensus! sequence,!LxxH/IIxxxI/L,! also!known!as! the!CoRNR!box! (Hu!and!Lazar,!1999).!Other!coIrepressors,! such!as!RIP140!and!LCOR,!share! the! same! binding! motif! as! coIactivators! (LxxLL)! and! as! for! coIactivator!recruitment,! they! are! recruited! by! agonist! bound! receptors,! e.g.! estrogen! bound!ERα.! RIP140! and! LCOR! exert! their! repressive! effects! by! recruiting! coIrepressors!such! as! CIterminal! binding! protein! (CtBP),! as! well! as! DNA! and! histone!methyltransferases! (Perissi! et! al.,! 2010;!Watson! et! al.,! 2012).! As! they! bind! in! the!same! manner! as! coIactivators! such! as! SRC1! and! AIB1,! it! is! unclear! as! to! what!mechanisms! determine! binding! of! coIactivators! or! these! coIrepressors.! However,!detailed! chromatin! immunoprecipitation! (ChIP)! studies! for! ERα! binding! at! the!estrogenIresponsive!pS2!gene!demonstrated!cyclical!association!and!dissociation!of!ERα!that!was!accompanied!by!cyclical!recruitment!and!dissociation!of!coIactivators!and! RNA! polymerase! II! (PolII)! and! PolIIIassociated! factors.! These! cyclical! events!were!accompanied!by!histone!acetylation!and!methylation!events! that! accompany!transcription!initiation!and!which!are!required!at!gene!promoters,!for!transcription!to!occur.!Again!histone!acetylation!and!methylation!were!cyclical,!indicating!that!coIactivators!and!coIrepressors!are!recruited!to!estrogen!responsive!genes!in!a!cyclical!manner,!with!the!cycles!of!coIactivator!recruitment!and!histone!modification!being!critical! for! regulation! of! target! gene! expression! (Metivier! et! al.,! 2003;! Reid! et! al.,!2003).!!!
1.2.3&ERα&Ligands&and&Modulators&&Ligand! specific! interaction! by! ERα! is! achieved! through! a! combination! of! specific!hydrogen! bonds! and! hydrophobic! residues! that! line! the! LBD.! The! specificity! for!
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estrogen!over!other!endogenous!steroidal!hormones!relates! to! the!extensive!polar!and! nonIpolar! interactions! allowing! estrogen! to! bind!with! subInanomolar! affinity!(Brzozowski! et! al.,! 1997).! Estrogen! is! relatively! small! in! comparison! with! the!binding!area!(245Å!versus!450Å),!so!the!size!of!the!ERα!LBD!also!allows!binding!of!other,! non! steroidal! compounds! (Brzozowski! et! al.,! 1997).! The! reason! for! the!relatively! large! size! of! the! binding!pocket! is! not! definitively! known!but! it!may!be!that!there!are!other,!as!yet!undiscovered,!ERα!ligands!or!modulators.!!Selective!ERα!modulators,!such!as!raloxifene!and!tamoxifen!bind!at!the!same!site!as!estrogen! but! differ! by! displacing! H12! due! to! their! structurally! distinct! long! side!chain,!which! is! too! long! to! be! contained!within! the! ligand!binding! pocket! (Figure!1.4).!!
Figure' 1.4' The' repositioning' of' Helix' 12' in' the' ER' LBD' by' SERM'





H12! is! essential! to! the! ability! of! the! AFI2! to! interact! with! coIactivators.! Loss! or!mutation!in!this!area!has!been!shown!to!result!in!a!loss!of!responsiveness!to!ligand!(Danielian! et! al.,! 1992).! Although! H12! is! the! main! αIhelix! involved,! mutational!analyses!also!suggest!that!H3,!H5/6!and!H11!are!important!in!ligand!binding!in!ERα!and!other!NRs! (Henttu!et!al.,! 1997;!Pakdel!et! al.,! 1993).!On!estrogen! (E2)!binding!H12!sits!over!the!binding!cavity!generating!a!groove!on!AFI2!enabling!the!binding!of!coIactivators.! This! binding! groove! is! formed! by! H3,! H4,! H5! and! H12.! Cofactor!binding!is!stabilised!by!a!charge!clamp!with!a!glutamic!acid!residue!in!H12!(Glu542)!and! a! lysine! at! the! C! terminal! end! of! H3! (Lys362)! (Nolte! et! al.,! 1998;! Pike! et! al.,!2000).!Binding!of!Raloxifene,! displaces!H12,! thus! changing! the! topography!of! this!binding!groove!and!enabling!coIrepressor!recruitment!(Pike!et!al.,!2000).!Tamoxifen!competitively!binds!to!the!ER!LBD!AF2,!to!inhibit!ERα!activity!in!breast!cancer!cells.!However,! tamoxifen! has! estrogenIlike! (agonist)! activity! in! many! other! estrogen!target!tissues,!including!bone,!brain!and!the!endometrium.!This!tissue!selectivity!of!tamoxifen! and! related! antiIestrogens! has! led! to! their! being! named! selective!estrogen! receptor! modulators,! or! SERMs.! The! mechanism! behind! this! tissue!diversity! is! multifactorial,! poorly! understood! and! and! may! be! important! in! the!development! of! endocrine! resistance.! One! possible! mechanism! underlying! the!tissueIspecific!agonist!or!antagonist!activity!of!SERMs!is!differences!in!relative!levels!of!coactivators!and!corepressors!(Shang!and!Brown,!2002).!In!agreement!with!this!model,!SRC1!coactivator!levels!are!high!in!the!Ishikawa!(uterine!carcinoma)!cell!line!and! low! in!MCF7!(breast!carcinoma)!cells!where! tamoxifen!acts!as!an!agonist!and!antagonist! respectively.! RNA! interference! mediated! reduction! in! SRC1! levels! in!Ishikawa! cells! resulted! in! ERα! mediated! recruitment! of! the! coIrepressors!NCOR/SMRT! to!ERα! target! genes! and! tamoxifen!no! longer!behaved!as! an! agonist.!Knockdown! of! NCOR/SMRT! in! MCF7! cells! resulted! in! tamoxifen! behaving! as! an!agonist! (Jepsen! et! al.,! 2000).! In! both! HepG2! and! Hela! cell! lines! the! over!expression/transfection! of! SMRT! inhibits! ERα! basal! activity! and! attenuates! the!agonism!of!4HT!by!70%.!SRC1!overIexpression!does!not!rescue!SMRT!inhibition!of!4HT! agonism! (Smith! et! al.,! 1997).! A! more! recent! study! using! chromatin!immunoprecipitation! (ChIP)! with! promoter! microarray! hybridization! in! breast!
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cancer!T47D!and!endometrial!cancer!ECC1!cell!lines!also!confirmed!the!above!data,!showing!that!differential!coIfactor!recruitment!altered!the!phenotype!of!tamoxifen!i.e.!over!expression!of!SRCI1!or!SMRT!altered!the!transcriptional!action!of!tamoxifen!on!a!number!of!target!genes!(Romano!et!al.,!2010).!In!nude!mice!transplanted!with!MCF7! cells! and! then! treated! over! a! prolonged! period! of! time! with! tamoxifen!resulted! in! a! tamoxifen! resistant! tumour!with! low! levels! of!NcoR! (Lavinsky! et! al.,!1998).!Clinical!data!also!supports!this,!with!breast!tumours!with!low!levels!of!NcoR!or!negative!for!SMRT!being!associated!with!a!short!disease!free!survival!(DFS)!and!shortened!DFS!and!overall! survival! (OS),! respectively! (Girault! et! al.,! 2003)! (Green!and!Carroll,!2007).!!!The! crosstalk! between! cell! surface! receptor! driven! signalling! pathways! and!transcriptional!cofactors!are!also!likely!to!play!a!role!in!the!mechanism!of!action!of!SERMs!and!the!development!of!resistance.!This!is!still!poorly!delineated!but!can!be!seen!in!clinical!outcome!data.!SRC1!(NCOA1)!is!overIexpressed!in!19I29%!of!breast!tumours! and! high! expression! correlates! with! ERBB2! expression,! lymph! node!positivity,!disease! recurrence,! and!poor!DFS! (Fleming!et! al.,! 2004a;!Fleming!et! al.,!2004b;! Hudelist! et! al.,! 2003;! Myers! et! al.,! 2004).! In$ vitro! data! show! that! overIexpression!of!SRC1!increases!cell!growth!in!MCF7!cells!treated!with!estrogen!(Tai!et!al.,! 2000)! and! knockdown! decreases! expression! of! estrogen! responsive! genes!(Cavarretta! et! al.,! 2002),! ERBB2! expression,! Akt! activation! and! CSF1! expression!(Wang! et! al.,! 2009).! There! is! less! data! available! for! SRC2! (TIF2! GRIP1! NCOA2),!however!expression!has!been!shown!to!correlate!with!cyclin!D1!expression!in!ERα+!breast! tumours! and! in$ vitro,! knockdown! of! SRC2! reduces! estrogen! induced! cell!proliferation! and! target! gene! expression! (Cavarretta! et! al.,! 2002;! Girault! et! al.,!2003).! Both! SRC1! and! SRC2! may! act! via! induction! of! CXCL12! (Kishimoto! et! al.,!2005).! !The!SRC3! (AIB1,!RAC3,!ACTR,!TRAM1,!NCOA3,!p/CIP)!gene!was!originally!identified! by! cloning! genes! in! a! region! of! the! genome! amplified! in! approximately!10%! of! breast! tumours! (Anzick! et! al.,! 1997).! AIB1! protein! expression! has! been!reported!to!be!elevated!in!9.8%!and!20%!of!cases!in!two!different!tumour!cohorts,!
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with! overIexpression! again! correlating! with! larger! tumour! size,! higher! grade,!poorer!DFS!and!tamoxifen!resistance!(Anzick!et!al.,!1997;!Bouras!et!al.,!2001;!Girault!et! al.,! 2003;!Hudelist! et! al.,! 2003;!List! et! al.,! 2001;!Osborne!et! al.,! 2003;!Qin!et! al.,!2008;!Zhao!et!al.,!2003).!AIB1!and!HER2,!EGFR!or!HER3!coexpression!is!associated!with!a!poor!tamoxifen!response!(Kirkegaard!et!al.,!2007).!!Another!mechanism!advanced!for!the!tissue!specificity!of!SERMs!is!that!the!relative!contribution! of! AF1! and! AF2! in! different! tissues! is! important! for! agonist! or!antagonist!activity,!with!AF1!activity!associated!with!the!agonist!action!of!tamoxifen!and! lack!of!AF1!activity!being! linked! to!antagonism!by! tamoxifen!(Mahfoudi!et!al.,!1995).!In!support!of!this,!in$vivo!studies!using!ERα!knockout!mice,!mice!lacking!the!ERαIAF1!and!mice!lacking!AF2!have!been!used!to!demonstrate!the!tissueIselective!importance! of! the! two! activation! functions.! For! example,! AF1! is! required! for!estrogen! responses! in! trabecular,! but!not! in! cortical! bone! (Borjesson! et! al.,! 2011)!Whether!AF1!activity!is!important!in!SRC1!recruitment!in!this!context!is!unexplored,!although!SRC1!can!be!recruited!to!the!ERα!AF1!(Webb!et!al.,!1998).!!Fulvestrant!and!the!related!compound!ICI164,384!binds!to! the!LBD!to! impair!ERα!dimerization,!promotes!ERα!export! from!the!nucleus!and! its!degradation!(Dauvois!et!al.,!1993;!Parker,!1993;!Parker!et!al.,!1993).!AntiIestrogens!in!this!class!have!been!named! selective! estrogen! receptor! downregulators! (SERD)! and! fulvestrantIbound!ERα!also!does!not!activate!AF1!or!AF2!(Osborne!et!al.,!2004).!!!In! view!of! the! evidence! of! the! shift! in! cofactor! recruitment! in! tamoxifen! resistant!breast!cancer!the!manipulation!of!the!cofactor/ERα!interaction!has!been!identified!as! an! attractive! potential! target! for! therapeutic! benefit! via! the! development! of!peptidomimetics.! Treatment! with! LXXLL! motif! containing! peptides! would!potentially! block! coIactivator! recruitment! by! competition! (Galande! et! al.,! 2005;!Leduc! et! al.,! 2003;! McDonnell! et! al.,! 2000).! However,! peptides! are! difficult! to!
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administer! clinically! due! to! proteolytic! degradation! (Gentilucci! et! al.,! 2010)! and!poor!cell!permeability.!Work!on!cell!permeable!peptides!targeting!ERαIcoactivator!interactions! began! with! the! development! of! thioether! side! chain! cyclization! as! a!means!of!providing!a! redox! stable! isoteric! replacement! for! the! cystine!disulphide.!Peptides!with!disulphide! linkages! are!potent! inhibitors! in$ vitro;! however! they! are!easily!cleaved!by!intracellular!glutathione!(Galande!et!al.,!2004).!This!work!has!not!progressed! further! to! date.! Carraz! et! al! designed! synthetic! cellIpermeable! LXXLL!peptide!probes!using! a!nonaIarginine! tag! and!biotin! to! enable!direct! visualization!with! confocal! microscopy,! showing! both! direct! inhibition! of! ERαIcoactivator!interaction! as! well! as! sequestration! to! the! nucleolus! in! U2OS! cells! transiently!transfected!with!full! length!ERα,!thereby!preventing!interaction!with!EREs!(Carraz!et! al.,! 2009).! The! nucleolar! sequestration! is! an! additional! property! of! the! nonaIarginine!tag.!!Small!molecule! inhibitors! (CBIs)! targeting! ERαIcoactivator! interactions!were! first!published!by! the!Katzenellenbogen! laboratory!using! alkyl! substituted!pyrimidines!which!mimic!the!tether!sites!of!the!three!leucines!on!the!LXXLL!coactivator!binding!motif!with!leucine!like!substituents.!These!compounds!have!shown!high!affinity!in!in$







• Crosstalk! between! growth! factors/cytokine! driven! signal! transduction!pathways.!!!The!retention!of!a!functional!ERα!in!over!50%!of!patients!tested!shows!that!a!change!in!ERα!expression! is!not! the!main!cause!of!endocrine!resistance! in!the!majority!of!patients!treated!with!tamoxifen!(Johnston!et!al.,!1997).!This!is!confirmed!by!clinical!data! and! routine!practice! showing! a! further! clinical! response! to! second! and! third!line!hormone! therapies! such!as! faslodex!and!aromatase! inhibitors! (Dowsett! et! al.,!2005).!Mutations!of!ERα!in!in!vitro!data!were!discussed!and!published!15!years!ago!however!the!relative!significance!of!these!mutations!in!clinical!specimens!has!taken!much!longer!to!confirm!due!to!issues!in!detection!methods!(Fuqua!et!al.,!2014).!The!Cancer!Genome!Atlas!(TCGA)!showed!that!significant!breast!cancer!mutations!occur!in!only!aproximately!1I5%!cases!(Conway!et!al.,!2007;!Fuqua!et!al.,!2000;!Koduri!et!al.,!2000;!Stephens!et!al.,!2012).! It!has!since!been!discovered!that!high!throughput!sequencing!is!unable!to!detect!K303R!(lysine!303!to!arginine)!the!somatic!mutation!in!ERα!first!reported!in!2000!by!Fuqua!et!al.!This!mutation!was!shown!to!occur!in!one! third! of! premalignant! breast! hyperplasia! specimens! and! half! of! invasive!carcinomas!(Fuqua!et!al.,!2000)!and!the!consequential!activation!at!S305!in!ERα!has!been! shown! to! occur! in! a! preclinical! model! of! aromatase! inhibitor! resistance!(Barone! et! al.,! 2009).!Other!ERα!mutations! linked! to! endocrine! resistance! include!Y537! (to! asparginine)! shown! in! 1/30! patients! which! resulted! in! a! constitutively!
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active!ERα!with!resistance!to!hormonal!therapies.!Phosphorylation!at!this!site!leads!to!poor!clinical!outcomes!in!patients!treated!with!tamoxifen!(Skliris!et!al.,!2010).!!Similarly!Y537S!mutation!was!found!in!3/15!xenograft!maintained!tumour!samples!again! showing! ! constitutively! active! ERα! with! raised! PgR! levels! maintaining!estrogen! responsiveness! (Li! et! al.,! 2013)! .! 5/11! and! 9/36! metastatic! tumour!samples! in! separate! series! (Robinson! et! al.,! 2013;! Toy! et! al.,! 2013)! are! further!evidence! to! support! the! frequency! of! this!mutation.! Less! frequently! E380! in! ERα!LBD!(Robinson!et!al.,!2013)!and!S118!(Piccart!M!et!al.,!2013;!Sarwar!et!al.,!2006).!Over! the! last! 15! years,!with! improvements! in! detection!methods,! it! has! therefore!become! clear! that! ERα!mutations!do!play! a! role! in!mechanisms!of! resistance.! For!patients! that!do! lose!ERα,! the!mechanisms! for! this! include!methylation!of! the!CpG!islands!in!the!promoter!regions!of!ERα!(Ottaviano!et!al.,!1994).!!Cofactor! expression! and! ratios! of! expression! in! different! tissue! types! is! discussed!above! and! certainly! plays! a! role! in! the! mechanism! of! action! and! acquisition! of!resistance!to!SERMs.!!The! phosphorylation! of! ERα! at! Ser118! in! AF1! leads! to! ligand! independent!transcription!of!ERα!regulated!genes!(Chen!et!al.,!2002).!This!has!been!shown!to!be!due! to! growth! factor! dependent! activation! of! the! MAPK/PI3K/Akt! pathways.!Similarly,! activation! via! overexpression! of! transmembrane!peptide! growth! factors!such!as!EGFR!and!HER2! leads! to!cross! talk!with!ERα!signalling! (Chen!et!al.,!2002;!Hutcheson!et!al.,!2003;!Knowlden!et!al.,!2003).!MCF7!cells!that!have!been!grown!in!estrogen! deprived! conditions! over! a! sustained! period! of! time! demonstrate!heightened!estrogen!sensitivity,!ongoing! transcription!of!ERα!regulated!genes!and!an! increase! in!peptide!growth! factor!activity!(Hutcheson!et!al.,!2003;!Knowlden!et!al.,!2003;!Martin!et!al.,!2003;!Santen!et!al.,!2008).!Similarly!in!our!own!laboratory!the!transient! overexpression! of! ERα! in! MCF7! cells! grown! in! estrogen! deprived!conditions! led! to! estrogen! independence! for! growth,! ongoing! transcription! of!
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estrogen! regulated! genes! and! an! increase! in! PIAKT! levels! with! an! increased!sensitivity!to!PI3K!inhibitor!(LY294002)!(Tolhurst!et!al.,!2010).!The!blockade!of!the!EGFR/HER2! pathways! has! been! shown! to! resensitise! Her2! overexpressing!xenograft!models!to!endocrine!treatment!and!prevent!the!development!of!endocrine!resistance!(Arpino!et!al.,!2007;!Gee!et!al.,!2003;!Schiff!et!al.,!2004;!Shou!et!al.,!2004).!Our!knowledge!of! the! importance!of! crosstalk! in! the!development!of! resistance! to!endocrine!treatments!!led!to!disappointing!initial!clinical!phase!1/2!trials!combining!endocrine!therapy!with!an!EGFR!inhibitor!(Gefitinib)!in!ERα!positive!patients!with!metastatic! breast! cancer,! however,! none! of! these! trials! selected! according! to!EGFR/HER2!status.!!(Mita!et!al.,!2005;!Osborne!et!al.,!2011).!In!aromatase!inhibitor!naïve! patients! with! ! newly! diagnosed! metastatic! breast! cancer! the! addition! of!gefitinib!did!show!a!statistical!advantage!in!PFS!(8.4!months!versus!14.7!months,!HR!0.55)! (Cristofanilli! et! al.,! 2010)! and! in! the! neoadjuvant! setting! two! phase! 2! trials!have! been! reported! (Polychronis! et! al.,! 2005;! Smith! et! al.,! 2007b),! with! only! the!study! that! selected! for! EGFR! status! showing! an! improvement! in! the! endpoint,!suppression!of!Ki67!(Polychronis!et!al.,!2005).!!!Patients! with! HER2! positive! tumours! are! more! likely! to! have! increased! de$ novo!resistance! to! endocrine! treatment! due! to! the! repression! of! ERα! by! activation! of!MAPK!pathways!(Oh!et!al.,!2001).!The!addition!of!HER2!inhibitors!(Trastuzumab)!or!a!dual!EGFR/HER2!inhibitor!(Lapatanib)!in!a!metastatic!setting!resulted!in!at!least!a!doubling!of!PFS! in! two!phase!3! trials! (Johnston!et!al.,!2009;!Kaufman!et!al.,!2009)!and!in!a!third!clinical!trial!showed!a!non!statistically!significant!improvement!in!PFS!(Huober!et!al.,!2012).!!!Similarly,! in! HER2! negative! patients,! combining! endocrine! treatment! with!everolimus,! an! MTOR! inhibitor,! ! phase! 2! (TAMRAD)! and! phase! 3! (BOLEROI2)!clinical! trials! confirmed!a! significant! improvement! in!PFS! in!patients! treated!with!either! tamoxifen! or! exemestane! respectively,! compared! with! hormone! treatment!
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&LRHI1! is! a!member! of! the! nuclear! receptor! superfamily! (Figure! 1.5).! Specifically,!LRHI1!belongs!to!the!fushiItarazu!1!subfamily!(NR5A)!of!nuclear!receptors!(Laudet,!1997).! The! fushiItarazu! 1! subfamily! (FtzIF1)! is! characterized! by! a! 26! amino! acid!FtzIF1!box!extension!CIterminal!to!the!DNA!binding!domain!and!the!ability!to!bind!DNA!response!elements!as!a!monomer!(Ueda!et!al.,!1992).!There!are!four!identified!members,! NR5A1I4,! and! the! evolutionary! importance! of! members! of! the! ftzIF1!subfamily! is!shown!by!conservation!from!caenorhabditis!elegans!(round!worm)!to!humans!(Asahina!et!al.,!2000).!!LRHI1!has!a!number!of!alternative!names:!Pancreas!hormone! receptor! (PHRI1),! Fetoprotein! transcription! factor! (FTF),! Human! B1Ibinding!factor!(hB1F)!and!Cyp7A1!promoter!binding!factor!(CPF).!LRHI1!orthologs!are!found!in!zebrafish,!xenopus,!chick,!mouse,!rat,!horse!and!human.!Human!LRHI1!
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shares! structural! homology! with! murine! LRHI1! (94%! within! the! DNA! binding!domain!and!89%!within!the!ligand!binding!domain)!and!with!human!SF1!(NR5A1,!89%!within! the!DNA!binding!domain!and!65%!within! the! ligand!binding!domain)!(Fayard!et!al.,!2004).!The!LRHI1!gene!is!located!on!chromosome!1!(C1q32.11)!and!codes! for! a! 150! kilobase! gene! consisting! of! 8! exons! (Zhang! et! al.,! 2001).! At! the!mRNA! level! there! are! four! identified! isoforms! arising! from! alternative! splicing!events!(Thiruchelvam!et!al.,!2011).!!





































































1.3.3&Expression&and&Function!!LRHI1!is!expressed!in!healthy!endodermal!tissues!such!as!the!liver,!pancreas!(Li!et!al.,! 1998;! Nitta! et! al.,! 1999)! and! intestine! (Botrugno! et! al.,! 2004),! steroidogenic!tissues! such! as! adrenal! (Wang! et! al.,! 2001),! ovary,! testis! (Sirianni! et! al.,! 2002)! as!well!as!preadipocytes!(Clyne!et!al.,!2002)!and!embryonic!stem!cells!(Gu!et!al.,!2005;!Heng! et! al.,! 2010;! Wagner! et! al.,! 2010).! It! has! a! diverse! number! of! functions!including!a!key!role!in!development,!metabolism,!proliferation,!steroidogenesis!and,!more!recently,!a!role!in!immune!response!has!been!identified.!!!!!
1.3.3.1"Roles"in"Development"and"Stem"Cells"Embryonal! stem! cells! strongly! express! LRHI1.! This! expression! has! been! carefully!studied!and!mapped!throughout!murine!embryogenesis.!LRHI1!is!present!in!all!cells!at! the!morula!stage!(E2.5=!embryonal!day!2.5)!but!by!E3.5! is! just! in! the! inner!cell!mass!and!trophoectoderm!of!the!blastocyst!stage,!limiting!to!the!visceral!endoderm!by!the!egg!cylinder!stage!(E5.5).!Throughout!gastrulation!(E6.5I7.5),!it!is!present!in!the!endoderm!and!primitive!mesoderm!and!by!mid!gestation!(E8I15)!is!abundantly!present!in!the!endodermal!tissues;!liver,!pancreas,!intestine,!bone!and!some!parts!of!the!brain.!A!similar!pattern!of!expression!then!persists! into!adulthood!in!the! liver,!exocrine!pancreas,!ovary!and! intestine! (FernandezIMarcos!et!al.,!2011;!Pare!et!al.,!2004;!Rausa!et!al.,!1999).!!!LRHI1!deficient!mice!embryos!die!at!day!E6.5!(Gu!et!al.,!2005;!Pare!et!al.,!2004)!due!to!a!deficiency! in!OCT4,! an! important!pluripotency! factor! in! embryonic! stem!cells!(Gu!et!al.,!2005).!OCT4!deficiency!in!mice!embryos!is!also!associated!with!lethality!due! to!disruption!of!differentiation! (Nichols!et!al.,!1998).!Furthermore,!LRHI1!has!been! shown! to! also! regulate! Nanog,! a! gene! essential! for! embryo! development!(Wagner!et!al.,!2010).!!
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At!later!stages!of!embryogenesis!LRHI1!plays!a!role!in!liver!development,!regulating!early!expression!of!AFP!and!binding!to!the!promoters!of!HNFI1α,!HNFI3ß!and!HNFI4alpha! hepatic! nuclear! factors! involved! in! embryonic! liver! development!(FernandezIMarcos!et!al.,!2011;!Galarneau!et!al.,!1996).!!
1.3.3.2"Metabolism"In!the!adult!liver,!LRHI1!plays!an!important!functional!role!in!bile!acid!homeostasis!and! reverse! cholesterol! transport.! In! humans,! bile! acids! are! important! for! the!absorption! of! fat! soluble! vitamins! and! dietary! fat! from! the! intestine,! and! for! the!elimination!of!cholesterol!by!direct!excretion!into!bile.!Most!of!our!understanding!of!the! role! that! LRHI1! plays! in! this! process! comes! from!mice! studies! and! there! are!significant! interspecies! variations! in! the! regulation! of! this! key! process.! The!main!difference!between!humans!and!mice!models!is!that!in!mice!excess!cholesterol!can!be! converted! into! bile! acids.! Humans! do! not! have! the! ability! to! divert! excess!cholesterol! into!bile!acids!and! therefore!have!a!much!greater! tendancy! to!develop!hypercholesterolaemia!(Goodwin!et!al.,!2003).!In!mice,!this!conversion!occurs!by!a!classical!pathway!that!increases!the!synthesis!of!oxysterols,!thereby!activating!LXRα!and! inducing! Cyp7A1! (Lu! et! al.,! 2000)! using! LRHI1! as! a! competence! factor.!Conversion!can!also!occur!by!the!acidic!pathway!via!Cyp27.!Cyp8B1!is!the!enzyme!crucial!for!synthesis!of!more!hydrophobic!bile!acids,!such!as!cholic!acid!(Fayard!et!al.,! 2004).! ! Hydrophobic! bile! acids! repress! both! Cyp7A1! and! Cyp8B1,! partly!mediated!by!FXR!which! induces!SHP,!with!SHP!in!turn!repressing!LRHI1!and!LXR,!and!consequently!repressing!Cyp7A1!and!Cyp8B1!transcription!(Nitta!et!al.,!1999).!!!The!pancreas!produces!the!enzyme,!carboxyl!ester!lipase!(CEL),!which!catalyses!the!hydrolysis!of!cholesteryl!esters!in!the!intestine,!an!important!step!in!the!absorption!of! dietary! cholesterol! from! the! intestine! and! the! assembly! and! secretion! of!chylomicrons!by!enterocytes! (Hui!and!Howles,!2002).!CEL!has!an!LRHI1!response!element! in! its! gene! promotor! and! is! coIexpressed! with! LRHI1! in! the! exocrine!
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pancreas! (Fayard! et! al.,! 2003),! implicating! LRHI1! in! the! regulation! of! CEL!expression.!!!In!the!enterohepatic!circulation!at!least!two!other!enzymes/genes!have!been!shown!to!be!regulated!by!LRHI1! in!the!control!of!bile!acid!homeostasis;!MRP3!and!ABST.!MRP3!(multi!drug!resistant!protein!3,!or!ABCC3)! is!expressed! in!both!murine!and!human! intestine! and! liver.! MRP3! is! involved! with! the! control! of! intracellular!accumulation! of! bile! acids! by! secretion! into! portal! blood! from! enterocytes! and!hepatocytes!(Bohan!et!al.,!2003;!Inokuchi!et!al.,!2001).!LRHI1!regulation!appears!to!be!mediated!by!two!adjacent!LRHI1!binding!sites! in! the!MRP3!gene!promoter!and!requires! TNFIα! (Bohan! et! al.,! 2003;! Inokuchi! et! al.,! 2001).! ASBT! (apical! sodiumIdependant!BA!transporter)!actively!transports!bile!acids!through!ileum!enterocytes!thereby!mediating!intestinal!reIuptake!of!bile!acids.!Again!in!the!mouse!model,!this!is!mediated!by!LRHI1!via!cyp7A1.!!!Reverse! cholesterol! transport! is! the! process! by! which! high! density! lipoproteins!transport! cholesterol! from! peripheral! tissue! to! the! liver! for! excretion.! SRIB1!(scavenger! receptor! type! B1)! and! CETP! (cholesterylIesterItransfer! protein)! have!both! been! identified! as! LRHI1! regulated! genes.! ABCA1! (ATPIbindingIcassette!transporter!A1),! is!also!known!as! the!cholesterol!efflux! regulatory!protein! (CERP)!and! as! its! alternative! name! suggests,! is! involved! with! the! efflux! of! cellular!cholesterol!to!apolipoprotein!to!form!high!density!lipoproteins!(HDLs).!A!mutation!in!this!gene!causes!Tangier’s!Disease!in!humans!which!results!in!very!low!levels!of!HDLs!(Oram!and!Vaughan,!2000;!Ordovas,!2000).!Following!the!formation!of!HDLs,!a!process!of!remodeling!occurs!via!CETP!and!the!HDL!is!then!circulated!back!to!the!liver!via!SRIB1.!CETP!transfers!cholesteryl!esters!from!HDL!to!triglyceride!rich!very!low!density! lipoproteins!(vLDL)!and! low!density! lipoproteins!(LDLs)!that!are!then!cleared!by!the!liver.!The!induction!of!CETP!is!prompted!by!high!levels!of!cholesterol,!mediated! by! LXR! and! potentiated! by! LRHI1! (Luo! et! al.,! 2001).! SRIB1! mediates!
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1.3.3.3"Proliferation"LRHI1!is!highly!expressed!in!proliferative!tissues!(crypts)!of!the!intestine,!lost!with!differentiation! and! there! is! animal! and! cell! based! evidence! showing! that! it! is!involved!with!coordinating!intestinal!cell!renewal!via!cell!cycle!regulation!(Botrugno!et!al.,!2004;!Mueller!et!al.,!2006).!!!The! role! of! LRHI1! in! promoting! cell! proliferation! has! been! demonstrated! by! the!increased! growth! of! two! cell! lines! (with! low! basal! expression! of! LRHI1),! when!transfected! with! both! mouse! and! human! LRHI1,! and! similarly! in! a! tet! inducible!system.! Animal! models! show! a! 20x! faster! growth! of! LRHI1! positive! tumours! in!athymic! mice! injected! with! LTPAIhLRHI1! (murine! pancreatic! cells! retrovirally!transduced! with! human! LRHI1)! cells! compared! with! control.! The! specific! role! of!LRHI1! in! the!cell! cycle!was!confirmed! following!an!observed! increase! in! the!BrdU!index!of!DNA!synthesis.!At!both!mRNA!and!protein! level,! growth!arrested! (serum!starved)!LRHI1!positive!cells,!on!release!from!growth!arrest!(by!addition!of!serum)!resulted! in! an! induction! of! cyclin! D1! and! E1! after! four! hours.! This! effect! was!confirmed!with!siRNAImediated!LRHI1!knockdown!(Botrugno!et!al.,!2004).!!!Within!the!intestine!cellular!proliferation!occurs!mainly!in!the!crypts!of!Lieberkuhn.!Mouse!models!with! a!heterozygous! loss!of! LRHI1! (I/+)! in! the! intestine!have!40%!reduction!in!mRNA!in!the!duodenum,! ileum!and!colon.!Although!no!morphological!differences! could! be! detected,! examination! of! the! crypts! showed! that! they! were!much!shorter!in!the!heterozygous!I/+!mouse!model!than!in!wildItype!mice,!implying!that!proliferation!is!reduced.!To!confirm!this!Cyclin!D1,!cyclin!E1,!cIMyc,!BrdU,!Ki67!and! H3! (marker! of! chromosomal! condensation)! were! also! assessed! and! were!reduced!(Botrugno!et!al.,!2004).!The!action!of!LRHI1! in! regulating!proliferation! in!the!crypts!involves!direct!regulation!of!gene!expression!by!binding!of!LRHI1!to!DNA!response!elements!in!the!cyclin!E1!gene!promoter!and!the!recruitment!of!ßIcatenin!through!a!direct! interaction!between!LRHI1!and!ßIcatenin!(Botrugno!et!al.,!2004).!
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Additionally,!however,!LRHI1!is!recruited!to!Tcf4!binding!sites!in!the!cyclin!D1!and!cIMyc!genes!by!interaction!with!ßIcatenin.!Thus,!interaction!between!LRHI1!and!ßIcatenin!appears!to!be!critical,!at!least!for!promoting!intestinal!proliferation.!!This! data! has! been! confirmed! to! some! extent! with! alternative! mouse! models! in!which!LRHI1!was!specifically!knocked!out!in!the!intestine!(Lee!et!al.,!2008).!In!this!model,!mice!with!no! intestinal!LRHI1!expression!had! reduced! cyclin!E1!and! cMyc!mRNA! levels.! However,! in! this!model! there!was! no! detectable! difference! in! BrdU!proliferation!index!or!Cyclin!D1!levels!in!the!LRHI1!knockout!cells.!!
1.3.3.4"Steroidogenesis""Steroid!hormones!are!synthesized!from!cholesterol.!As!described!in!section!1.3.4.2,!LRHI1! plays! an! important! role! in! reverse! cholesterol! transport! and! therefore!contributes!indirectly!to!the!many!cellular!functions!of!cholesterol!including!steroid!hormone!biosynthesis.!LRHI1!also!plays!a!direct!and!critical!role!in!reproduction.!It!is!expressed!in!the!granulosa!and!luteal!cells!of!the!ovary!and!mice!lacking!LRHI1!in!granulosa! cells! are! sterile! due! to! anovulation! (Duggavathi! et! al.,! 2008).! This! is!thought! to!be!due!to!dysregulation!of! the!prostaglandin!and!hyaluronan!pathways!and!key!regulators! in! the!progesterone!pathway!because!of! reduced!expression!of!direct! LRHI1! targets! such! as! StAR! and! Cyp11A1! (cholesterolIsideIchainIcleavage!protein)!(Duggavathi!et!al.,!2008;!Sirianni!et!al.,!2002;!Stocco,!2001).!StAR!controls!the!movement!of!cholesterol!to!Cyp11A1,!the!rate!limiting!enzyme!in!the!conversion!of! cholesterol! to! pregnenolone! (Stocco,! 2001).! HSD3B2! (3βIhydroxysteroid!dehydrogenase! type! II),! which! converts! pregnenolone! in! the! corpus! luteum! to!progesterone! is! also! regulated! by! LRHI1! (Peng! et! al.,! 2003).! Progesterone! can! be!catalysed!by!17αIhydroxylase!into!androgens!such!as!testosterone!which!in!turn!are!converted,! in! the!ovarian! follicle,! to!estrogen!by!Cyp19!(aromatase)! (Fayard!et!al.,!2004).! Cholesterol! is! delivered! to! steroidogenic! tissues! by! SRIB1,!which! is! LRHI1!regulated!(section!1.3.4.2).!Cyp19!is!widely!expressed!in!both!ovarian!granulosa!and!
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in! luteal! cells! and! CYP19! expression! follows! the! onset! of! expression! of! LRHI1,!suggesting!that!Cyp19!expression!is!regulated!by!LRHI1!(Hinshelwood!et!al.,!2003)!(see!also!section!1.3.6.1).!!!With! further! regard! to! steroidogenesis,! LRHI1! has! also! been! implicated! in! the!regulation!of!extraIadrenal!glucocorticoid!production!in!the!intestine.!The!intestine!synthesises! and! secretes! glucocorticoids! in! a! paracrine! manner! to! regulate! local!immune!cell!homeostasis!(Noti!et!al.,!2009).!This!was!discovered!by!injecting!mice!with! a! CD3! antibody,! triggering! TIcell! activation,! which! induced! a! counter!regulatory! immune! response! in! intestinal! epithelial! cells,! strongly! inducing!expression! of! cyp11A1! and! cyp11B1.! Cyp11A1! is! the! enzyme! responsible! for! the!steroidogenic! cholesterol! side! chain! cleavage! enzyme! p450scc! that! converts!cholesterol! to!pregnalone.!Cyp11B1!(11ßIhydroxylase)!catalyses! the!conversion!of!deoxycorticosterone!into!corticosterone.!!This!response!appears!to!be!limited!to!the!basal!compartment!of!the!intestinal!mucosa!(Cima!et!al.,!2004)!where!the!crypts!are!located!and!where!LRH! is!predominantly!expressed.!LRHI1!has!been! shown! to!be!essential! for! local! production! of! corticosterone! via! regulation! of! Cyp11A1! and!cyp11B1!(Mueller!et!al.,!2006).!!




in$ vivo! (Venteclef! and!Delerive,! 2007).! The! C/EBPs! are! a! family! of! leucine! zipper!transcription! factors! involved! in! the! control!of! inflammation!and!native! immunity 
(Poli, 1998). All! of! the! acute!phase! response! genes! inhibited!by!LRHI1!had!C/EBP!DNA!binding!sites!within!their!promoter!regions!and!and!transfection!experiments!showed!that!LRHI1!negatively!regulates!the!acute!phase!response!gene!expression!by!antagonising!the!C/EBP!signalling!pathway!(Venteclef!et!al.,!2006).!This!has!since!been! postulated! to! occur! by! the! SUMOylation! of! LRH,! whereby! ligand! binding!triggers! the!stabilisation!of! the!SUMOylated!LRHI1!pool!which! then! interacts!with!coIrepressor! complex! and! prevents! the! dissociation! of! the! coIrepressor! complex!from!gene!promoters!of!acute!phase!response!genes!(Venteclef!et!al.).!!!ExtraIadrenal! glucocorticoid! synthesis! regulated! by! LRHI1! in! the! intestine,! (see!previous!section),!also!adds!to!the!role!of!LRHI1!in!the!immune!system!(Coste!et!al.,!2007;!Mueller!et!al.,!2006).!!
1.3.4& LRHQ1& is& expressed& in& Breast& Cancer& and& Breast& Cancer& Associated&




1.3.4.1"LRHB1"regulation"of"Aromatase"gene"expression"In!preImenopausal!women!estrogen!production!mainly! takes!place! in! the!ovaries.!However! in! postImenopausal! women,! the!major! source! of! estrogen! is! due! to! the!conversion! of! circulating! androgens! to! estrone! or! estradiol! in! peripheral! tissues,!such! as! adipose! tissue! and! in! estrogen! target! tissues! such! as! breast,! brain,!endothelium! and! skin! (Figure! 1.9).! The! key! step! in! conversion! of! androgens! to!estrogens!is!mediated!by!the!aromatase!enzyme!(CYP19).!!














































































!LRHI1!is!also!expressed!in!cancer!associated!fibroblasts,!shown!in!experiments!at!an!mRNA! level! and!also!by! confirmatory!quantitative! IHC! in!an! independent! cell! line!panel!(Knower!et!al.,!2013).!LRHI1!knockdown!and!chromatin!immunoprecipitation!studies!show!LRHI1!directly!binds!to!a!response!element!in!aromatase!promoter!II!with! LRHI1! knockdown! resulting! in! a! decrease! in! total! aromatase! mRNA! and!forskolin/PMA!mediated!aromatase!expression!(Chand!et!al.,!2011;!Wu!et!al.,!2011).!This!confirms!previously!published!studies!using! the!mouse!preadipocyte!cell! line!(3T3IL1)!and!primary!cultures!from!human!breast!adipose!tissue!(Clyne!et!al.,!2004;!Clyne!et!al.,!2002).! !Adenoviral!overexpression!of!LRHI1,! in! the! rat! testis,! leads! to!large!increases!in!mRNA!aromatase!levels,!again!with!confirmation!of!direct!binding!of!endogenous!LRHI1!to!aromatase!PII!by!ChiP!(Sierens!et!al.,!2010).!!!
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Figure' 1.12' A' schematic' representation' of' the' PLZF;ERα' fusion'




Gene!expression!microarray!analysis!of!this!line!identified!1,627!estrogenIregulated!genes,! numbers! similar! to! those! reported! by! other! studies.! However,! only! 149! of!these!genes!were!additionally!repressed!upon!PLZFIERα!expression,!suggesting!that!these! estrogen! regulated! genes! are! especially! important! for! the! growth! of!MCFI7!cells! in! response! to! estrogen.! One! of! these! 149! genes! was! LRHI1.! This! study!identified! an! ERα! binding! site! located! 10! kb! upstream! of! the! major! LRHI1! gene!transcription!start!site!in!MCFI7!cells.!!Importantly,!these!studies!use!siRNA!mediated!LRHI1!silencing!to!demonstrate!that!LRHI1! is! required! for! estrogenIstimulated!growth!of!MCFI7! cells! (Annicotte! et! al.,!2005;! Thiruchelvam! et! al.,! 2011).! Moreover,! LRHI1! was! shown! to! regulate! ERα!expression! through! binding! to! LRHI1! binding! sites! in! the! ERα! gene! promoter!(Thiruchelvam! et! al.,! 2011),! identifying! a! positive! feedback! loop! in! which! ERα!stimulates!LRHI1!expression!and!LRHI1!in!turn!upIregulates!ERα.!Subsequent!LRHI1!ChIPIseq!in!MCFI7!cells!demonstrated!that!LRHI1!is!required!for!the!recruitment!of!ERα! to! its!binding!sites,! indicative!of! coIoperativity!between!LRHI1!and!ERα!at!ERα!target!genes!in!breast!cancer!cells!(Lai!et!al!2013).!In!addition!to!its!importance!for! the! growth!of! ERαIpositive!breast! cancer! cells,! LRHI1!has! also!been! shown! to!promote!breast!cancer!cell!motility!and!invasion!(Chand!et!al.,!2012).!!!
1.3.5& LRHQ1&Ligands&
&
1.3.5.1" LRHB1" and" SFB1" are" FtzBf1" subfamily"members" of" the" nuclear" receptor"
superfamily"that"bind"Phospholipids"" "LRHI1!and!SFI1!have!been! classed!as!orphan!nuclear! receptors!due! to! the! lack!of!identified! ligands.! However,! clues! to! potential! ligands! were! provided! by!crystallographic!determination!of!their!LBDs.!These!structures!were!generated!from!expression!of!the!LBDs!in!bacterial!cells!and!the!structures!showed!the!presence!of!bacterial!phospholipids!in!the!ligandIbinding!pocket!of!both!murine!(although!only!a!very!small!proportion!~10%)!and!human!LRHI1!LBDs!(Krylova!et!al.,!2005;!Li!et!al.,! 2005;!Ortlund! et! al.,! 2005;! Sablin! et! al.,! 2009;! Sablin! et! al.,! 2003;! Sablin! et! al.,!
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2008;!Wang!et!al.,!2005b).!Mutations!in!the!LRHI1!LBD,!that!reduced!phospholipid!binding!to!the!LBD,!inhibited!coactivator!recruitment!and!transcriptional!activity!(Li!et!al.,!2005;!Ortlund!et!al.,!2005).!What!is!not!clear!from!these!studies!is!whether!the!phospholipids!are! ligands! for! these!receptors,!or! if! the!phospholipids!are!required!simply! for! maintaining! the! structural! integrity! of! the! LBD.! However,! a! recent!publication! shows! that! phosphatidylcholines! (PC),! in! particular! dilauroyl!phosphatidylcholine! (DLPC)! and! diundecanoyl! phosphatidylcholine! (DUPC),!stimulate!LRHI1!activity!and!displace!bacterial!phospholipids!from!the!LBD!(Lee!et!al.,!2011;!Ortlund!et!al.,!2005).!These!PCs!are!dietary!lipids,!which!decrease!hepatic!steatosis!and!serum!glucose!levels!in!mouse!models!of!insulin!resistance!(Lee!et!al.,!2011)! and! which! may! therefore! be! bona$ fide! ligands! for! LRHI1.! A! subsequent!publication! confirmed! that! DLPC! (PC! 12:0I12:0,! a! medium! chain!phosphatidylcholine)! acts! as! an! LRHI1! agonist,! resulting! in! increased! binding! of!LRHI1!with!the!coactivators!SRC1!and!TIF2,!whilst!having!no!effect!on!recruitment!of! PGC1α! by! LRHI1! and! abolishing! the! interaction! of! LRHI1!with! SHP.! The! same!study! generated! LRHI1! LBD! lacking! phospholipids! in! the! LBD! by!denaturation/renaturation! (apo! LRHI1)! and! found! that! apoILRHI1,! but! not! the!DLPCIbound! LRHI1! LBD! interacted! with! high! affinity! with! the! transcriptional!corepressor!SMRT!(Musille!et!al.,!2012).!
"The!large!size!of!the!LRHI1!ligand!binding!pocket!and!the!visualization!of!bacterial!phospholipids! on! crystallography! has! led! to! the! hypothesis! that! there! are! other!endogenous!ligands!for!LRHI1!and!SFI1,!such!as!sphingolipids.!!!LRHI1!expression! is!up!regulated!by!sphingosineI1Iphosphate!(S1P)! in!MCF7!cells!in!a!PGE2!dependent!manner!by!stimulating!the!recruitment!of!LRHI1,!CREB,!C/EBP!and!PolII!to!the!LRHI1!promoter!!(Hadizadeh!et!al.,!2008).!!!Sphingosine!and! lysoIsphingomyelin!have!been!shown!to!act!on!SF1!by! increasing!the!recruitment!of!SMRT!and!decreasing!the!SF1!dependent!transcription!of!CYP17!
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reporter! constructs! (Urs! et! al.,! 2006),! however,! sphingosine! had! no! effect! on!proliferation!or!transcription!in!SF1!positive!cells!(Doghman!et!al.,!2009).!!!Sphingomyelin! is! a! structural! component! of! all! cell! membranes.! Hydrolysis! of!sphingomyelin! produces! ceramide,! which! can! be! additionally! hydrolysed! to!sphingosine.! Structurally! sphingosine! is! a! sphingolipid! comprising! of! a! longIchain!sphingoid!base!backbone,!a!polar!head!group!and!an!amide!linked!long!chain!fatty!acid.!The!phosphorylation!of!sphingosine!by!two!isoIenzymes,!sphingosine!kinase!1!and!2!(SK1!and!SK2)!produces!sphingosineI1Iphosphate!(S1P).!S1P!is!known!to!act!via! a! multitude! of! cell! signalling! pathways! especially! via! GPCRs! (Maceyka! et! al.,!2012)!inducing!cell!proliferation,!prolonging!cell!survival!and!promoting!the!release!of! proIangiogenic! cytokines.! In! murine! xenograft! models,! using! a! monoclonal!antibody!against!S1P,!tumor!invasion!is!substantially!reduced!(Visentin!et!al.,!2006).!Overexpression! of! S1P! in! NIH3T3! and! HEK293T! cell! lines! results! in! cellular!transformation!with!increased!cell!growth!and!serum!independent!survival!(Pitson!et!al.,!2005).!Elevated!levels!(2!fold!or!more)!of!sphingosine!kinase!mRNA!have!been!identified! in! a! range! of! tumours! compared!with!matched! adjacent! non! cancerous!tissue!(French!et!al.,!2003).!More!recently!S1P!has!been!confirmed!in!in!vitro!studies!to!be!important!for!tumour!progression!and!tumour!induced!haemaniogenesis!and!lymphangiogenesis!in!breast!cancer!(Nagahashi!et!al.,!2012).!!!Sphingolipids! are! important! in! the! progression! of! cancer! however! there! is! little!direct!evidence,!as!yet,!for!their!direct!role!as!ligands!for!LRHI1!and!SFI1.!!!
1.3.5.2"Atrazine"Atrazine! is! a!widely! used!herbicide,!which! causes! demasculinization,! feminisation!!and! reproductive! abnormalities! on! fish,! amphibians! and! mammals.! It! has! been!shown!to!activate!aromatase!in!an!SFI1!dependent!manner!(Fan!et!al.,!2007a;!Fan!et!al.,!2007b;!Suzawa!and!Ingraham,!2008).!The!mechanism!of!this!activation!has!not!been!confirmed.!!!
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An!initial!study!demonstrated!that!activation!by!atrazine!does!not!occur!by!binding!to!the!SFI1!LBD,!but!suggested,!via!mutational!studies,! that! it!does!occur!by!direct!binding! to! the!DBD.!The! same! study!demonstrated!proof! of! a! physical! interaction!between!SFI1!and!atrazine!by!using!a!27Mhz!quartz!crystal!microbalance!measuring!the!decrease! in! frequency!with! increasing!physical!mass! following! the! addition!of!recombinant!SFI1! to! immobilized!atrazine! (in! comparison!with!a!positive! control:!phospholipid!and!negative!control).!In!this!paper!no!activation!of!other!members!of!the!NR5A!family!was!seen,!notably!LRHI1.!!A!subsequent!paper!by!Suzawa!et!al!confirmed!that!the!activation!of!aromatase!by!SFI1! in!response!to!atrazine!but!also!showed!activation!by!LRHI1.! It!confirms!that!this!does!not!involve!the!binding!of!Atrazine!to!the!SFI1!ligand!binding!domain,!as!it!does!not!activate!a!Gal4ISFI1!LBD!fusion!construct!but!also!does!not!increase!DNA!binding! of! SFI1.! Similarly,! it! was! unable! to! displace! bound! phospholipid!(phophatidyl!glycerol)!or!an!exchanged!PIP3!ligand!present!in!the!LBD!and!atrazine!also! stimulated! SFI1! LBD! pocket!mutants.! Suzawa! et! al! hypothesise! that! atrazine!acts!indirectly!by!increasing!the!intracellular!production!of!cAMP,!phosphorylation!of!SFI1!and!by!generating!SFI1!ligands!(Suzawa!and!Ingraham,!2008).!!!
1.3.5.3"Inverse"agonists"SFB1"As!described!above,!the!SFI1!LBD!is!structurally!extremely!similar!to!the!LRHI1!LBD!(65%!amino!acid!sequence! identity).!Using!a!Receptor!Selection!and!Amplification!Technology! (RISAT)! screening! approach,! a! cellIbased! functional! assay! that! allows!the!monitoring!of!receptorIdependent!proliferative!responses,!which!is!a!technique!previously!validated!and!used!for!other!receptor!types!such!as!tyrosine!kinases!and!GPCRs,!screening!of!280,000!compounds!with!drug!like!characteristics! identified!a!SFI1!inverse!agonist!4I(heptyloxy)phenol!ACI45594!(IC50!=!50I100nM).!Analogues!with! different! alkyloxy! chain! lengths! showed! that! compound! activity! was!constrained!by!a!6I10!carbon!length!chain!(Del!Tredici!et!al.,!2008).!This!alkyl!chain,!is! noted,! by! the! authors,! to! be! a! feature! in! other! potential! SFI1! ligands! such! as!
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phosphatidylinositol!(Krylova!et!al.,!2005;!Ortlund!et!al.,!2005;!Wang!et!al.,!2005b)!and!sphingosine!(Urs!et!al.,!2006).!!Madoux! et! al! screened! 64,908! compounds! from! the!National! Institute! of! Health's!molecular! libraries! Small! Molecule! Repository! with! a! transactivation! luciferase!reporter!cellIbased!assay!using!a!chimeric!SFI1!construct!in!which!the!SF1!LBD!was!fused! to! the! GAL4! DBD! (Madoux! et! al.,! 2008).! This! screen! identified! two!isoquinolinones!with!IC50!values!of!255nM!and!760nM,!as! inhibitors!of!SFI1.!Their!inhibitory!activity!was!confirmed!in!a!reporter!gene!assay!using!fullIlength!SF1!(IC50!=!16!and!30nM).! !Moreover,! these!compounds!were!selective! for!SFI1!over!LRHI1!Subsequent!work!developed!two!analogues!with! improved!potency!and!selectivity!against!other!nuclear!receptors!(Roth!et!al.,!2008).!!The! proliferative! effects! of! these! two! classes! of! compound!were! tested! in! H295R!adrenocortical! carcinoma! cells! positive! for! SF1! and! in! SWI13! cells! that! do! not!express!SFI1.!The!alkyloxyphenol!compounds!had!significant!offItarget!effects!and!decreased!growth!in!both!cell! lines,!whereas!the!isoquinolones!were!active!only!in!the! SF1Ipositive! cells! (Doghman! et! al.,! 2009).! However,! the! activity! of! these!isoquinolones!was!not!reproduced!by!another!study!(Whitby!et!al.,!2011).!!
1.3.5.4"Synthetic"small"molecule"agonists"of"LRHB1"and"SFB1""Whitby!et!al!published!the!first!synthetic!small!molecule!agonists!for!LRHI1!and!SFI1.!The!lead!compound,!5A!(GSK8470)!has!a!cisIbicyclo(3.3.0)octI2Iene!skeleton.!The!functionality! of! this! compound! was! tested! using! a! LRHI1! responsive! SHP! gene!promoter! driving! the! firefly! luciferase! gene.! CoItransfection! of! LRHI1! and! the!reporter! gene! showed! a! modest! stimulation! of! LRHI1! by! compound! 5A! and!established!an!EC50!of!1µM.!Moreover,! compound!5A!stimulated!expression!of! the!endogenous!SHP!gene!in!the!liver!HepG2!cells!and!in!primary!hepatocytes!(Whitby!et!al.,!2006).!The!problems!with!this!compound!related!to!acid!instability,!biological!variability! and! nuclear! receptor! promiscuity,! as! it! activates! LRHI1,! SFI1! and! to! a!lesser! extent!ERα.! Since! then,!Whitby!et! al! have!developed!a!new!series!of! LRHI1!
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agonists.! Of! the! new! series,! compound! RJW101!was! selective! for! LRHI1! but!with!poor! potency,! whilst! compound! RJW100! activated! both! LRHI1! and! SF1.! Other!compounds!described!were!selective!for!SFI1!(Whitby!et!al.,!2011).!This!publication!also!reported!a!crystal!structure!of!the!human!LRHI1!LBD!with!compound!5A,!which!shows!that!compound!5A!sits!within!the!binding!pocket,!occupying!a!similar!volume!as! the! terminal! 12! carbon! atoms! in! both! chains! of! the! phospholipid.! The! binding!pocket!was!seen! to!contract! to!about!5Å,! indicating! that! the!LRHI1! ligand!binding!pocket!is!extremely!flexible!and!takes!up!a!conformation!appropriate!to!the!size!of!the!bound!molecule!(Whitby!et!al.,!2011).!!!!
1.3.6&LRHQ1&CoQFactors&
1.3.6.1"LRHB1"CoBActivators"LRHI1!coactivators!include!PGC1α,!SRC1,!SRC2!and!SRC3,!FXR!and!MBFI1.!PGC1α!is!important! for! the! potentiation! of! transcriptional! activity! of! LRHI1! in! hepatocytes,!progesterone!production!in!ovarian!granulosa!cells!and!has!been!implicated!in!the!regulation!of!aromatase! in!preadipocytes!(Clyne!et!al.,!2002;!Safi!et!al.,!2005;!Shin!and!Osborne,!2008;!Yazawa!et!al.,!2010).!!SRC1!and!SRC2!have!both!been!shown!to!be! coIactivators! for! LRHI1,! although! the! binding! of! SRC1! appears! to! be! via! an!alternative! mechanism! than! the! classical! LXXLL! binding! region,! and! involves! a!glutamine!rich!domain!of!SRC1!and!the!helix1!and!AF2!regions!of!LRHI1.!SRCI1!and!SRCI2! interact!with! LRHI1! in! a!mammalian! 2! hybrid! assay! and! in! GST! pull! down!assays,!to!potentiate!its!activity!(Xu!et!al.,!2004).!!!Another! coIactivator! identified! with! an! alternative! binding! mechanism! is! MBFI1,!which!does!not!have!an!LXXLL!motif!but!interacts!with!the!FtzIF1!box!in!the!DBD.!It!seems!to!act!as!a!bridging!factor!by!binding!to!TATA!box!binding!protein!(TBP)!or!to!the! transcription! factor! IID! (TFIID)! complex! (which! includes!TBP)! (Brendel! et! al.,!2002).!
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FXR!is!a!nuclear!receptor,!predominantly!expressed!in!the!liver!and!intestine.!It!is!a!key! regulator! of! enterohepatic! bile! acid! metabolism.! ChIPIseq! and! coIimmunoprecipitation! experiments! have! shown! that! FXR! and! LRHI1! function!together! to! coIregulate! expression! of! target! genes! (Chong! et! al.,! 2010).! Similarly!LRHI1! has! been! shown! to! be! required! for! maximal! activation! of! the! fatty! acid!synthase!(FAS)!gene!by!the!nuclear!receptor!LXR!(Matsukuma!et!al.,!2007).!LXR!is!a!nuclear! receptor! that! acts! as! a! cholesterol! sensor! in! the! liver! and! has! at! least! 26!direct! gene! targets! relating! to! bile! acid,! lipid! and! glucose!metabolism,! as! well! as!playing!a!role!in!inflammation!and!immune!responses!(Calkin!and!Tontonoz,!2012).!!These! alternative! binding! mechanisms! and! functions! of! LRHI1! have! led! to!suggestions! that! LRHI1! functions! as! a! competence! factor! i.e! by! binding! to! other!nuclear! receptors! and! transcriptional! complexes! to! promote! gene! expression!(Lazarus! et! al.,! 2012).!The! coIoperative! action!of!ERα!and!LRHI1! in!breast! cancer!cells,! which!we! have! recently! established! (Lai! et! al! 2013),! fits! into! this!model! of!LRHI1!action.!!
1.3.6.2"LRHB1"CoBRepressors"LRHI1! coIrepressors! include! SHP,! DAXI1,! PIASγ! and! PROXI1.! SHP! and! DAXI1! are!both! orphan! nuclear! receptors! that! lack! a! DNA! binding! domain! and! share! 41%!structural! homology! in! the! LBD! (Lee! and! Moore,! 2002).! They! have! both! been!identified! as! coIrepressors! of! LRHI1! that! act! by! competitive! inhibition! of! coIactivator! binding! (Zhang! et! al.,! 2000).! The! binding! of! SHP! to! LRHI1! has! been!demonstrated! in! mammalian! two! hybrid! assays,! and! GST! pullIdown! experiments!(Lu!et!al.,!2000).!Studies!also!suggest!a!second!mechanism!of!action!via!a!CIterminal!autonomous!repression!function!in!SHP.!Point!mutations!within!this!region!of!SHP!lead! to! abrogation! of! LRHI1! mediated! transactivation! (Lee! and! Moore,! 2002;!Nishigori! et! al.,! 2001;! Seol! et! al.,! 1997).! SHP!has! two!motifs! that! closely! resemble!LXXLL! motifs! (ILYTLL! =! ID1! and! ILKKIL! –! ID2! (Johansson! et! al.,! 2000;! Li! et! al.,!
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2005))!in!the!AFI1!region.!These!two!motifs!were!studied!in!an!in!vitro!Alpha!Screen!using! purified! human! LRHI1! LBD,! showing! preferential! binding! to! LRHI1! over!coactivatorIderived!LXXLL!motifs!(Li!et!al.,!2005).!The!crystal!structure!of!the!LRHI1!LBD!and!SHP!ID1!shows!a!conformational!change!in!the!topology!of!the!LRHI1!coIactivator!binding!site!allowing!high!affinity!SHP!binding.!!!Full! length!DAXI1!binds! to! the!LRH!LBD! in$ in$ vitro! GST!pull! down!assays.! Crystal!structures!of!the!DaxI1/LRHI1!LBD!complex!reveal!that!binding!occurs!as!a!trimeric!structure!and!subsequent!analyses!have!shown!this!to!be!a!DaxI1!homodimer!and!a!LRHI1!monomer.!There!do!not!appear!to!be!any!conformational!changes!seen!in!the LRHI1!LBD!on!DaxI1!binding.!Mutational!analyses!have!confirmed!that!the!first!DaxI1!protein!binds!in!the!coIactivator!groove!via!a!repression!helix!and!the!NIterminal!part!of!H9,!with!the!sequence!PCFXXLP.!The!second!DaxI1!is!positioned!just!outside!the!LRHI1!ligand!binding!pocket!but!binds!to!the!LRHI1!LBD!using!the!same!region!in! DaxI1! as! the! first! DaxI1! molecule! i.e.! the! repression! helix! and! PCFXXLP!motif!(Sablin!et!al.,!2008).!!PIASγ! (Protein! inhibitor! of! activated! STAT)! represses! LRHI1! mediated!transactivation!of!CYP11A1!in!luciferase!assays.!Mutant!constructs!confirm!that!this!requires! the! PIASγ! repression! domain! 1! (RD1)! rather! than! repression! domain! 2!(RD2)! (Hsieh! et! al.,! 2009).! PIASγ! can! act! as! an! E3! SUMO! ligase! and! enhances!substrate! SUMOylation,! causing! repression! of! activity,! however! in! the! LRHI1!SUMOylation!deficient!mutant!(K289R)!repression!of!CYP11A1!expression!occurred!to! the! same! level!as! the!wild! type! indicating! that! the!PIASγ! induced!repression!of!LRHI1!is!not!associated!with!LRHI1!SUMOylation.! !Mammalian!twoIhybrid!and!coIimmunoprecipitation! studies! confirm! previous! publications! showing! that! the!interaction!of! SRC1!with! LRHI1! is! via! the! LRHI1!AF2! region! (Xu! et! al.,! 2004)! and!went!on!to!show!that!coItransfection!of!PIASγ!with!VP16–SRCI1!and!Gal4–LRH191I560!
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resulted!in!complete!abrogation!of!the!interaction,!suggesting!that!PIASγ!!competes!with!SRC1!(Hsieh!et!al.,!2009).!!!PROXI1! as! a! potential! cofactor! for! LRHI1! was! initially! identified! as! a! nuclear!receptor! interacting! protein! in! a! yeastI2Ihybrid! screen! (Johansson! et! al.,! 1999).!Subsequently! it! has! been! confirmed! in! mammalian! cells! and! in! vitro! as! a! direct!interaction!with! LRHI1! via! the! entire! LRHI1! LBD! (aa! 317I! 560)! and! a! portion! of!PROXI1!containing!two!LXXLL!motifs!within!amino!acids!48I132!(Steffensen!et!al.,!2004).! The! importance! of! PROXI1! for! LRHI1! function! is! yet! to! be! determined,!although!high! expression!of! PROXI1! is! seen! in!many!LRHI1! target! tissues! such! as!liver!and!pancreas,!with!lower!levels!in!the!ovary!and!small!intestine.!(Steffensen!et!al.,!2004)!
 
1.3.7&PostQtranslational&modifications&of&LRHQ1&Potential! means! of! regulating! LRHI1! activity,! other! than! ligands! and! cofactors!include! postItranslational! modifications,! particularly! phosphorylation! and!sumoylation!(see!above).!Activation!of!the!ERK1/2!MAPK!pathway!has!been!shown!to!lead!to!phosphorylation!of!SerI238!and!SerI243!in!the!LRHI1!hinge!domain.!This!leads! to! stimulation! of! transactivation! by! LRHI1.! Mutation! of! these! serines! to!alanine! eliminates! the! PMA! induced! phosphorylation! of! LRHI1! and! decreases!transactivation.! Conversely,! mutation! to! aspartate! (i.e.! mimicking! the! effects! of!phosphorylation)!increases!LRHI1!activity!(Lee!et!al.,!2006).!!Sumoylation! occurs! in! the! hinge! region! of! LRHI1! and! results! in! repression! of!transcriptional! activity! by! the! localization! of! LRHI1! in! the! transcriptionally! inert!promyelocytic! leukaemia! protein! bodies! (Chalkiadaki! and! Talianidis,! 2005).!Forskolin! and! Cholera! toxin! both! inhibited! the! accumulation! of! LRHI1! in! nuclear!bodies,!suggesting!that!the!cAMP!signalling!pathway!is!involved!in!the!regulation!of!LRHI1!sumoylation!(Yang!et!al.,!2009).!
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However,!the!importance!of!these!postItranslational!modifications!in!the!context!of!coIfactors!and!potential!ligands!was!queried!by!the!findings!that!the!agonists!DLPC!and!DUPC!continued!to!activate!mutant!LRHI1!constructs!i.e.!LRHI1!derivatives!that!have! inactive! LRHI1! responses! to! phosphorylation! and! sumoylation! respectively!(Lee! et! al.,! 2011).! This! has! been! interpreted! to! mean! that! the! LRHI1! LBD! and!potential! ligands! are! of! greater! regulatory! importance! than! postItranslational!modifications!(Lazarus!et!al.,!2012).!!
1.4&Aims&!Estrogens! are! known! to! promote! breast! cancer! development! and! progression.!Estrogen!actions!are!largely!mediated!by!ERα!and!endocrine!agents!(antiIestrogens,!aromatase! inhibitors)!are!used!to! inhibit!ERα!activity! in!breast!cancer!cells.!These!therapies!have!contributed!considerably!to!the!falls!in!breast!cancer!mortality!over!the! last! 2I3! decades.! However,!many! patients! do! not! respond! to! these! therapies,!whilst!many! patients! become! resistant! following! a! period! of! response.! Endocrine!resistance! therefore! represent! a! clinically! important! problem.! Unfortunately,! the!mechanisms! underlying! endocrine! resistance! remain! largely! unclear.! Studies! to!understand! mechanisms! underlying! endocrine! resistance! are! therefore! urgently!needed.!Additionally,! it! is! important! to! identify!new!therapeutic! targets! that!could!be!used!for!the!treatment!of!endocrine!resistant!breast!cancer.!!!Previous!studies!in!the!group!have!led!to!the!development!of!breast!cancer!cells!that!grow! in! an! estrogenIindependent! manner! (Tolhurst! et! al.,! 2010).! MCFI7! cells!represent! the!most! commonly! used! breast! cancer! cell! line!model! of! ERαIpositive!and! estrogenIresponsive! breast! cancer.! MLET5! cells! represent! a! clonal! line,!established! following! longIterm!of!MCFI7!cells! in! the!absence!of!estrogen.!Despite!continued!expression!of!ERα,!MLET5!cell! growth! is!only!partially! inhibited!by! the!antiIestrogens,!tamoxifen!and!fulvestrant.!!
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2.1.3&Cell&Lines&The!MCFI7,! MDAIMBI231! and! COSI1! cell! lines! were! obtained! from! the! American!Type!Culture!Collection!(ATCC)!(LGC!promochem,!Middlesex,!UK).!The!MLET! lines!were! developed! in! this! laboratory! by! transient! overIexpression! of! ERα! using!adenoviral!gene! transduction,! followed!by!selection!over!6!months! for! clones! that!grew! in! estrogenIfree! culture! conditions! (Tolhurst! et! al! 2011).! The! clones! were!expanded! and! three! cell! lines,! MLET! 1,! MLET2! and! MLET5! were! obtained.!Microsatellite!genotyping!confirmed!lineage!from!MCF7cells!(Tolhurst!et!al.,!2010).!All!cell!lines!were!tested!every!three!months!for!mycoplasma!and!genotyped!on!an!annual!basis!(LGC!Standards,!Teddington,!UK).!!MCFI7:!Human!breast!adenocarcinoma!cell!line!expressing!ERα!and!LRHI1!COSI1:!SV40!transformed!African!Green!Monkey!kidney!cells!negative!for!ERα!and!LRHI1!expression.!!MDA!MB!231:!Human!breast!carcinoma!cells!negative!for!ERα!and!LRHI1.!MLET1:!negative!for!ERα!expression.!MLET2:!negative!for!ERα!expression.!MLET5:!ERαIpositive!cells!(Tolhurst!et!al.,!2010)!!




2.1.5&Sundries&Cell! culture!and!general! laboratory!plastics!were!obtained! from!Triple!Red! (Oxon,!UK)! and! Corning! (supplier! Appleton! Woods,! Birmingham,! UK).! Eppendorf! tubes!were!purchased! from!Anachem!(Bedfordshire,!UK).!Sterilin!plates!were!purchased!from! Barloworld! Scientific! (Staffordshire,! UK).! Kodak! BioMax! light! film! was!supplied!by!SigmaIAldrich!(Poole,!UK).!White,!opaque!384!well!plates!(OptiPlateTMI384)! for! use! in! the! Alphascreen! assay! were! obtained! from! PerkinElmer!(Buckinghamshire,! UK).! For!western! blotting! NuPAGE!Novex! 4I12%!BisITris! preIcast!protein!gels!were!obtained!from!Invitrogen!(Paisley,!UK).!
&
&
2.1.6&Bacterial&media&and&plates&!LIBroth!(LB)!(LuriaIBetani)! LB!capsules!(16g!bactoItryptone,!10g!bactoIyeast!extract,!5g!NaCl).!Adjusted!to!pH7.0,!made!up!to!1!litre!with!doubleIdistilled,!deionized!H2O!(DDW).!Autoclaved!and!stored!at!4!oC.!LB!Plates! LB! agar! 11.1g! in! 300mls! DDW! autoclaved! to!sterilise!then!cooled!to!50oC!prior!to!the!addition!of!appropriate! antibiotics.! The! molten! LBIagar! was!then! poured! into! Sterilin! Petri! dishes,! allowed! to!set! and! stored! inverted! at! 4oC.! Prior! to! use,! the!plates! were! left! inverted! in! an! incubator! oven! at!37oC!for!30!minutes!to!dry.!
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SOC!Medium! 2%! Tryptone,! 0.5%! yeast! extract,! 10mM! NaCl,!2.5mM! KCl,! 10mM! MgCl2,! 10mM! MgSO4,! 20mM!glucose.! Purchased! from! Invitrogen! (Paisley,! UK).!Stored!at!room!temperature.!Terrific!Broth! 12g/L! Casein! enzymic! hydrolysate,! 24g/L! yeast!extract,! 2.2g/L! Monopotassium! phosphate,! 9.4g/L!Dipotassium!phosphate,!0.4%!Glycerol.!Made!up!to!1L! with! DDW.! Final! pH! 7.2.! Purchased! from!Invitrogen!(Paisley,!UK).!Stored!at!4!oC.!!!














β!Actin! Abcam!ab8226! Mouse!monoclonal! 1I100! 1:200,000!GAPDH!! Abcam!ab9484! Mouse!monoclonal! ! 1:200,000!His!tag! Abcam!ab14923! Rabbit!polyclonal! ! 1:1000!LRHI1! Sigma!HPA017067! Rabbit!polyclonal! 393I531! 1:1000!Bcl2! Abcam!ab692! Mouse!monoclonal! 41I54! 1:1000!Bad! Santa!Cruz!scI8044! Mouse!monoclonal! 1I168! 1:200!Bik! Santa!Cruz!scI10770! Rabbit!polyclonal! 1I160! 1:200!Bid! Santa!Cruz!scI11423! Rabbit!polyclonal! 1I195! 1:200!HRPIconjugated!goat! antiIMouse!igG!
DakoCytomation,!Ely,!UK! Goat!polyclonal! ! 1:2500!
HRPIconjugated!goat! antiIrabbit!IgG!











Gene& Company& Approach& Sequence/Assay&ID&no.&ERα! Primer!Design! Sybr!green! AAGAAAGAACAACATCAGCAGTAAA!TCTTTGGATGACCTAGCCTCTC!PgR! Primer!Design! Sybr!green! GAGTCACCTTGCCCCTTCA!GCCTTTTATGCTTGCCTGTAAA!PS2! Primer!Design! Sybr!green! CCCCCGTGAAAGACAGAATT!ACGTCGATGGTATTAGGATAGAAG!GREB1! Primer!Design! Sybr!green! ATAAGAGAATCCACAATAGAGACCTT!CTCTCATCAGTTTCAGTGCCATTT!CD36! Primer!Design! Sybr!green! TGTAGAAACCACTTTAATCATATCCA!CCAGGACAGCACCAATGAC!IGFL1! Primer!Design! Sybr!green! TGGAGAAAGAGGCTGGTGTT!GAATGAAGTGGGCAGTTGAGT!TM4SF1! Primer!Design! Sybr!green! TGTATTGGCTGCTCTCATTGG!CCGAGGGAATCAAGACATAGTG!Calb2! Primer!Design! Sybr!green! ATCCTGCCAACGAAGAGAA!CGATGTAGCCACTCCTGTCT!BCL2! Primer!Design! Sybr!green! GAGGTCACGGGGGCTAATT!GAGGCTGGGCACATTTACTG!BCL6! Primer!Design! Sybr!green! GGACTGTGAAGCAAGGCATT!GGAGACGATTAAGGTTGAGAAGA!NUPR1! Primer!Design! Sybr!green! CTTATTCCCGCTGACTGAGT!TAGCTTTCTTTTCTGGGGGATC!SOCS2! Primer!Design! Sybr!green! TTTTATCAGAATGCCTTGCCTTC!GGTTCCTTCCCACTTCTTCAG!DR6! Primer!Design! Sybr!green! GCCTTGACTGACCGAGAATG!CTTACACCGCACATCCTCAG!
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ANXA1! Primer!Design! Sybr!green! GAGCCCCTATCCTACCTTCAA!CTTCATCCACACCTTTAACCATTAT!BAD! Primer!Design! Sybr!green! CCTGGTGGGATCGGAACTT!TGGGAACGGGTGGAGTTTC!BID! Primer!Design! Sybr!green! CTGTAAACTTCCAATTTCTAGCCATA!GTCCAACTGCTCTTTCATCTTTT!BIK! Primer!Design! Sybr!green! TGAAGTAAGACCCCTCTCCAG!CCAAAGAATCGAAGTCCTCCAT!IGFBP3! Primer!Design! Sybr!green! ATATGGTCCCTGCCGTAGAG!TAAAATCCCTTCTTGTCACAGTTG!PPARG! Primer!Design! Sybr!green! GAATAAAGATGGGGTTCTCATATCC!AACTTCACAGCAAACTCAAACTT!NR5A2! Primer!Design! Sybr!green! GATCACACCAACGACAGGAG!AATCGGCTAACAATCAACATTAGAG!NR5A1! Primer!Design! Sybr!green! GGTGCATGGTCTTCAAGGAG!GCGGTAGATGTGGTCGAAC!SCNN1A! Primer!Design! Sybr!green! CTGCCAGAGAACTCCTATGC!TCAATTTTGGGGAAGACAAGATG!BCAS1! Primer!Design! Sybr!green! AGAGATTATAAAGTCCAAGGAAGTAGA!GTTTCGCTTCTGTGGGTTCA!CYP1B1! Primer!Design! Sybr!green! CACTGGAAACCGCACCTC!AGCACCGACAGGAGTAGC!CYP1A1! Primer!Design! Sybr!green! CAAGGTGTTAAGTGAGAAGGTG!AGCACCGACAGGAGTAGC!LCOR! Primer!Design! Sybr!green! GCCACTAATAGCCAGCACCAA!TGAATTTAGTAGTTATCGTGAAGA!ACOX2! Primer!Design! Sybr!green! CCAGAATGAGCGTTATAAGGC!CGTCTCCAGAAAGGGCTCT!BIRC3! Primer!Design! Sybr!green! GCTTCAAGACACTTCAAGATACAC!GCTGCTCAGGATTAACTAGAACA!PMP22! Primer!Design! Sybr!green! TACTCCTACGGTTTCGCCTAC!ACATAGATGACACCGCTGAGAA!TACC1! Primer!Design! Sybr!green! GCCATGACCGTTATGAGGAAA!CATTCTGCCCAGTATATTCTCTTG!GPERv2!! Primer!Design! Sybr!green! ACCAACATCTGGACGGCAG!CACACCGGCATGGTGCATC!
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GPERv3! Primer!Design! Sybr!green! GGGAAGAGGCCACCAACATC!GCTGCAGGAGGTGTACCTCTG!GPERv4! Primer!Design! Sybr!green! CGGGTCTCTTCCTCTCTCTAGC!GCCCATCAGGCTGGAGGTG!SLC9A6! Primer!Design! Sybr!green! TCCAGACCAAGACCGTAGAAG!CTTTACTCGCCTCTTGCTCTC!PCP4! Primer!Design! Sybr!green! CACCAAATTCAACCATCATCTGT!TTGCTATGCGTGTGTGGATT!GFRA1! Primer!Design! Sybr!green! TGAGAGGCGAGAAACTAGCA!AGCGGACTAACTGGCGAAT!ADCY1! Primer!Design! Sybr!green! CTGTCCGAGAAAAGTTGTGTAAG!AGTGAGTTGTATTGTGCGAGAA!RAMP3! Primer!Design! Sybr!green! AACGAGACAGGCATGTTGG!GGACAGGTTGCACCACTTC!MYB! Primer!Design! Sybr!green! CCTTAGCCACTGGAGACTGTA!AGAACTGCGAGGGAGAGAAG!GAPDH! Primer!Design! Sybr!green! N/A!sequence!kept!in!house!GAPDH! Applied!Biosystems! Taqman! Hs99999905_m1!!ESR1! Applied!Biosystems! Taqman! Hs00174860_m1!GREB1! Applied!Biosystems! Taqman! Hs00536409_m1!pS2! Applied!Biosystems! Taqman! Hs00170216_m1!PgR! Applied!Biosystems! Taqman! Hs00172183_m1!!!
2.1.10&Compounds&Estrogen!(17ßIestradiol)!was!prepared!in!ethanol!at!a!concentration!of!10!mM!and!used! at! a! final! concentration! of! 10nM.! 4IHydroxy! Tamoxifen! (OHT),! Raloxifene,!Faslodex! (ICI! 182,! 780)!were! prepared! in! ethanol! or! DMSO! at! a! concentration! of!100mM!and! used! at! a! final! concentration! of! 100! nM!unless! stated! otherwise.!Mr.!Andrew! Bayly! (AB),! Mr.! Jullien! Rey! (JR)! and! Dr! Timothy! O’Riordan! (TJC)! made!
!!
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experimental! compounds! under! the! supervision! of! Professors’! Alan! Spivey! and!Anthony!Barrett!in!the!chemistry!department!at!the!Imperial!College!London!South!Kensington!campus.!Experimental!compounds!were!solubilised!in!DMSO.!!
2.1.11&Coactivator&Peptides&&Biotinylated! coactivator! peptides,! for! use! in! the! in! vitro! Alpha! Screen,! were!synthesized! by! Cambridge! Research! Biochemicals! (Cambridge,! UK).! Peptide!sequences!have!previously!been!described!(Li!et!al.,!2005;!Whitby!et!al.,!2006).!!SRC2!BiotinIAHXILYSIGLUILYSIISILYSIILEILEUIHISIARGILEUQLEUQGLNIASPISERISERISERIPROINH2!
&SRC2!mutant!BiotinIAHXILYSIGLUILYSIHISILYSIILEILEUIHISIARGIALAQALAQGLNIASPISERISERISERIPROINH2!! !!PGC1Ialpha!!!BiotinIAHXIALAIGLUIGLUIPROISERILEUILEUILYSILYSILEUQLEUQLEUIALAIPROIALAIASNITHRINH2!!PGC1Ialpha!mutant!BiotinIAHXIALAIGLUIGLUIPROISERILEUILEUILYSILYSIALAQALAILEUIALAIPROIALAIASNITHRINH2!!!Biotinylated!his!!BiotinIAHXIHISIHISIHISIHISIHISIHISINH2!









2.2.1&Cell&culture&MCFI7!cells!were!routinely!maintained!in!DMEM!supplemented!with!10%!FCS!and!1%!(v/v)!P/S/G,! in!a!humidified! incubator! supplied!with!5%!CO2!at!37°C.!MLET1,!MLET2! and! MLET5! cells! were! routinely! maintained! in! phenolIred! free! DMEM!medium! supplemented! with! 10%! DSS! and! 1%! P/S/G.! Cells! were! passaged! at!approximately!80%!confluency!by!washing!in!1x!trypsin!(Trypsin!in!0.02%!EDTA)!and!then!leaving!in!1x!trypsin!for!5!minutes,!or!until!cells!detach,!in!the!incubator!as!above.!The!detached!cells!were!thoroughly!pipetted!to!ensure!an!even!monolayer!on!reIseeding.!
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!To!freeze!cells!down!for!storage,!cells!at!approximately!80%!confluency! in!a!T150!flask! were! washed! twice! with! preIwarmed! PBS,! trypsinised! and! recovered! cells!were!centrifuged!at!1300!rpm!for!three!minutes!to!forms!a!cell!pellet.!The!cell!pellet!was! resuspended! in! 4.5mls! of! freeze! media! (90%! FCS! and! 10%! DMSO)! and!aliquoted! in! 1.5mls! into! 1.8ml! cryovials! and! stored! at! I80°C! for! 24! hours! before!being!placed!in!liquid!nitrogen!storage!tanks.!!To! revive! frozen! stocks,! the! cryovials!were! removed! from! liquid!nitrogen!storage,!tubes!cleaned!with!100%!ethanol!and!placed!at!37°C!water!bath!for!1!minute.!Cell!suspensions!were! diluted! in! 25mls! of! culture!medium! in! a! 50ml! falcon! tube! and!centrifuged! at! 1300rpm! to! remove! the! remaining! freeze! media.! The! cell! pellet!resuspended!in!7!mls!of!medium,!seeded!in!a!T25!tissue!culture!flask!and!grown!at!37°C!with!5%!CO2!as!above.!!For! growth! experiments! in!which! the! effects! of! estrogen! and! antiIestrogens!were!determined,!cells!were!cultured!in!phenol!red!free!DMEM!supplemented!with!10%!DSS!for!three!days!before!the!experiments.!!
&
2.2.2&Sulphorhodamine&B&(SRB)&growth/toxicity&assay&&The!SRB!was!carried!out!as!described!(Skehan!et!al.,!1990).!Briefly,! the!cells!were!cultured! in! either! phenolIred! free! DMEM! supplemented! with! 10%! DSS! and!antibiotics!for!3!days!(growth!experiments)!or!DMEM!supplemented!with!10%!FCS!and! antibiotics! (off! target! effect! experiments).! Cells! were! seeded! (1x104)! in! flatIbottomed! 96Iwell! plates,! in! medium! (100! µl/well)! as! above.! Culture! medium,!supplemented!with!ligands,!was!added!after!48!hours!and!cell!growth!was!assessed!using! the! sulphorhodamine! B! (SRB)! assay! over! a! 12Iday! period.! Culture!medium!supplemented!with!ligands!as!appropriate,!was!changed!every!three!days.!The!cells!were!fixed!by!adding!100µl!iceIcold!40%!trichloroacetic!acid!(TCA)!to!each!well!and!incubated!at!RT!for!1!hour.!The!wells!were!then!washed!five!times!in!distilled!water!and!100!µl!of!0.4%!SRB!(Sigma,!UK)!prepared! in!1%!acetic!acid!was!added! for!30!minutes.!Following!this,! the!wells!were!washed!five!times!with!1%!acetic!acid!and!
!!
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allowed! to!airIdry.!The!bound!dye!was! then!solubilised!by!adding!100µl!of!10mM!TrisIbase! to! the! wells! and! placed! on! a! plate! shaker! for! 10! minutes! at! room!temperature.! The! absorbance! of! the! dye! was! read! at! 492nm! on! a! Tecan! Sunrise!Optical!Plate!Reader!(TecanIUK,!Reading,!UK).!
&






































2.2.7&Preparation&of&Protein&lysates&for&Western&Blotting&Cells!were!twice!washed!in!preIwarmed!PBS!(37°C)!before!500!µl!of!preIheated!hot!lysis! buffer! (composition! as! per! section! 2.1.7)! (100°C)! was! added! to! the! cells! in!wells.! The! cells! were! scraped! and! transferred! to! 1.5ml! Eppendorf! tubes.! The!collected!lysates!were!heated!to!100°C!for!5!minutes,!cooled!on!ice!and!stored!at!!I80°C.!!
2.2.8&Western&Blotting&MCF7!and!MLET5! cell!were! seeded! (1x106),! in!10! cm!plates,! in!DMEM!containing!FCS!and!lysed!after!48!hours!in!hot!lysis!buffer.!For!experiments!in!which!estrogen!and/or! antiIestrogens!were! added! to! the! cells,! the! cells!were! incubated! in!phenol!redIfree!DMEM!containing!10%!DSS!for!72!hours!prior!to!seeding.!The!ligands!were!
!!
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added! 24! hours! after! seeding! and! the! cells! harvested! as! above! after! a! further! 24!hours.!!Protein!lysates!were!heated!at!100°C!for!5!minutes!and!vortexed!prior!to!loading!on!a!NuIPAGE!BisITris!SDSIPAGE!preIcast!gradient!gel!(4I12%).!The!gel!was!prepared!and! assembled! in! the! Xcell! Sure$ LockTM! Mini! Cell! as! per! the! manufacturer’s!instructions! (Invitrogen,! UK).! The! gel! running! apparatus! was! filled! with! NuPAGE!MOPS! SDS! 1x! running! buffer,! the! protein!marker! and! samples! loaded,! and! run! at!200V!constant!for!35!minutes.!!The! resolved! protein! gels! were! transferred! onto! a! nitrocellulose! membrane! for!immunodetection! using! an! iBLOT! dry! transfer! unit.! The! membrane! was! then!incubated!with!blocking!buffer!(5%!Marvel!in!PBS!with!0.05%!TweenI20)!for!1!hour!at!room!temperature!to!prevent!nonIspecific!binding!of!the!antibody.!After!removal!of! blocking! buffer,! the! primary! antibody! diluted! by! the! appropriate! amount! (see!Section!3.1.8)! in! blocking! buffer,!was! added! to! the!membrane! and! the!membrane!was! incubated! for! 1.5! hrs! at! room! temperature! on! a! shaking! platform.! The!membrane! was! then! washed! 3! times! for! 15! minutes! in! PBS! containing! 0.05%!TweenI20,! prior! to! the! addition! of! the! appropriate! HRPIconjugated! secondary!antibody! in! blocking! buffer! and! incubation! for! 1! hour! at! room! temperature,!with!shaking.!The!membrane!was!once!again!washed!in!wash!buffer!for!a!total!of!1!hour!with!four!changes!of!buffer.!SuperSignal!West!Pico!Chemoluminescent!Substrate!(Pierce!Biotechnology,!UK)!was!added,!as!per!manufacturers!instructions,!followed!by!autoradiography!using!Kodax!Biomax!Light!film!(Sigma,!UK)!and!the!film!developed!with!a!Konica!SRXI1001A!XIray!developer.!!




2.2.9.1"Bacterial"Cell"Transformation"40! µl! Subcloning! EfficiencyTM! DH5αTM! Competent! Cells! (Invitrogen,! Paisley,! UK)!were!added!to!0.1!µg!of!plasmid!DNA!and!incubated!on!ice!for!30!minutes!in!1.5!ml!Eppendorf!tubes.!After!30!minutes!the!tube!was!heated!to!42°!in!a!water!bath!for!45!seconds.! The! mixture! was! then! incubated! on! ice! for! 2! minutes! and! 600! µl! SOC!medium! added! followed! by! incubation! in! shaker! incubator! 200rpm! at! 37°! for! 1!hour.!The!cells!were!centrifuged!for!20!seconds!at!13,000!rpm,!900µl!medium!was!removed,!the!remainder!was!gently!pipetted!to!resuspend!the!cells!and!50µl!spread!on!LBIagar!plates!containing!ampicillin(50µg/ml) and incubated!overnight!at!37°.!!!
2.2.9.2"Plasmid"Preparation"A! single! colony! was! added! to! 4! mls! LB! medium! containing! ampicillin! to! a! final!concentration!of!50µg/ml,!and!placed!in!a!shaking!incubator!(200!rpm)!at!37oC!for!6I8!hours.!500µl!of!the!medium!was!added!to!200mls!LB!media!containing!antibiotic!as!above!and!placed! in!a!shaking! incubator! for!at!37oC!for!18I24hrs.!Plasmid!DNA!was!prepared!using!Qiagen!columns!(Qiagen,!UK),!according!to!the!manufacturer’s!methods!and!quantified!by!measuring!nucleic!acid!concentration!and!purity!on!NDI1000!spectrophotometer.!!
2.2.10&Reporter&Assays&5x104!COSI1!cells!were!plated!in!each!well!of!24Iwell!plates,!in!1!ml!DMEM!lacking!phenol! red!and!containing!10%!DSS.!After!24!hours! the!medium!was! changed! for!serum!free!OptiMEM!(Invitrogen,!UK)!and!the!cells!were!transfected!with:!!




• pRLITK!!(internal!control!Renilla)! ! 100ng!per!well!
• BSM!(blue!script!carrier!DNA)! ! 150ng!per!well!Or!!
• pSG5!HEG0!(ERα)! ! ! ! 10ng!per!well!
• EREI3ILUC!(ERαIpromoterILuciferase)! 100ng!per!well!
• pRLITK!! ! ! ! ! 100ng!per!well!
• BSM! ! ! ! ! ! 190ng!per!well!The! transfection!mix!was!made!up! to!a! concentration!of!0.02µg/µl!with!OptiMEM!(Invitrogen,! UK).! Fugene! HD! transfection! reagent! (Roche,! UK)! was! added! to! the!DNA/Optimem!mix!as!5!volumes!of!Fugene!HD!to!2!µg!of!DNA.!The!transfection!mix!was! vortexed! and! left! at! room! temperature! for! 15!minutes! before! adding! 20µl! to!each!well.!Five!hours! following! transfection! the! compounds! to!be! tested!were! added.!As! the!compounds!were!prepared!in!DMSO,!an!equal!volume!of!DMSO!was!added!to!control!wells.! The! cells! were! lysed,! and! the! Firefly! and! Renilla! luciferase! activities!determined!after!24!hours,!using! the!DualIGlo!Luciferase!Assay!System!(Promega,!UK).! Transfection! efficiency! was! normalized! using! renilla! reporter! activity.!!Luciferase!readings!represent!the!mean!of!three!individual!transfections,!and!error!shown!as!SEM.!!!!
2.2.11&siRNA&Transfection&MCFI7! cells,! maintained! in! DMEM! supplemented! with! 10%! FCS,! or! cultured! in!phenol!red! free!DMEM!supplemented!with!10%!DSS,!and!MLET5!cells,! cultured! in!DMEM!lacking!phenol!red!and!containing!10%!DSS!for!3!days,!were!transfected!with!doubleIstranded! RNA! (dsRNA)! oligonucleotides! using! the! reverse! transfection!method!with!Lipofectamine!RNAiMAX.!!
!!
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2.2.14.1"Transformation"into"bacterial"cells"40! µl! competent!Rosetta 2 (DE3 pLysS) Competent Cell! bacteria! (Novagen,! Merck!KGaA,! Darmstadt,! Germany,)! was! added! to! 0.1! µg! of! pMALCH10TILRHI1ILBD!plasmid!DNA!(a!kind!gift! from!Dr!Eric!Ortlund,!Emory!University,!USA!(Ortlund!et!al.,!2005))!and!transformations!were!performed!as!in!section!3.2.9!using!antibiotics!100!µg/ml!ampicillin!and!34!µg/ml!chloramphenicol.!!
2.2.14.2"Growth"and"Induction"of"Protein"Expression"A!single!bacterial!colony!was!picked!from!the!LBIagar!plate!above!and!grown!for!6!hours! in!1!ml! of!Terrific!Broth! (TB! Invitrogen,! Paisley,!UK)! containing!100!µg/ml!ampicillin! and! 34! µg/ml! chloramphenicol.! This! culture! was! then! expanded! into!100mls!of!TB!with!ampicillin!and!chloramphenicol!and!grown!at!37°C! in!a!shaker!incubator!overnight.!The!baseline!OD!was!measured!prior!to!further!expansion!into!500mls!of!TB!with!antibiotics!until!the!OD!measured!0.8I1.0!(A600).!At!this!point!the!temperature! was! dropped! to! 32°C! and! 0.1mM! IPTG! added! to! induce! protein!expression!for!4!hours.!The!bacterial!culture!was!then!harvested!by!centrifugation!at!5000rpm,!4°C,!weighed!and!frozen!at!I80°C!overnight.!!
2.2.14.3"Purification"The! frozen!pellet!was!defrosted!and! resuspended! in!4mls!per!gram!Buffer!A!with!0.1mM!DNAase,!Protease! Inhibitor!Cocktail! and!0.2%!Triton!X100.!The!pellet!was!sonicated! for! 1I2! minutes! until! the! cells! appeared! to! be! lysed! and! the! sonicated!suspension!centrifuged!at!4°C,!15000!rpm!for!60!minutes.!The!supernatant!was!then!removed,!transferred!to!a!new!cold!tube,!and!stirred!on!ice!for!5!minutes!followed!by!further!centrifugation!for!60!minutes!as!above.!The!HisTALONTM!Gravity! columns! (Clontech,! UK)!were! prepared! according! to! the!manufacturer’s! protocol.! The! supernatant! was! added! to! the! column! and!
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flowthrough!collected.!The!flowthrough!was!passed!over!the!column!three!times!to!ensure!histidine!tagged!binding!to!cobalt!resin.!The!column!was!washed!with!8!mls!of!buffer!A,!followed!by!7!mls!buffer!B!(with!5mM!Imidazole).!The!purified!protein!was!eluted!from!the!column!using!250mM!Imidazole!in!elution!buffer.!The!imidazole!was!removed!from!the!purified!protein!by!dialysis.!Buffer!A 5mM!Imidazole!!150mM!NaCl!!!!pH!7.4!20mM!Tris!5%!Glycerol!+!protease!inhibitor!cocktail!and!DNAase!Buffer!B!! 5mM!Imidazole!!!!!!!pH!7.4!100mM!NaCl!20mM!Tris!5%!Glycerol!+!protease!inhibitor!cocktail!Elution!Buffer! 250mM!Imidazole!!!pH!7.4!150mM!NaCl!20mM!Tris!+!protease!inhibitor!cocktail!Dialysis!Buffer! 150mM!NaCl!!!!!!!!!!!pH!7.4!20mM!Tris!!Glycerol!5%!After!Elution/Dialysis! DTT!2mM!EDTA!0.5mM!
&
2.2.14.4"Dialysis"The! dialysis! containers! were! thoroughly! washed! and! autoclaved! with! dialysis!buffer.!The!dialysis!cassettes!(SlideIaILyzer,!10K!MWCO,!ThermoScientific,!UK)!were!preIhydrated!in!dialysis!buffer!for!1I2!minutes!followed!by!insertion!of!the!sample!
!!
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via!a!beveled!needle!and!syringe!as!per!manufacturer’s!instructions.!Excess!air!was!removed!to!ensure!maximal!buffer!exchange!and!a!buffer!volume!of!200I500x!size!of!sample!used.!The!sample!was!dialysed!for!2!hours!at!room!temperature!followed!by! a! change! of! buffer! and! further! dialysis! at! room! temperature! for! 2! hours! and!subsequent! final! change! of! buffer! and! the! dialysis! at! 4°C! overnight.! Following!recovery!of! the!dialysed!sample,!DTT!and!EDTA!were!added,!prior! to! freezing!at! I80°C.! Analysis! of! protein! concentration! was! carried! out! using! a! Pierce! BCA!(bicinchonic!acid)!protein!Assay!(Thermo!Fisher!Scientific!UK!Ltd,!Leicester)!or!by!measuring!UV!absorbance!at!580nm.!!
2.2.15&Cleavage&and&reQpurification&of&His&tagged&LRHQ1&LBD&Cleavage!of! the!LRHI1!LBD!from!the!histidine! tagged!maltose!binding!protein!was!achieved!using!a!TEV!protease!(AcTEV!Protease,!Invitrogen,!UK).!Component! Amount/Volume!His!tagged!LRHI1!LBD! 100µg!20X!TEV!buffer! 37.5µl!AcTEV!Protease! 5µl!DDW! to!750µl!!The! reaction!mixture!was! incubated!at! room! temperature! for!6!hours!on!a! gentle!shaker!platform.!!The! sample! was! reIpurified! using! the! cobalt! metal! affinity! column,! as! described!above,! to! enable! removal! of! the! hisItagged! protein! and! the! AcTEV! protease.! A!further!purification! ! step!was! included! to! remove! the!MBP!bound!protein!using! a!MBP! Trap! column! (Dextrin! Sepharose! High! Performance/MBPTrap! HP,! GE!Healthcare,! UK)! as! per! manufacturer’s! methods.! The! resulting! sample! was!
!!
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concentrated! using! Amicon! Ultra! 3K! MWCO! centrifugal! filter! (Millipore! (UK),!Watford)!and!purity!assessed!using!SDS/PAGE!analyses.!!!!






2.2.17&Fluorescence&activated&cell&sorting&(FACS)&Analysis&!100,000!cells!per!well!were!seeded!in!six!well!plates!in!DMEM!containing!10%!FCS.!After!48!hours!the!cells!were!treated!with!1nMI100µM!etoposide!(SigmaIAldrich)!or!DMSO!and!incubated!for!a!further!48!hours.!After!this!time,!the!cells!were!harvested!by! trypsinisation,! centrifugation! for! 5!minutes! and!washing! in! 5!mls! iceIcold! PBS!before!a!further!5!minute!centrifugation!and!gently!resuspending!in!1!ml!ethanol!at!4°C!for!1!hour.!The!cells!were!then!washed!twice!with!5mls! ice!cold!PBS!as!above!and! resuspended! in! 100µl! PBS! containing! 100µg/ml! RNAase! (SigmaIAldrich)! and!1ml! 50µg/ml! propidium! iodide! (PI)! (SigmaIAldrich)! and! incubated! in! the! dark! at!
!!
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3.1& Gene& Expression& Profiling& of& MCFQ7& and& the& MCFQ7& derived,& EstrogenQ
Independent&MLET&Cells&&The!MCFI7!cell!line!was!generated!from!a!pleural!effusion!from!a!patient!with!breast!cancer! (Brooks! et! al.,! 1973;! Horwitz! et! al.,! 1975).! MCFI7! cells! express! ERα! and!require!estrogen!for!their!growth.!Hence,!culturing!in!the!absence!of!estrogen!in!the!culture!medium!results!in!a!block!in!growth!and!treatment!with!antiIestrogens!also!inhibits! their!growth.!MCFI7!cells! also!express! the!progesterone! receptor! (PgR),! a!classic!ERα!target!gene!(Horwitz!et!al.,!1975).!As!such,!MCFI7!cells!have!become!the!prototypical!cell!line!model!of!ERαIpositive!breast!cancer.!Searching!for!publications!with! the! terms! “MCF7”! and! “breast! cancer”! (26! June! 2014)! yielded! 16,786!publications! in! Pubmed! (http://www.ncbi.nlm.nih.gov/pubmed/).! Evaluation! of!signaling!pathways! in!MCFI7!has! identified!key!ERα!regulated!genes,!using!among!other!methodologies!gene!expression!microarray!analysis!(Frasor!et!al.,!2003).!The!identification! of! global! ERα! binding! sites! using! chromatin! immunoprecipitation!followed!by!hybridization!of! immunoprecipitated!DNA! to! genomic! tiling! arrays!or!by! high! throughput! DNA! sequencing! (ChIPIseq)! (Carroll! et! al.,! 2006),! as! well! as!numerous! studies! have! begun! to! determine! the!molecular! mechanisms! by! which!ERα! regulates! gene! expression! (Metivier! et! al.,! 2006).! Within! this! laboratory,! Dr!Robert!Tolhurst!utilized!MCFI7!cells!for!the!investigation!of!the!processes!by!which!MCFI7! cells! could! be! engineered! for! estrogenIindependent! growth,! thus! allowing!possible!mechanisms!of! endocrine! resistance! to!be!evaluated.!The! initial! rationale!behind! this!work! stemmed! from!observations! that! ectopic!ERα!expression! in!ERα!negative! breast! cancer! cell! lines! inhibits! cell! growth! (Jiang! and! Jordan,! 1992;!Lazennec! and! Katzenellenbogen,! 1999;! Zajchowski! et! al.,! 1993)! however,!conditional! overexpression! increased! the! growth! of! MCF7! cells! in! the! absence! of!ligand!(Fowler!et!al.,!2004;!Lazennec!and!Katzenellenbogen,!1999).!This!suggested!that! ERα! overexpression! may! be! a! mechanism! of! cellular! adaptation! to! estrogen!deprivation!(Tolhurst!et!al.,!2010).!Previous!studies! investigating!the!development!
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of! estrogenIindependence! in! MCFI7! cells! have! frequently! observed! ERα!upregulation! during! the! early! stages! of! progression! from! estrogenIdependence! to!estrogenIindependence!(Chan!et!al.,!2002).!Dr!Tolhurst!infected!MCFI7!cells!with!an!adenovirus!encoding!ERα! to!achieve! transient!ERα!overIexpression! in!MCFI7!cells!that! were! cultured! in! the! absence! of! estrogen.! AdenoIERα! infected! cells! showed!ligandIindependent!activation!of!ERα! target!genes!and! ligandIindependent!growth!(Tolhurst! et! al.,! 2010).! ERα! overIexpression! fell! over! a! 3I6! week! period,!concomitant!with!loss!of!detectable!adenoviral!genome!sequences.!At!this!stage!the!cultures! underwent! a! “crisis”! with! loss! of! cells! over! the! next! 2! months,! with!outgrowth!of!distinct!clones!over!a! further!3Imonth!period.!One!of! the!clones!that!grew! out! was! named! MLET5.! Repeat! experiments! generated! two! other! lines!(MLET1,!MLET2),!although!these!differed!from!MLET5!cells!in!being!representative!of! derived! cultures,! rather! than! being! distinct! clones! as! in! the! case! of! MLET5!(Tolhurst,!2006).!!!MLET1,!MLET2!and!MLET5!grew!in!an!estrogenIindependent!manner,!with!growth!being! uninhibited! by! treatment! with! the! antiIestrogens! tamoxifen,! raloxifene! or!fulvestrant! (Tolhurst,! 2006;! Tolhurst! et! al.,! 2010).! Gene! expression! analysis!determined!that!MLET5!continues!to!express!ERα!and!the!ERα!target!genes!PgR!and!pS2!were!also!expressed!(Tolhurst!et!al.,!2010).!By!contrast,!MLET1!and!MLET2!did!not!express!ERα,!PgR!or!pS2!(Tolhurst,!2006).!As!previously!mentioned!most!ERαIpositive! breast! cancer! remain! ERαIpositive! following! onset! of! resistance! to!tamoxifen! and! frequently! these! patients! respond! to! fulvestrant! or! an! aromatase!inhibitor,!indicating!the!continued!importance!of!ERα!in!endocrine!resistant!breast!cancer!(Howell!et!al.,!2002;!Johnston!et!al.,!1995;!Osborne!et!al.,!2002).!About!30%!of!ERαIpositive!breast!cancer!do,!however,!progress!to!ERαInegative!breast!cancer!(Johnston!et!al.,!1995).!Thus,!this!panel!of!MCFI7Iderived!resistant!cells!represents!interesting! models! for! investigation! of! the! molecular! changes! that! may! drive!acquired! endocrine! resistance.! Investigating! the! gene! expression! profiles! of! these!lines!using!gene!expression!microarray!analysis!should!provide!important! insights!
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2640681 GREB1 10.3- 0.001 6.2- 0.033 
2260156 PDZK1 9.5- 0.001 7.7- 0.035 
4670202 CXCL12 7.2- 0.001 4.2- 0.030 
6940286 CXCL12 5.9- 0.001 4.4- 0.031 
5550187 IGFBP4 5.7- 0.001 5.2- 0.030 
4150474 KRT13 5.7- 0.001 3.5- 0.045 
3140465 PKIB 5.7- 0.001 3.6- 0.033 
50347 H19 5.0- 0.001 2.7- 0.035 
1190735 PRSS23 4.8- 0.001 4.1- 0.034 
4570400 SEMA3B 4.5- 0.001 3.3- 0.029 
940370 FLJ30058 4.4- 0.001 2.3- 0.030 
6840647 RAPGEFL1 4.3- 0.001 3.5- 0.028 
6130239 SGK 4.0- 0.000 2.8- 0.030 
4610551 PGR 4.0- 0.001 4.7- 0.030 
1300326 SFXN2 3.9- 0.001 2.6- 0.039 
4280762 SEC14L2 3.9- 0.001 2.1- 0.033 
7210286 MYB 3.9- 0.002 2.2- 0.030 
4390338 CELSR2 3.8- 0.001 2.7- 0.028 
1430519 TPD52L1 3.6- 0.001 2.7- 0.028 
5360687 RAMP3 3.6- 0.002 2.5- 0.030 
7160274 NPY1R 3.6- 0.002 3.7- 0.030 
2350482 CXCL12 3.3- 0.002 2.7- 0.041 
5700341 SOX3 3.2- 0.001 2.3- 0.045 
4670025 OLFM1 3.2- 0.001 2.2- 0.030 
1740040 FOXC1 3.2- 0.002 2.5- 0.030 
3310204 RERG 3.1- 0.001 2.8- 0.030 
6450148 IL17RB 2.9- 0.001 2.2- 0.030 
5260209 SGK3 2.9- 0.001 2.2- 0.030 
6560162 PTGES 2.8- 0.001 4.5- 0.033 
3370026 PCP4 2.7- 0.001 4.5- 0.033 
3060044 MYEOV 2.6- 0.001 2.1- 0.033 
5080576 CALCR 2.6- 0.001 2.5- 0.038 
5890717 SUSD3 2.6- 0.002 3.2- 0.048 
5720681 TIPARP 2.5- 0.002 2.1- 0.033 
990128 GFRA1 2.4- 0.002 2.7- 0.030 
2350243 UGT2B17 2.4- 0.001 2.5- 0.041 
1110441 ADAMTS9 2.3- 0.001 2.4- 0.030 
1690386 NT5DC3 2.3- 0.002 2.1- 0.030 
20349 FKBP4 2.3- 0.001 2.2- 0.030 
1010731 C1QTNF6 2.3- 0.005 3.8- 0.030 
4560561 TUBA3E 2.2- 0.001 2.5- 0.037 
2760092 FAIM3 2.2- 0.001 3.4- 0.030 
6280168" NEIL2" 2.1- 0.001" 2.0- 0.033"
5290215 HSPB8 2.1- 0.002 2.3- 0.040 
2760168 KCNK6 2.1- 0.001 2.1- 0.030 
2450414 SERPINA1 2.1- 0.002 2.2- 0.032 
7550072 HS.388347 2.0- 0.002 2.4- 0.030 
3610372 PLAC1 2.0- 0.002 3.1- 0.036 










3940082" FAM83A" 0.5- 0.001" 0.5- 0.033"
3940376" FAM107B" 0.5- 0.001" 0.5- 0.042"
4890360" BLNK" 0.5- 0.003" 0.4- 0.037"
2190113" KRTHB6" 0.5- 0.002" 0.5- 0.033"
6420386" EFNA1" 0.5- 0.005" 0.4- 0.030"
7400523" TGFB3" 0.5- 0.002" 0.4- 0.033"
2260148" NELL2" 0.5- 0.001" 0.5- 0.032"
6380563" YPEL3" 0.4- 0.001" 0.4- 0.033"
4860689" TFPI" 0.4- 0.006" 0.4- 0.045"
6220554" HS.25318" 0.4- 0.001" 0.4- 0.033"
510543" ABCC3" 0.4- 0.001" 0.5- 0.031"
4920576" ST8SIA4" 0.4- 0.002" 0.5- 0.030"
1980458" RND3" 0.4- 0.001" 0.5- 0.040"
2900450" PUNC" 0.4- 0.001" 0.5- 0.036"
5570672" CLDN9" 0.4- 0.003" 0.4- 0.037"
5810047" MGC59937" 0.4- 0.001" 0.4- 0.038"
4670717" PGM5" 0.4- 0.001" 0.3- 0.039"
5860477" EDG3" 0.4- 0.003" 0.5- 0.048"
10673" HS.510367" 0.3- 0.001" 0.3- 0.045"
2570129" PGM5" 0.3- 0.001" 0.3- 0.033"
5820689" EFEMP1" 0.3- 0.001" 0.4- 0.031"
4390634" TNS3" 0.3- 0.001" 0.4- 0.033"
4540768" SALL4" 0.3- 0.001" 0.3- 0.042"




































































































!EstrogenIresponsive! genes,!whose! expression! becomes! estrogenIindependent! and!which! are! highly! expressed! in! the! absence! of! estrogen! in! MLET5! cells,! may! be!interesting! candidates! for! exploration! as! potential! mediators! of! estrogen!independence! in! endocrine! resistant! breast! cancer.! In! this! context,! several! genes!demonstrated! considerable! upIregulation! in!MLET5! cells.! Interestingly,! of! the! top!four! genes! upIregulated! in! MLET5! (Figure! 3.5A),! three! were! genes! whose!expression!is!repressed!by!estrogen!in!MCF7!cells!(IGFL1,!TM4SF1,!CD36)!and!only!one!that!was!estrogenIstimulated!in!MCF7!cells!(CALB2).!!
$IGFL1,! (IGFIlike! gene! 1)! is! structurally! related! to! the! IGF! superIfamily! of! growth!factors.!A!study!using!qPCR!has!demonstrated!expression!in!the!ovaries!and!spinal!cord,! and,! using! BLAST! analysis! of! GenBank! human! EST! database,! in! fetal! skin,!normal! breast,! head! and! neck! tumours,! squamous! cell! carcinoma,! uterine! tumour!and! carcinoma! cell! lines! (Emtage! et! al.,! 2006).! The! biological! activity! of! IGFL1!remains!to!be!defined!but!may!be!similar!to!the!IGF!growth!factor!family.!In!MLET5!cells! IGFL1! is! significantly! upIregulated! by! approximately! 3! fold,! compared! with!MCF7! cells! in! the! absence! and! presence! of! estrogen,! and! retains! the! estrogen!repression!seen!in!MCF7!cells!(Figure!3.5B).!!!TM4SF1,! is! a! transImembrane! protein! that! is! associated! with! cancer! growth!(Hellstrom!et!al.,!1986),!motility!(Chang!et!al.,!2005)!and!invasion!(Kao!et!al.,!2003;!Lekishvili! et! al.,! 2008).! More! recently! it! has! been! shown! to! play! a! key! role! in!angiogenesis! (Shih!et! al.,! 2009)!and! in!vitro!and!xenograft!models!have! shown! its!promise!as!a!potential!therapeutic!target!(Lin!et!al.,!2014).!TM4SF1!is!significantly!upIregulated!in!MLET5!cells!by!approximately!10!fold!compared!with!MCF7!cells!in!the! absence! and! presence! of! estrogen! and! again! retains! the! estrogen! repression!seen!in!our!MCF7!cells!(Figure!3.5B).!
!!
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CALB2! is! a! Ca2+! buffering! protein,!which! has! been! used! as! a!marker! in!malignant!mesothelioma! to! differentiate! from! adenocarcinomas! (Husain! et! al.,! 2009)! and! is!under! investigation! as! a! potential! therapeutic! target! (Blum! and! Schwaller,! 2013).!However! a! recent! study! confirms! that! it! is! also! expressed! on! 15%! of! breast!carcinomas,! although!more! likely! to! be! associated!with! ERα! negative,! high! grade,!basal! –like! phenotype! (Powell! et! al.,! 2011).! In! this! experiment,! CALB2! was!significantly! upIregulated! in! MLET5! cells! (approximately! 3! fold)! compared! with!MCF7,!in!the!absence!of!estrogen.!It!is!also!upIregulated!in!response!to!estrogen!in!MCF7!cells!and!retains!this!response!in!MLET5!(Figure!3.5B).!!!CD36! is! a! transImembrane! receptor! that! is! expressed!on!epithelial! cells,! platelets,!phagocytes,!adipocytes,!hepatocytes!and!myocytes.!It!has!been!shown!to!play!a!role!as!a!negative!regulator!of!angiogenesis!via!thrombospondin!1!(Jimenez!et!al.,!2000)!and! 2! by! inducing! apoptosis! via! loss! of! mitochondrial! membrane! potential! and!activation!of!caspaseI3!(Koch!et!al.,!2011).!More!recently!the!loss!of!CD36!has!been!linked! to! increased!collagen!deposition!and! increased!breast! tissue!density,!which!may!play! a! role! in! breast! carcinogenesis! (DeFilippis! et! al.,! 2012;! Seewaldt,! 2012).!Uray!et!al!demonstrated!that!hormone!dependent!cell!lines,!MCF7!and!T47D,!down!regulate! CD36! in! response! to! estrogen! and! Faslodex! prevents! the! loss! of! CD36!which!may!contribute!to!its!mechanism!of!action!(Uray!et!al.,!2004).!This!supports!the!data!I!show!for!CD36,!with!strong!upIregulation!in!MLET5!cells!compared!with!MCF7! cells,! in! the! absence! and! presence! of! estrogen! (by! approximately! 500! fold)!and!estrogen!inhibition!(approximately!two!fold)!is!seen!in!both!MLET5!and!MCF7!cell!lines,!as!documented!in!the!literature!(Uray!et!al.,!2004)!(Figure!3.5B).$$
















"Probe"ID" "Gene"Symbol" FC" FC" FC" FC"
1" "3990167" "CD36" 89.2" 78.3" 0.7" 0.8"
2" "3390468" "TM4SF1" 20.9" 41.0" 0.3" 0.2"
3" "2490021" "IGFL1" 20.6" 32.2" 0.6" 0.4"
4" "4260433" "CD36" 45.3" 31.9" 0.7" 0.9"



















































































3.1.4&Functional&Group&Analysis&of&MLET5&Differential&Gene&Expression!The! aboveIdescribed! realItime! RTIPCR! analysis! provides! evidence! confirming! the!gene!expression!microarray!profiles.!In!order!to!identify!signaling!pathways!that!are!altered! in!MLET5,!pathway!analysis!was!performed!of! the!differentially!expressed!genes! shown! in! MLET5! using! DAVID! online! software!(http://david.abcc.ncifcrf.gov/gene2gene.jsp).! This! revealed! “Development”,!“Adhesion”,! “Differentiation! and! Death”! and! “Motility”! amongst! the! most! highly!enriched! functional! groups.! This! program! uses! enrichment! scores! based! on!published!data!as!a!statistical!likelihood!of!association.!The!initial!five!groups!with!a!strong! association! or! enrichment! score! appeared! to! be! loosely! linked! in! terms! of!functional!grouping!(Table!3.2).!As!one!of!the!highest!scoring!GO!functional!groups,!I!investigated! the!potential! involvement!of! “Differentiation!and!Death”!or! apoptosis!genes.!Examination!of!the!differentially!expressed!genes!identified!95!genes!whose!expression! placed! them! in! the! apoptosis! pathways! and! whose! expression! was!significantly! altered! in!MLET5! cells,! relative! to! expression!profiles! in!MCFI7! cells.!Foremost!amongst!these!genes!were!BCL2!(antiIapoptotic),!which!was!upIregulated!in! MLET5! cells! and! related! genes,! BAD! (upIregulated)! and! BIK! (downIregulated)!(Hur!et!al.,!2004)(Figure!3.6A).!!
  Enrichment score Number of genes 
Cluster 1: Development 10.3  
Developmental process  208 
Anatomical structure development  150 
Organ development  98 
System development  122 
Multicellular organismal development  149 
Multicellular organismal process  193 
Cluster2: Adhesion 8.07  
Biological adhesion  68 
Cell adhesion  68 
Cell adhesion  37 
Cluster3: Differentiation and death 4.05  
Cell differentiation  114 
Cellular developmental process  114 
Cell development  81 
Cell death  56 
Death  56 
Apoptosis  52 
Programmed cell death  52 
Regulation of apoptosis  35 
Regulation of programmed cell death  35 
apoptosis  20 
Cluster 4: Motility 3.81  
Localisation of cell  35 
Cell motility  35 
Cell migration  22 
Cluster 5: Negative regulation 3.78  
Negative regulation of cellular processes  73 
Negative regulation of biological processes  74 
Negative regulation of metabolic processes  29 
Cluster 6: Development 3.58  
Tissue development  31 
Ectoderm development  17 
Epidermis development  15 
Table' 3.2' Functional' group' analysis' of' genes' differentially'











"Probe"ID" "Gene"Symbol" FC" FC" FC" FC"
3850082 BCL2 5.7 5.8 1.7 1.7 
50563 BCL6 2.9 2.7 0.9 0.9 
5860181 NUPR1 2.1 2.2 0.8 0.7 
1070307 SOCS2 0.2 0.4 0.9 0.6 
5090195 TNFRSF21 0.1 0.3 1.1 0.5 
150630 ANXA1 0.1 0.2 0.9 0.6 
3170280 BAD 2.6 2.5 0.8 0.9 
4540551 IGFBP3 2.6 1.7 0.5 0.8 
2600091 BIK 0.4 0.4 0.6 0.6 
10133 BID 0.5 0.6 1.1 0.8 
Figure' 3.6A' ' Validation' of' expression' of' genes' involved' in'




























































































Figure' 3.6B' ' Validation' of' expression' of' genes' involved' in'







&Bcl2! is!a!known!estrogenIstimulated!gene!(Su!et!al.,!2014)!and! its!expression!was!elevated! 12Ifold! increase! in! MLET5! cells! compared! with! levels! of! expression! in!MCFI7!cells!(Figure!3.6B).!Estrogen!treatment!further!elevated!Bcl2!levels,!the!level!of! stimulation! being! similar! to! that! observed! in!MCFI7! cells.! Bcl2! is! the! founding!member!of! the!Bcl2! family! of! antiIapoptotic!proteins! and! functions!by!preventing!programmed! cell! death! (Vaux! et! al.,! 1988).! It! was! initially! identified! due! to! a!chromosomal!translocation!t(14;18)!found!in!85%!of!follicular!lymphomas!and!20%!of! diffuse! large! B! cell! Non! Hodgkin! Lymphomas! (DLBC! NHL)! (Tsujimoto! et! al.,!1985).!There!are!three!sub!families!within!the!Bcl2!family,!BH1I4!(containing!Bcl2,!BclIXL),! BH123! proteins! (containing! Bax! and! Bak)! and! BH3! only! proteins!(containing!BAD,!BIK! and!BID).! The!BH3!only!proteins! are! the! largest! subclass! of!Bcl2! family!proteins,!which!act,! in! the!main,!by! inhibiting!antiIapoptotic!Bcl2.! It! is!thought! that! the!balance!between! levels!of! the!proI!and!antiIapoptotic!Bcl2! family!members! determines! if! a! cell! undergoes! apoptosis! (Korsmeyer! et! al.,! 1993).! The!mechanism! by! which! the! BH3! proteins! cause! apoptosis! has! historically! been!thought! to! be!due! to! displacement! of! antiIapoptotic!Bcl2! or!Bcl2XL! from!Bax! and!Bak!by!competitive!binding.!However,!there!is!also!evidence!that!direct!interaction!with! Bax! or! Bak! can! induce! activation! of! caspases! and! therefore! apoptosis!(Leibowitz! and! Yu,! 2010),! and! postItranslational! modification! of! Bcl2! family!members!also!being! important! in!determining! the!balance!between!apoptosis!and!survival!(Danial,!2008).!&!Expression!of! the!proIapoptotic!BAD!was!elevated!2Ifold! in!MLET5!cells,!whereas!expression!of! the!proIapoptotic!BIK!and!BID!genes!was!reduced!in!MLET5!(Figure!3.6B).!Phosphorylation!of!BAD!at!S155,!S112!and!S136!has!been!shown!to!decrease!its!proIapoptotic!ability!(Datta!et!al.,!2000;!Tan!et!al.,!2000)!and!contribute!to!cancer!cell!survival!(Virdee!et!al.,!2000).!This!may!occur!for!two!reasons;!firstly,!S155!lies!
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within! the!BH3! antiIapoptosis! factor! hydrophobic! binding! site,! although!has! been!shown!to!be!dependant!on!the!two!other!sites!of!phosphorylation,!S112!and!S136!in!mutational! studies! therefore! may! be! the! rate! limiting! step! in! a! tiered!phosphorylation! system! (Danial,! 2008).! Secondly,! the! location! of! the! majority! of!phosphorylated! BAD! changes! from! mitochondrial! to! sequestration! within! the!cytosol! (Hirai! and! Wang,! 2001;! Zha! et! al.,! 1996).! NonIphosphorylated! BAD!dimerizes!BCLIXL!and!BCL2!displacing!BAX!which!is!then!free!to!initiate!an!increase!in! mitochondrial! membrane! permeability! and! apoptosis! (Moses! et! al.,! 1990).! A!previous! study! (Virdee! et! al.,! 2000)! has! shown! an! increase! in! the! percentage! of!pBAD! relative! to! total!BAD! in! cancer! cell! lines! (breast,! ovary! and! lung)! compared!with!immortalized!normal!cells!(Stickles!et!al.,!2015).!It!would!therefore!have!been!of!value!to!assess!pBAD!in!conjuntion!with!total!BAD.!BIK!and!BID!are!also!members!of!the!BH3!family!of!proIapoptotic!proteins.!Bik!acts!indirectly!via!BCLIXL!to!trigger!BAXIdependant!apoptosis!(Chinnadurai!et!al.,!2008;!Gillissen!et!al.,!2003;!Rashmi!et!al.,!2008)!and!has!been!implicated!in!playing!a!role!in!the!development!of!lung!and!breast!carcinomas(Vijayalingam!et!al.,!2010).!BID!is!thought!to!be!related!both!structurally!and!functionally!to!the!BH123!(or!multi!BH!proteins)! by! its! ability! to! function,! once! cleaved! by! caspaseI8! or! other! proteases!initiated! by! death! receptors,! at! the! mitochondrial! membrane! and! induce!permeabilization!via!Bax!+/I!Bak.!(Billen!et!al.,!2008).!!ANXA1!promotes! apoptosis! by! associating!directly!with! the!p65! subunit! of!NFIkB!thereby! preventing! binding! to! target! DNA! sequences! (Zhang! et! al.,! 2010).! The!mechanism! for! this!prevention! is!not!yet! fully!known!but!cell!work!shows!ANXA1!induced! inhibition!of!NFIkB! results! in! a! change! in! associated! signalling!molecules!such!as!BCl2!and!survivin!(Shen!and!Tergaonkar,!2009).!ANXA1!expression!has!been!shown! to! be! upIregulated! in! response! to! estrogen! via! the! activation! of! cAMPIresponsive! element! binding! protein! and! the! estrogen! receptor! and! this! published!data!suggests! it!may!act!as!a! tumour!suppressor!gene! in!breast!cancer!(Ang!et!al.,!2009).! This! correlates! with! an! associated! loss! of! expression! seen! previously! in!
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association!with!breast!cancer!development!and!progression!(Shen!et!al.,!2006).!In!this!experiment!ANXA1!expression!was! reduced!10Ifold! in!MLET5!cells! compared!with!MCF7!cells,!with!repression!in!response!to!estrogen!(Figure!3.6B).!!!TNFRS21!(DR6),!also!acts!through!NFIkB!to!promote!apoptosis!(Kasof!et!al.,!2001).!Although!a!full!understanding!of!this!mechanism!is!not!yet!known,!studies!suggest!that! one! mechanism! may! be! via! S5a,! a! subunit! of! the! 26S! proteasome! enzyme!complex!which!in!turn!binds!polyubiquitin!to!target!proteins!for!removal!(Wang!et!al.,!2005a;!Wang!et!al.,!2014).!TNFRS21!expression,!like!that!of!ANXA1,!is!inhibited!by!estrogen!in!MCF7!cells!and!expression!was!significantly!reduced!in!MLET5!cells!(Figure!3.6B).!!Suppressor! of! cytokine! signaling! 2! (SOCS2)! has! proIapoptotic! actions! via! the!JAK/STAT!pathway.! It! is!known! to! inhibit! growth!hormone!action!and!SOCS2!null!mice!exhibit!gigantism!(Favre!et!al.,!1999;!Metcalf!et!al.,!2000).!Intriguingly,!cell!line!data!(HEK293,!ERα!positive!embryonic!kidney!cells)!shows!that!the!effects!of!SOCS2!on! Growth! Hormone! (GH)! are! mixed,! with! suppression! of! action! at! low!concentrations!and!enhanced!action!at!higher!concentrations!(Favre!et!al.,!1999).!In!my!experiment,! expression!of! SOCS2!was! reduced!approximately!5! fold! in!MLET5!cells! and! shows! a! repression! of! expression! following! treatment! with! estrogen!(approximately!2!fold)!by!qPCR!at!16!hours.!This!is!in!contrast!to!published!data!for!alternative! cell! lines,! HEK293! (Leung! et! al.,! 2003)! and! HuH7! cells! (Leong! et! al.,!2004).! This! contrasting! result!may! be! attributed! to! their!measurement! of! SOCSI2!expression!at! time!points!up! to!4!hours!after!estrogen! treatment!with!a!peak! fold!difference!of!approximately!1.8!at!2!hours.!!!BCL6! is! a! transcriptional! repressor! that! inhibits! apoptosis! by! recruiting! coIrepressor! complexes,! such! as! SMRT! and! NCoR! (Ahmad! et! al.,! 2003;! Huynh! and!Bardwell,!1998).!It!has!been!shown!to!be!elevated!in!approximately!50%!of!breast!
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tumour!samples!and!the!majority!of!breast!tumour!derived!cell!lines!(Walker!et!al.,!2014).!!In!this!experiment,!BCL6!was!elevated!in!MLET5!with!no!significant!estrogen!response!in!either!MCF7!or!MLET5.!!!NUPR1,! is!upIregulated! in!metastatic!breast!cancer!and!has!been!shown!to!play!a!role! in! cellular! growth! inhibition! (Bratland! et! al.,! 2000;! Ree! et! al.,! 2000).! It! was!significantly!down!regulated!(14.2!fold)!in!a!p23!overIexpressing!MCF7!cell!line!that!has! been! shown! to! exhibit! increased! invasiveness! whilst! maintaining! estrogen!dependent! proliferation! (Simpson! et! al.,! 2010).! It! has! been! implicated! in! chemoIresistance,! in! pancreatic! and!breast! cancer,! possibly! via! p21! and! activation! of! the!antiIapoptotic! BclIxL,! (Chowdhury! et! al.,! 2009;! Clark! et! al.,! 2008;! Vincent! et! al.,!2012)!but!also!in!contributing!to!adriamycinIinduced!apoptosis!in!mouse!embryonic!fibroblasts! (MEFs)! (Vasseur!et!al.,!2002).!The!role!of!NUPR1! in! the!progression!of!pancreatic! cancer! was! shown! more! recently! to! be! via! the! alternative! RelBIdependent!NFkappaB!pathway!(Hamidi!et!al.,!2012).!Further!evidence!for!the!role!of!NUPR1!in!apoptosis!was!shown!by!the!knockdown!of!NUPR1!in!non!small!cell!lung!cancer!xenograft!models!in!nude!mice!which!significantly!inhibited!cell!proliferation!and!arrested!cells!in!G0!phase!of!the!cell!cycle!with!an!increase!in!apoptosis!shown!by! flow! cytometry! experiments! (Guo! et! al.,! 2012).! ! Despite! the! conflicting! role! of!NUPR1!there! is!certainly!strong!evidence! that! it!plays!a!part! in!apoptosis!across!a!variety! of! tumour! types,! including! breast! cancer,! although! it! is! likely! to! be! a!multifunctional! protein,! which! would! explain! this! disparity! of! results.! ! In! this!experiment! it! is!upIregulated!approximately!4! fold! in!MLET5!cells! compared!with!MCF7!and!estrogen!repressed!consistent!with!published!data!(Sarvari!et!al.,!2010).!!IGFBP3! functions! as! a! tumour! suppressor! gene! by! inhibiting! cell! growth! and!inducing!apoptosis! (Baxter,! 2014).!The!mechanism! for! this! can!be! independent!of!p53!and! IGF! (Furstenberger!and!Senn,!2002;!Rajah!et! al.,! 1997)!although!p53!has!also!been!shown!to!induce!expression!of!IGFBP3!(Grimberg,!2000).!The!initial!work!
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Figure' 3.7' Altered' protein' expression' of' genes' associated' with'










































3.2&LRHQ1&&As! described! in! the! Introduction,! previous! work! in! the! laboratory! has! identified!liver!receptor!homologue!1!(LRHI1;!NR5A2)!as!an!estrogen!regulated!gene!in!breast!cancer! cells.! LRHI1! has! been! shown! to! regulate! aromatase! expression! and! ERα!expression!in!breast!cancer!cell!lines!and!siRNA!mediated!LRHI1!knockdown!causes!growth! inhibition! in!LRH1I! expressing! cells! (Clyne! et! al.,! 2004;!Clyne! et! al.,! 2002;!Thiruchelvam!et!al.,! 2011).!These! findings! indicate! that!LRHI1!plays!an! important!role! in! breast! cancer! and! that! inhibition! of! LRHI1! activity! may! provide! a! new!therapeutic!strategy!for!the!treatment!of!ERαIpositive!breast!cancer.!LRHI1!does!not!appear!to!be!differentially!regulated!between!MLET5!and!MCF7.!We!have!therefore!performed! further! microarray! studies! assessing! the! role! of! LRHI1! on! gene!expression!in!MCF7!cells.!!!!






































!RNA!was!prepared!from!four!biological!replicates!for!MCFI7!cells!transfected!with!a!nonItargeting! siRNA! (control)! and! siLRHI1! #2! and! #3.! These! RNA! preparations!were! quality! controlled! and! sent! to! the! Centre! for! Microarray! Resources,!Department! of! Pathology,! Cambridge! University,! for! hybridization! to! Illumina!HumanHT/12!version!3!BeadChip!Expression!Array!(http://www.illumina.com/).!The!resulting!raw!and!normalised!expression!data!was!obtained!in!a!format!that!allowed!further! analysis! using! GeneSpring! software! (Agilent).! Bioinformatics! analysis!was!carried!out!under!the!supervision!of!Dr!Ross!Thomas,!Imperial!College!London.!!!!Quantile! normalization! was! performed! and! the! normalised! gene! expression!microarray! data! set! was! analysed! to! remove! background! noise/nonIsignificant!probes.!This!was!performed!by!setting!detection!flags!as!‘present’!for!p<0.01,!which!equated! to!12,589!probes! in!at! least! two!replicates!of!any!of! the! three!conditions.!Data!shown!in!the!heat!map!relate!to!all!the!significantly!expressed!probes!(p<0.01)!with!a!fold!change!≥1.5!(Figure!3.10).!The!siRNA!LRHI1!#2!and!#3!treated!samples!are!shown!in!comparison!with!the!nonItargeting!siRNA.!DownIregulated!probes!are!depicted!in!blue!and!the!upIregulated!genes!in!yellow.!The!difference!in!the!samples!with! LRHI1! knockdown! in! comparison! with! the! nonItargeting! control! sample! is!clearly!visible.!!
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siControl" siLRHI1"#2"siLRHI1"#3"
Figure' 3.10' Gene' expression' pro`iling' of' LRH;1' knockdown' in'

























Figure' 3.11'Overlap' of' genes' between' LRH;1' SiRNA'2' and' 3'with'













sAmuli" 0.002" 14" 2.8"
Response"to"estrogen"sAmulus" 0.002" 7" 5.4"
Response"to"hormone"sAmulus" 0.002" 13" 2.9"
Response"to"steroid"hormone"
sAmulus" 0.003" 9" 3.8"
Response"to"organic"substance" 0.003" 19" 2.1"
Response"to"pepAde"hormone"
sAmulus" 0.042" 6" 3.1"
Figure' 3.12' ' Pathway' enrichment' analysis' for' LRH;1;regulated'




Gene-Symbol- FC-si2-vs-NT- P$value- FC-si3-vs-NT- P$value-
ADCY1" 0.2- 0.000" 0.4- 0.002"
CALCR" 0.4- 0.000" 0.5- 0.000"
SOCS2" 0.4- 0.000" 0.4- 0.000"
ADCY1" 0.4- 0.001" 0.5- 0.001"
SOCS2" 0.5- 0.001" 0.5- 0.001"
KCNJ8" 0.5- 0.000" 0.6- 0.000"
BCL2" 0.5- 0.002" 0.4- 0.001"
ESR1" 0.5- 0.001" 0.6- 0.000"
CAV1" 0.6- 0.003" 0.3- 0.000"
TFF3" 0.6- 0.000" 0.5- 0.000"
MGP" 0.6- 0.000" 0.2- 0.000"
GATA3" 0.7- 0.002" 0.6- 0.001"
MGP" 0.7- 0.023" 0.2- 0.000"
BCL2" 0.7- 0.043" 0.6- 0.005"
MGST1" 1.4- 0.008" 1.4- 0.003"
IDH1" 1.5- 0.003" 1.8- 0.001"
EDEM3" 1.6- 0.006" 1.5- 0.008"
IDH1" 1.7- 0.000" 2.4- 0.000"
MGST1" 1.7- 0.000" 1.7- 0.002"
TNFRSF1A" 1.7- 0.033" 1.6- 0.020"
BTG2" 1.7- 0.008" 1.8- 0.007"
GAL" 1.9- 0.001" 1.5- 0.014"
CYP1A1" 2.2- 0.000" 1.7- 0.002"
PPARG" 2.2- 0.000" 1.8- 0.003"
CYP1B1" 2.3- 0.001" 2.1- 0.001"
A"
Figure' 3.13A' List' of' probes' included' in' Cluster' 1,' Response' to'
















































































































































Figure' 3.13B' Q;RT;PCR' expression' analysis' of' ER,' SOCS2,' BCL2,'
































CXCL12 0.000 0.4- 0.002 0.5- 0.001 7.2-
CXCL12 0.000 0.4- 0.001 0.5- 0.001 7.2-
FLJ30058 0.000 0.4- 0.000 0.4- 0.001 4.4-
AGR3 0.000 0.3- 0.000 0.6- 0.001 4.3-
SGK 0.000 0.5- 0.000 0.4- 0.000 4.0-
PGR 0.000 0.4- 0.001 0.5- 0.001 4.0-
MYB 0.002 0.5- 0.000 0.3- 0.002 3.9-
RAMP3 0.000 0.2- 0.000 0.4- 0.002 3.6-
RAMP3 0.001 0.4- 0.003 0.5- 0.002 3.6-
RBM24 0.000 0.4- 0.000 0.5- 0.001 3.6-
OLFM1 0.001 0.5- 0.000 0.6- 0.001 3.2-
HEY2 0.000 0.3- 0.002 0.5- 0.001 3.1-
MGP 0.000 0.6- 0.000 0.2- 0.003 2.8-
MGP 0.023 0.7- 0.000 0.2- 0.003 2.8-
PCP4 0.000 0.3- 0.000 0.3- 0.001 2.7-
CALCR 0.000 0.4- 0.000 0.5- 0.001 2.6-
DEPDC6 0.000 0.5- 0.001 0.6- 0.001 2.6-
HS3ST3A1 0.001 0.4- 0.001 0.4- 0.001 2.5-
GFRA1 0.000 0.2- 0.000 0.4- 0.002 2.4-
GFRA1 0.000 0.3- 0.002 0.4- 0.002 2.4-
RAB31 0.000 0.5- 0.000 0.4- 0.002 2.3-
FAIM3 0.001 0.6- 0.002 0.6- 0.001 2.2-
PCDH19 0.004 0.6- 0.004 0.6- 0.001 2.1-
GOLSYN 0.004 0.6- 0.002 0.5- 0.002 2.0-
PLAC1 0.001 0.6- 0.000 0.3- 0.002 2.0-
SLITRK4 0.002 0.6- 0.004 0.6- 0.001 1.9-
SEPT5 0.003 0.5- 0.001 0.4- 0.002 1.9-
LOC647784 0.000 0.4- 0.001 0.6- 0.004 1.9-
BIRC3 0.003 2.0- 0.027 1.8- 0.002 1.8-
ACOX2 0.004 2.0- 0.000 3.9- 0.001 1.8-
ASCL1 0.005 0.7- 0.000 0.2- 0.005 1.8-
GAL 0.001 1.9- 0.014 1.5- 0.013 1.8-
MAFB 0.000 0.4- 0.000 0.4- 0.004 1.8-
KCNF1 0.002 0.5- 0.001 0.4- 0.012 1.7-
LONRF2 0.000 0.6- 0.002 0.6- 0.001 1.7-
BCL2 0.002 0.5- 0.001 0.4- 0.001 1.7-
NR5A2 0.001 0.5- 0.011 0.7- 0.001 1.7-
NR5A2 0.005 0.6- 0.015 0.6- 0.001 1.7-
ADCY1 0.000 0.2- 0.002 0.4- 0.005 1.7-
ADCY1 0.001 0.4- 0.001 0.5- 0.005 1.7-
H2AFJ 0.000 0.6- 0.002 0.6- 0.003 1.7-
TMEM26 0.000 0.5- 0.000 0.6- 0.002 1.6-
HCK 0.006 0.6- 0.008 0.6- 0.002 1.5-












SLC11A2 0.001 1.5- 0.000 2.1- 0.007 0.7-
CLSTN2 0.001 0.6- 0.002 0.6- 0.001 0.7-
AHNAK 0.011 0.6- 0.004 0.6- 0.032 0.7-
GPNMB 0.014 1.7- 0.006 2.0- 0.004 0.6-
CAPN9 0.001 2.2- 0.000 3.5- 0.005 0.6-
CAPN9 0.000 2.3- 0.000 4.2- 0.005 0.6-
MGST1 0.000 1.7- 0.002 1.7- 0.004 0.6-
PACSIN1 0.001 0.5- 0.003 0.6- 0.006 0.6-
FAM174B 0.015 1.8- 0.001 2.4- 0.007 0.6-
VSIG2 0.000 2.9- 0.001 2.5- 0.006 0.6-
KRT81 0.000 2.9- 0.001 2.1- 0.014 0.6-
CEACAM6 0.000 4.3- 0.000 4.3- 0.004 0.6-
TPK1 0.000 2.2- 0.000 3.8- 0.003 0.6-
KIAA1199 0.003 1.7- 0.002 1.8- 0.003 0.6-
SERPINB1 0.003 1.8- 0.004 1.7- 0.003 0.6-
SCNN1A 0.001 2.3- 0.000 7.8- 0.007 0.6-
BIK 0.001 1.8- 0.000 2.2- 0.006 0.6-
BNIPL 0.000 0.4- 0.005 0.6- 0.001 0.6-
INHBB 0.000 3.2- 0.006 1.5- 0.007 0.6-
SLC29A3 0.003 1.9- 0.000 2.1- 0.002 0.6-
SOCS2 0.000 0.4- 0.000 0.4- 0.002 0.6-
SOCS2 0.001 0.5- 0.001 0.5- 0.002 0.6-
SGCG 0.001 0.4- 0.000 0.4- 0.003 0.6-
ST3GAL1 0.000 3.4- 0.002 2.2- 0.009 0.6-
CNN2 0.001 2.6- 0.004 1.6- 0.002 0.6-
KCNJ8 0.000 0.5- 0.000 0.6- 0.001 0.6-
NRP1 0.000 2.5- 0.002 2.2- 0.001 0.6-
EMP1 0.000 1.6- 0.001 1.5- 0.003 0.6-
RAP1GAP 0.004 1.7- 0.000 2.6- 0.003 0.5-
TACC1 0.005 0.7- 0.000 0.5- 0.004 0.5-
PMP22 0.000 0.4- 0.000 0.4- 0.003 0.5-
PMP22 0.014 0.6- 0.002 0.4- 0.003 0.5-
PMP22 0.001 0.6- 0.002 0.5- 0.003 0.5-
SAT1 0.001 2.1- 0.001 1.9- 0.008 0.5-
KRT86 0.000 1.8- 0.001 1.6- 0.002 0.5-
NELL2 0.000 0.3- 0.000 0.4- 0.001 0.5-
ALDH3A1 0.000 1.9- 0.000 2.5- 0.005 0.4-
LIMA1 0.003 1.5- 0.002 2.2- 0.001 0.4-
ABCC3 0.004 1.9- 0.000 2.6- 0.001 0.4-
RND3 0.000 3.1- 0.003 1.8- 0.001 0.4-
DDIT4 0.000 1.9- 0.001 1.5- 0.001 0.4-
C9orf169 0.004 1.5- 0.000 2.5- 0.001 0.4-
EPAS1 0.000 3.6- 0.004 2.0- 0.002 0.4-
BCAS1 0.001 2.5- 0.001 2.6- 0.002 0.3-
BCAS1 0.000 3.3- 0.000 3.7- 0.002 0.3-
TNS3 0.000 2.4- 0.001 1.7- 0.001 0.3-
TP53INP1 0.001 2.0- 0.005 1.8- 0.001 0.2-
TP53INP1 0.000 2.2- 0.003 2.0- 0.001 0.2-
Table'3.3B.'List'of'estrogen'repressed'probes'(n=80'genes)'differentially'regulated'1.5'fold'or'more'






























































































































identi`ied' in' the'microarray' analysis' of' siRNA' LRH;1' versus' Non'


















































































!Figure! 3.17! shows! two! other! genes;! LCoR! and! GPER,! variants! 2,! 3,! and! 4.! These!genes! were! not! shown,! in! this! experiment,! to! be! either! significantly! estrogen!regulated! (GPER)! or! estrogen! regulation! fell! below! the! 1.5! fold! cut! off! (LCOR)!however! in! view! of! their! significant! differential! regulation,! may! be! of! potential!importance!in!the!role/function!of!LRHI1.!LCoR! (Ligand! dependent! corepressor)! is! a! known! nuclear! receptor! corepressor!which!functions!through!the!recruitment!of!CIterminal!binding!proteins!(CtBPs)!and!histone! deacetylases! (HDACs)! to! its! NIterminal! and! central! domains,! respectively!(Calderon! et! al.,! 2012;! Fernandes! et! al.,! 2003).! Unlike!many! nuclear! receptor! coIrepressors,! which! are! recruited! to! the! LBD! via! coRNR! boxes! to! unIliganded! or!antagonist!bound!receptors,!LCoR!is!recruited!to!agonistIbound!NR,!via!LXXLL!type!motifs.!This!experiment! showed!LCOR!was!upIregulated!approximately!1.5! fold! in!SiRNA!LRHI1!versus!MCF7.!GPER! is! a! seven! transImembrane! receptor! (7TMR)! belonging! to! the! GIproteinIcoupled! receptor! family! (GPCR).! It! has! been! associated! with! poor! prognosis! and!metastases! in!breast! (Filardo!et!al.,! 2006),!ovarian! (Smith!et!al.,! 2009)! (Yan!et!al.,!2013)!and!endometrial!(Smith!et!al.,!2007a)!cancer.!GPER!binds!estrogen!leading!to!activation!of!the!MAPK!and!PI3K!pathways!(Lin!et!al.,!2009).!Its!role!in!breast!cancer!remains! controversial,!with! studies! analyzing! the! association!between! expression,!as! determined! by! immunohistochemistry,! and! survival! in! patients! with!inflammatory!breast!cancer!showing!that!the!presence!of!both!ERα!and!GPER!(24%)!is!associated!with!an!improved!overall!survival!(p<0.03)!and!conversely!the!absence!of! both! being! associated! with! poor! prognosis! (p<0.03).! In! this! study! 19%! of!specimens! expressed! ERα! only,! whereas! 46%! expressed! GPER! suggesting! that!estrogen!signalling!without!ERα!may!be!important!in!these!patients!(AriasIPulido!et!al.,!2010).!More!recently,!a!knockdown!of!GPER!in!breast!cancer!cell!lines!(MDAIMBI435! and! HCC1806)! negative! for! ERα,! PgR! and! HER2! abolished! the! proliferative!effects! of! 17Iβ! estradiol! and!4Ihydroxytamoxifen! (Girgert! et! al.,! 2012),! suggesting!that!pharmacological!inhibition!of!GPER!maybe!of!therapeutic!benefit!in!this!group!of! patients.! Our! results! show! that! knocking! down! LRHI1! leads! to! a! significant!
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microarray' analysis' of' LRH;1' siRNAs' versus' Non' Targeting' (NT)'






LRHQ1&&Synthetic!agonists!and!antagonists!have!been!designed!for!many!nuclear!receptors.!A! full! list! is! beyond! the! scope! of! this! thesis,! however,! include! ERα:! tamoxifen!(Harper! and! Walpole,! 1967),! raloxifene! (Gottardis! et! al.,! 1990),! faslodex! (ICI!182,780)! (Wakeling,! 1991;! Wakeling! et! al.,! 1991),! the! androgen! receptor:!bicalutamide!(Lunglmayr,!1989),! flutamide!(Prout!et!al.,!1975;!Sogani!et!al.,!1975),!metribolone! (R1881)(Andersen!et!al.,!2010;!Ghanadian!et!al.,!1978),!enzalutamide!(Tran!et!al.,!2009),!ARNI509!(Clegg!et!al.,!2012)! ,!EPII001!(Andersen!et!al.,!2010)! ,!!the!progesterone!receptor:! !mifepristone!(RU486)!and!derivative!compounds!such!as!ulipristal!acetate,!asopisnil!and!telapristone!acetate!!(ChabbertIBuffet!et!al.,!2005)!GR:! mifepristone! (Bourgeois! et! al.,! 1984),! prednisone! and! related! compounds,!dexamethasone! and! fludrocortisones! (Brattsand! et! al.,! 1982;! Gessi! et! al.,! 2010),!PPARα:!GW6471,!GW409544! (Xu!et!al.,! 2001;!Xu!et!al.,! 2002),!PPARδ:!GW501516!(Oliver! et! al.,! 2001),!PPARγ:! rosiglitazone!and!pioglitazone! (Erdmann!et! al.,! 2007;!Kahn!et! al.,! 2006;!Viberti! et! al.,! 2002),!Vitamin!D! receptor:! synthetic! analogues!of!alfacalcidol! and! 1,25I(OH)2D3! (Carlberg! et! al.,! 2012),! LXR:! LXRI623,! YT32! and!GW6340!(De!Boussac!et!al.,!2013;!Kaneko!et!al.,!2003;!Katz!et!al.,!2009;!Yasuda!et!al.,!2010).!!!Thus,! the! small!molecule! (e.g.! steroid!hormones)!mediated!activation!of! this! large!family! of! transcription! factors! appears! to! make! this! family! amenable! to! the!development! of! synthetic! compounds! that! activate! or! inhibit! their! activities.! This!makes! it! possible! to! consider! the! development! of! synthetic! small! molecule!modulators!of!LRHI1!that!act!by!binding!to!its!ligand!binding!domain.!!!The!solution!of!the!LRHI1!LBD,!by!crystallography,!together!with!the!identification!of!potential!ligands!(phospholipids)!and!the!(albeit)!weak!synthetic!agonists!already!
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3.3.1& Space& filling& approaches& for& identifying& compounds& that& are& similar& to&
phospholipids&and&synthetic&LRHQ1&agonists&One!avenue!of!computational!identification!of!compounds!that!potentially!target!the!protein!of! interest! is! to!use!modeling!algorithms,! in!which!screening! is!performed!for!compounds!that!have!similar!electrostatic!charge!and!space!filling!as!a!selected!reference!compound.!Two!computational!approaches,!using!software!developed!by!the! Cresset! group! and! scaffold! hopping! (SHoP)! were! used! by! our! collaborator,!Professor! Alan! Spivey! (Department! of! Chemistry,! Imperial! College)! to! identify!commercially!available!compounds!that!have!similar!space! filling!and!electrostatic!properties! as! the!most! potent! LRHI1! agonist! reported! at! that! time! (Whitby! et! al.,!2006)!(compound!5L,!5L,!a!cisCbicyclo(3.3.0)IoctI2Iene!(Figure!3.19).!One!reason!for!attempting! to! identify! alternative! compounds! rather! than!using! compound!5L! (or!related! compounds)!was! because! the! published! compounds! require! an! extremely!complex! synthetic! route! and! are! very! unstable! ((Whitby! et! al.,! 2011);! Richard!Whitby! personal! communication).! Alternative! compounds! that! are! easier! to!synthesise! and! to! derivatize! for! analogue! generation! might! yield! new! and! more!facile! chemical! starting! points! for! modification! to! generate! potent! LRHI1!antagonists.!!!The!Cresset!methodology!utilises!the!ability!of!structurally!different!compounds!to!bind!to!the!same!biologically!active!site!by!redefining!a!compound!based!on!its!‘field!point’!data!including!electrostatic,!steric!and!hydrophobic!fields.!The!hypothesis!of!this!approach!is!that!it!is!not!the!three!dimensional!structure!which!is!important!but!the!way!that!molecules!interact!via!their!electrostatic!and!Van!der!Waal!forces!and!that! compounds! with! similar! field! patterns! will! have! similar! binding! properties.!Four! field! types! are! described! and! assigned! a! colour;! electrophilic! (red),!nucleophilic! (blue),! van! der!Waals! attractive! (yellow)! and! hydrophobic! (orange).!
!!
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The!size!and!position!of!these!field!points!on!a!3D!image!can!then!be!used!to!match!with!compounds!having!similar!chemical!properties!(Cheeseright!et!al.,!2006).!!!Using!this!technique!and!the!published!agonist,!compound!5L!(Whitby!et!al.,!2006)!200! commercially! available! compounds! (similarity!0.76I0.82),! of!which!102! could!be!purchased,!were!identified!(Figure!3.19A).!!!!Another! Cresset! virtual! screen! approach! was! carried! out,! in! order! to! identify!compounds! with! similar! electrostatic! and! space! filling! properties! as! the! LRHI1!interacting!αIhelical!motif! present! in!DaxI1,!was! also! used! to! identify! compounds!that!might! act! as! coIactivator!binding! inhibitors! (CBIs).! (Figure!3.18).!This! screen!was!facilitated!by!the!availability!of!the!LRHI1!DaxI1!crystal!structure!(Sablin!et!al.,!2008).!Using!this!approach!a!peptide!portion!of!DAXI1,!observed!to!bind!to!LRHI1!and! having! the! sequence,! PCFXXLP,! was! then! modeled! to! identify! commercially!available!compounds.!Twelve!of!the!top!30!hits!were!purchased!for!screening.!!!
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Compound R1 R2 
JR476 






























































































































































































































3.3.4&Coactivator&binding&Inhibitors&(CBIs)&The! alternative!method! of! targeting! the! coIfactor! binding! domain,! other! than! the!Cresset!approach!detailed!above,!was!the!use!of!a!rational!structure.!Transcriptional!coIactivator!proteins!bind! to! the!nuclear! receptor!LBD! through!a! charge! clamp! in!the! LBD! interacting! with! the! alpha! helical! motifs! having! the! consensus! sequence!LXXLL! in! coIactivator! proteins.! Some! coIrepressors,! such! as! SHP! also! bind! LRHI1!through! an! LXXLL! type! motif.! (Li! et! al.,! 2005;! Ortlund! et! al.,! 2005;! Sablin! et! al.,!2008).! Using! an! approach! already! described! for! the! design! and! development! of!novel!CBIs!for!ERα!(LaFrate!et!al.,!2008),!!a!scaffold!was!designed!based!on!the!LRHI1!binding!region!alpha!helix! in!SHP!that!has! the!sequence! ILYTLLS!(Krylova!et!al.,!2005).!!Described!below!is!the!screening!strategy!and!results!for!the!compounds!designed!using!the!approaches!outlined!above.!! !
3.4&Screening&Assays&for&compounds&with&LRHQ1&activity&
3.4.1&CellQbased&LRHQ1&regulated&luciferase&reporter&gene&assay&for&screening&
of&selected&compounds&Initially!the!compounds!were!screened!using!a!cellIbased!assay!in!which!LRHI1!was!coItransfected! in! COSI1! cells!with! an! LRHI1! responsive! firefly! luciferase! reporter!gene! (Thiruchelvam! et! al.,! 2011),! allowing! scoring! of! compounds! by! measuring!firefly! luciferase! activity! as! a! surrogate! for! LRHI1! transcriptional! activity.!Antagonists!would!be!expected!to!inhibit!LRHI1!activity!and!thus!reduce!luciferase!output,!whereas!agonists!would!stimulate!reporter!gene!activity.!!!To!validate!this!approach,!and!develop!the!basis!for!experiments!with!our!designed!compounds,! LRHI1!was! coItransfected!with! an!LRHI1! responsive! firefly! luciferase!
!!
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Figure'3.24'Cell'based' screening' system' for' compounds' targeting'














































































































































































































































Figure'3.27'AB_WC'Compound'Screen'(001;102)'COSN1$ cells$ were$ transfected$ with$ LRHN1,$ LRHN1Nluc$ and$ renillaNluc.$Cells$ were$ treated$ with$ compounds$ identi\ied$ from$ Cresset$ screening$using$compound$5A.$Shown$are$the$mean$activities$for$each$compound$(n=3)$ for$ all$ compounds$ used$ at$ a$ \inal$ concentration$ of$ 25µM.$Compounds$ that$ activated$ LRHN1$ as$ better$ than$ compound$ 5A$ are$shown$in$blue$rectangles,$compounds$that$inhibited$LRHN1$are$shown$in$orange.'$
182"
Figure'3.28'Determination'of'dose'dependent'activation'of' LRH;1'
by'AB_WC'compounds'(A)$ Table$ showing$ compounds$ and$ structures.$ (B)$ COSN1$ cells$ were$transfected$ with$ LRHN1,$ and$ the$ LRHN1Nluc$ and$ renilla$ luc$ reporter$genes.$ Compounds$ were$ added$ 5$ hours$ following$ transfection$ and$luciferase$activities$were$determined$after$a$further$24$hour.$Bar$charts$show$mean$LRHN1Nluc$reporter$activities$(n=4)$following$normalization$against$renillaNluc.$Reporter$activity$for$the$DMSO$(vehicle)$control$was$taken$ 100%$ and$ all$ other$ activities$ shown$ relative$ to$ this.$ Error$ bars$show$SEM.$$$$
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!We! reIexamined! the! reporter! gene!data! for! all! the! compounds! to! identify!weaker!LRHI1!activators,!which!show!activity!at!lower!doses.!Of!the!101!compounds,!three!(ABIWC!057,!61! and!79)! activated!LRHI1!at!1µM!concentrations! (Figure!3.32).!Of!these!AB_WC!057!was!also!evaluated!against!ERα,!which!it!activated!(Figure!3.33C),!although!there!was!no!notable!effect!on!renilla!luciferase!activity.!In!growth!assays,!AB_WC! 057! did! not! stimulate!MCFI7! cell! growth! in! estrogenIdepleted! conditions!despite! stimulating!ERα!and!LRHI1! activities! in! the! reporter! gene! assay,! implying!that! the!ERα!and!LRHI1!stimulation!by!AB_WC!057! is!extremely!weak.!There!was!also! no! affect! on!MDA_MB_231! cell! growth,! so!AB_WC!057!does! not! appear! to! be!deleterious!for!cell!growth.!!!Additional!chemistry!was!carried!out!(Prof!Spivey!group)!to!generate!analogues!of!the! related! indole! CI3! benzothioethers,! compounds! 66! and! 88.! Nine! compounds!were! tested!and!of! these!compounds!107,!111!and!112!stimulated!LRHI1!activity,!with!no!detectable!activity!for!the!remaining!compounds!(data!not!shown).!!!Compound! AB_WC! 107! appeared,! in! additional! reporter! gene! assays! to! inhibit!renilla! activity! at! the! active! doses,! with! some! evidence! of! activation! of! ERα,!indicative!of!offItarget!and!nonIspecific!growth!inhibitory!effects!at!the!active!doses!(Figure! 3.34).! ! Similar! results! were! obtained! for! compound! 111! (Figure! 3.35).!Interestingly!compound!ABIWC!112,!which!stimulated!LRHI1!and!ERα!(Figure!3.36)!promoted!MCF7!cell!growth!at!a!concentration!of!10µM,!although!this!effect!was!lost!at!25µM,!likely!due!to!offItarget!‘toxicity’,!since!the!growth!of!MDAIMBI231!cells!was!also! inhibited! at! this! concentration.! These! results! indicate! that! the! CI3!benzothioether!scaffold!could!be!use! to!generate!LRHI1!agonists.!However,!LRHI1!selectivity!is!clearly!a!problem!with!the!compounds!tested!to!date.!!
Compound 
Number Verbal Label Structure MW 
AB_WC057 Benzimidazole 268.37 
AB_WC061 Benzofuran 250.29 











5a                                      5L 
Figure' 3.32' Determination' of' dose' dependent' activation' of'





























































































































































































































































































































Figure' 3.34'AB_WC'107' shows' no' effect' on' LRH;1' and' stimulates'





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































!In! terms! of! the! compounds! with! potential! antagonist! activity! from! the! Cresset!screen! there! were! only! two! compounds! from! the! reporter! screen! showing! an!inhibition!of!activity!below!vehicle!treated!cells!of!greater!than!5%,!compounds!54!(17%)! and! 102! (21%).! I! chose! to! investigate! these! compounds! further! and! also!picked!three!other!compounds!(19,!44!and!101)!that!only!weakly!activated!LRHI1!(Figure! 3.37).! Only! compound! 102! showed! a! dose! dependent! inhibition! of! LRHI1!activity.! However,! no! reduction! in! activation! of! LRHI1! by! 5A!was! seen! indicating!that!LRHI1!inhibition!by!the!compounds!may!be!indirect!(Figure!3.38).!
Compound 




















































































































!Taken! together,! screening! of! commercially! available! compounds! identified! on! the!basis!of! an! in! silico! screen! for! compounds!with! structural! similarity! to!previously!reported! LRHI1! agonists,! identified! a! series! of! compounds! that! strongly! activated!LRHI1! in! a! reporter! gene! assay.! Further! evaluation! of! these! compounds! is!suggestive! of! potential! binding! to! LRHI1,! but! all! of! the! compounds! that! activated!LRHI1!also!activated!ERα.!Therefore,!either!these!compounds!bind!widely!to!nuclear!receptors! and/or! the! activation! is! due! to! offItarget! effects,! for! example! through!modulation!of!protein!kinase!pathways!or!chromatin!remodeling!enzymes.!This!may!explain!the!“toxicity”!observed!at!higher!concentrations.!It!is!likely,!therefore,!that!a!considerable!amount!of!chemistry!design!would!be!needed!for!obtaining!improved,!selective! LRHI1! inhibitors,! most! likely! achievable! only! by! screening! libraries! of!compounds!related!to!the!compounds!that!activate!LRHI1.!!!With!respect!to!the!potential!LRHI1!inhibitors,!the!effects!were!extremely!small!and!are! likely! to! be! indirect.! Given! the! very! few! compounds! that! inhibited! LRHI1,! as!opposed! to! the! many! that! activated! LRHI1! it! is! possible! that! an! approach! for!generating!LRHI1!antagonists!that!is!based!on!modeling!of!a!LRHI1!agonist,!may!not!be!appropriate.!!!!
3.4.1.3" Design" of" LRHB1" inhibitors" based" on" modeling" of" Nuclear" Receptor"
antagonists"in"the"LRHB1"LBD"Section! 3.3.3! describes! the! modeling! approach! that! was! used! to! determine! if!compounds! similar! to! available! antagonists! for! other! nuclear! receptors,! where!structures!of!the!antagonist!bound!in!the!LBD,!are!available.!In!particular,!the!antiIestrogens! raloxifen,! tamoxifen! and! faslodex! in! the! ERα! LBD!were!modeled! in! the!LRHI1!LBD,!to!identify!compounds!that!might!be!accommodated!in!the!LRHI1!LBD.!The!antiIestrogens,!raloxifene,!tamoxifen!and!Faslodex,!nor!estrogen!itself,!affected!the!activity!of!LRHI1!in!reporter!gene!assays!(Figure!3.39).!!
Figure' 3.39' Anti;estrogens' and' estrogen' do' not' affect' activity' of'











































































!A! small! number! of! compounds! based! on! raloxifene! (nine! compounds),! tamoxifen!(six! compounds)! and! 6! steroidal! compounds! based! on! the! FXR! agonist! (MFAI1)!(Soisson!et!al.,!2008),!!were!assessed!using!the!LRHI1!responsive!luciferase!reporter!assay.! These! compounds! were! much! more! difficult! to! solubilise! in! DMSO! and!subsequently!in!aqueous!cell!media.!The!starting!concentration!was!therefore!10!µM!with! 1µM! and! 0.1µM! to! provide! a! dose! titration.! Again,! as! with! the! Cresset!compounds,! visually! significant! cell! toxicity!was! seen!with! higher! concentrations,!with! reduced! renilla! luciferase!activation!at!10µM!doses!of!most! compounds.!At!a!concentration!of!1µM,!when!no!reduction!on!renilla!luciferase!activity!was!seen!for!any!of!the!compounds!(Figure!3.40)!several!compounds!activated!LRHI1,!including!JR430,!JR476!and!JR442.!!!Similar! problems!with! renilla! activity!were! observed! for! the! tamoxifen! analogues!(Figure!3.41).!Moreover,! there!was!no!significant!activation!or! inhibition!of!LRHI1!by!the!tamoxifen!analogues.!!Finally,!the!FXR!steroidal!derived!compounds!also!had!little!or!no!affect!on!LRHI1,!with! the! exception! of! TJC123,! which! activated! LRHI1! at! higher! concentrations!(Figure!3.42).!
Figure'3.40'Effects'of'Raloxifene'analogues'on'LRH;1'



























































































































































































3.4.1.4"Cresset"Screen:"DaxB1"peptide"Twelve!compounds!arising! from!modeling!of! the!DAXI1!LRHI1! interacting!peptide!were!purchased.!Of! these!compounds!AB_DC!08!and!12!showed!a!dose!dependent!inhibition!of!LRHI1!activity!(Figure!3.43).!Compounds!AB_DC!01,!03!and!11!showed!apparent! activation! on! normalised! data! however! this! was! an! exaggeration! of!decreased!transfection!efficiency!with!signs!of!cell!toxicity.!!!Based! on! the! inhibition! observed! with! AB_DC! 12,! twelve! analogues! were!synthesized,! including! stereoIisomers! of! compound! AB_DC! 12,! AB_DC12a! and!AB_DC12b.! However,! none! of! these! compounds! inhibited! LRHI1! activity! (Figure!3.44).!!
Figure'3.43'Effects'of'Dax;1'mimetics'on'LRH;1'transcriptional'


































































































































































3.4.1.5"αBhelix"mimetics$Three! compounds! that! were! designed! to! mimic! the! αIhelical! LRHI1! interacting!region! in!the!SHP!protein,!(αIhelical!mimetics)!were!generated!by!Dr!A.!Bayly!and!Professor!A.!Spivey!(Imperial!College!London)!(Figure!3.45A).!Compound!ARB_238!did! not! affect! LRHI1! reporter! activity! (Figure! 3.45B).! Compounds! ARB_190! and!ARB_260!modestly!stimulated!LRHI1!activity!at!the!highest!dose.!The!stimulation!of!LRHI1!activity! is!unexpected!and!may!be!a! reflection!of! inhibition!of! coIrepressor!recruitment,!although!the!αImimetics!would!also!be!expected!to!prevent!coactivator!recruitment.! Of! the! three! compounds! submitted! two! showed!minimal! agonism! at!10µM!up!to!1.7!fold!compared!to!vehicle!treated!cells!(Figure!3.45B).!
Figure'3.45'Effects'of'α'helix'mimetics'on'LRH;1'transcriptional'
activity'(A)$Structures$of$the$α$helix$mimetics$based$on$the$analysis$of$the$SHP$NR$ box$ peptides$ binding$ residues$ with$ LRHN1$ (B)$ COSN1$ cells$ were$transfected$ with$ LRHN1,$ and$ the$ LRHN1Nluc$ and$ renilla$ luc$ reporter$genes.$ Compounds$ were$ added$ 5$ hours$ following$ transfection$ and$luciferase$activities$were$determined$after$a$further$24$hour.$Bar$charts$show$ mean$ LRHN1Nluc$ reporter$ activities$ following$ normalization$against$renillaNluc.$Reporter$activity$for$the$DMSO$(vehicle)$control$was$taken$ 100%$ and$ all$ other$ activities$ shown$ relative$ to$ this.$ Error$ bars$show$ SEM.$ Compounds$ ARB$ 190$ and$ 260$ show$ cellular$ toxicity$ and$Renilla$drop$off$at$10$and$25µM$
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Figure' 3.46' Effects' of' SHoP' compounds' on' LRH;1' transcriptional'
























































3.4.2&Development&of&an& in&vitro&screen& for& identification&of&compounds& that&
bind&the&LRHQ1&LBD,&to&block&coQactivator&recruitment&Ligand! binding! assays! allow! for! direct!measurement! of! compound! binding! to! the!ligand!binding!domain.!Generally!these!assays!involve!the!use!of!radioactive!ligands,!whose! displacement! by! the! compound! of! interest! allows! binding! affinities! to! be!determined!(LaFrate!et!al.,!2009).!In!the!case!of!nuclear!receptors,!ligand!binding!to!the!LBD!can!be!assessed!indirectly,!by!measuring!the!ligandIdependent!recruitment!of!transcriptional!coIactivators!by!interaction!with!the!LBD!(e.g.!(Albers!et!al.,!2006;!Xu!et!al.,!2002).!Agonists!would!be!expected!to!promote!coactivator!recruitment!and!conversely,! antagonists!will! inhibit! coIactivator! interaction.! Such! an! assay! can! be!performed! in! vivo,! using! proteinIprotein! interaction! assays,! for! example! the!mammalian! 2Ihybrid! approach! (Albers! et! al.,! 2006;! Xu! et! al.,! 2002).! As! with! the!reporter!assay!used!in!the!preceding!section,!there!is!however,!the!problem!that!offItarget!effects!obscure! identification!of!compounds! that!bind! to! the!LRHI1!LBD.!To!develop! an! alternative! approach! for! identifying! synthetic! compounds! that! bind! to!the! LRHI1! LBD,! I! therefore! developed! and! optimized! an! in$ vitro$ assay,! using! the!Alpha!Screen!system!(Glickman!et!al.,!2002;!Li!et!al.,!2005;!Taouji!et!al.,!2009;!Wu!et!al.,!2005;!Xu!et!al.,!2002),!for!LBDIcoactivator!interaction!screening!of!compounds.!The!alpha!screen!method!allows!rapid,! screening!of!nuclear! receptor!LBD!binding!molecules! that! change! the! interaction! between! the! LBD! and! coIactivator! or! coIrepressor! proteins.! Importantly,! this! assay! can! be! scaled! up! for! highIthroughput!screening! of! compound! libraries.! The!method! depends! on! the! proximity! of! donor!and!acceptor!beads!provided!by!a!proteinIprotein!interaction,!where!one!protein!is!coupled! to! the! donor! bead! and! the! second! to! an! acceptor! bead.! Excitation! of! the!donor!bead!with!a!high!intensity!laser!at!680nm!generates!a!singlet!ambient!oxygen!molecule!on!the!surface!of!the!donor!bead!(Figure!3.47).!A!photoIsensitiser!present!on!the!bead!converts!this!ambient!oxygen!singlet!into!a!more!excited!state!with!the!ability! to! diffuse! up! to! 200nm.! If! an! acceptor! bead! is! within! this! proximity! the!oxygen! singlet! will! react! with! a! thioxene! derivative! in! the! acceptor! beads,!generating! chemoluminescence! at! 370nm! and! further! activating! a! cascade! of!
!!
210!
fluorophores!which! emit! light! at! 520I620nm.! This! light! can! then! be! detected! and!used! as! a! measure! of! bead! based! proximity.! If! the! acceptor! is! not! within! this!proximity! the! oxygen! will! decay.! ! This! system! has! been! used! previously,! among!other!indications,!to!look!at!LRHI1!LBD!coIfactor!recruitment!(Li!et!al.,!2005;!Taouji!et! al.,! 2009)! and! can! be! carried! out! in! 384! well! plate! formats.! Compounds! that!stimulate! the! LRHI1! LBDIcoactivator! interaction! upon! binding! to! the! LRHI1! LBD!(agonists)! should! increase! emission! at! 520I620nm! whilst! those! that! inhibit! the!interaction!will!reduce!the!level!of!emission.!























































































































































































3.4.2.1"Alpha"Screen"Optimisation""To! set! up! the! interaction! assay,! the! HisIMBPILRHI1ILBD! fusion! protein! (100nM)!was! incubated!with! increasing! concentrations! of! the! biotinylated! PGC1α! or! SRC2!coactivator!peptides.! LRHI1! interaction!with!both!peptides!was!observed,!with!an!expected!bell!shaped!curve!with!varying!peptide!concentration!(Figure!3.49A).!The!bell! shaped! curve! is! due! to! reagent! depletion! or! the! documented! ‘hook! effect’!(www.perkinelmer.co.uk/resources/technicalresources).! The! optimum! concentration!combination! was! assessed! by! a! titration! of! PGC1α! and! SRC2! against! several!concentrations! of! LRHI1! (20nM,! 50nM! and! 100nM;! Figures! 3.49B! and! 3.49C!respectively).! The! results! showed! a! titratable! increase! in! binding! with! increased!concentration! of! LRHI1! LBD! protein! and! peptide.! The! peak! concentration! or! the!peak!of!the!hook!effect!is!defined!by!the!coIactivator!peptide!and!occurred!at!137nM!for!both!peptides!with!100nM!of!LRHI1!(Figure!3.49A).!PGC1α!gave!overall!higher!alpha!signals!at!each!concentration!combination!in!comparison!with!SRCI2!(Figures!3.49B!and!C).!At!50nM!of!LRHI1,! the!EC50! for!PGC1α!was!35nM!versus!369nM!for!SRC2.!However,!using!100nM!LRHI1!LBD,! the!values!were!more!comparable,!with!EC50!values!of!27!and!28nM,!respectively.!!!On!the!basis!of!these!experiments,!a!combination!of!50nM!LRHI1!LBD!with!50nM!coIactivator!peptide!was!felt!to!be!optimum!for!experiments!assessing!compounds!with!agonism,! i.e.! an! increase! in! the! alpha! signal,! whereas! compounds! assessing!antagonism,! i.e.! a! decrease! in! alpha! signal!were! felt! to! be! better! assessed! using! a!baseline!combination!of!50nM!LRHI1!with!100nM!coIactivator!peptide.!This!would!allow,! in!both! instances,! a! robust! ‘z’! score,!detailed! in! section!3.2.16! (Zhang!et! al.,!1999)! and! therefore! an! adequate! background! to! signal! window! for! experimental!compounds.!!
AB
C
Figure' 3.49' Optimisation' and' Validation:' Co;Activator' Peptides/'
LRH;1'LBD'Comparison$ of$ the$ af\inity$ of$ coNactivator$ peptides$ with$ 100nM$ his$tagged$ LRHN1$ LBD$ protein$ (A).$ 100nM$ protein$ plus$ the$ coNactivator$peptide$ titration$ (ranging$ from$ 100µM$ to$ 1.6nM$ over$ 11$ data$ points)$and$buffer$are$incubated$with$the$nickel$chelate$coated$acceptor$beads$in$ triplicate$ wells$ per$ peptide$ concentration$ on$ 384$ well$ plate.$Following$ a$ 30$ minute$ incubation$ the$ streptavidin$ donor$ beads$ are$added$and$the$reaction$further$incubated$for$1$hour$prior$to$reading$the$plate.$ Statistical$ reliability$ of$ each$ experiment$ is$ assessed$ using$ a$ Z$score$ and$ accepted$ if$ >0.45.$ The$ plate$ results$ are$ analysed$ via$ Prism$software.$The$mean$values$of$the$alpha$signal$are$shown,$corrected$for$background$signal$and$the$error$bars$represent$the$SEM.$Results$show$good$binding$by$both$coNactivators$with$a$marginally$increased$af\inity$of$PGC1α$for$LRHN1$LBD$over$SRC2.$The$af\inity$of$PGC1α$(B)$or$SRC$2$(C)$ peptide$ with$ 20nM,$ 50nM$ and$ 100nM$ of$ his$ tagged$ LRHN1$ LBD$protein.$ Each$ coNactivator$ peptide$ titration$ (ranging$ from$ 100µM$ to$1.6nM$over$10$data$points$as$before)$ is$added$in$triplicate$to$384$well$plate$ to$ 20nM,$ 50nM$ and$ 100nM$ his$ tagged$ LRHN1$ LBD$ respectively$with$nickel$ chelate$acceptor$beads$ to$a$ total$ volume$20µl.$Following$a$30$minute$incubation$the$streptavidin$donor$beads$are$added$to$a$total$volume$of$ 25µl$ and$ the$ reaction$ further$ incubated$ for$1$hour$prior$ to$reading$ the$ plate.$ Statistical$ reliability$ of$ each$ experiment$ is$ assessed$using$a$Z$score$and$accepted$if$>0.45.$Results$show$a$titratable$increase$in$binding$with$increased$concentration$of$protein.$Again,$PGC1α$has$an$increased$ signal$ with$ LRHN1$ with$ an$ EC50$ of$ 35nM$ versus$ 369nM$ at$50nM$ although$ more$ comparable$ at$ 100nM$ with$ EC50$ 27nM$ versus$28nM$respectively.$$
Cambridge peptides: titration with 100nM LRH-1 LBD
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using"compound"5A"Whitby"agonist"compound"5A"To!determine!if!the!Alpha!Screen!assay!set!up!can!be!used!to!screen!for!compounds!that!bind! the!LRHI1!LBD,!we!used!compound!5A,! (Whitby!et!al.,!2006).!The!assay!was! performed! in! two!ways,! initially! by! keeping! a! set! concentration! of! HisIMBPILRHI1ILBD! and! peptide! (50nM:50nM)! and! adding! increasing! concentrations! of!compound! 5A,! or! by! keeping! a! set! concentration! of! LRHI1! and! titrating! in! a! coIactivator! peptide! in! the! presence! or! absence! of! a! fixed! concentration! (5µM)! of!compound! 5A.! In! the! first! assay,! increasing! 5A! concentrations! stimulated! LRHI1/PGC1α! interaction! in! a! dose! dependent! manner,! with! an! EC50=221nM! (Figure!3.50A).! The! second! assay! was! performed! using! the! SRC2! peptide.! Addition! of!compound!5A!resulted!in!a!shift!in!the!EC50!for!the!interaction!of!LRHI1!with!SRC2,!from! 246nM! to! 92nM! (Figure! 3.50B)! again! demonstrating! that! compound! 5A!promotes! the! interaction! of! LRHI1!with! coIactivator! peptides,! consistent! with! its!action!as!a!LRHI1!agonist.!
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Figure' 3.50' Optimisation' and' Validation:' Increased' binding' with'
Whitby''Compound'5A'(A)$A$\inal$concentration$of$50nM$his$tagged$LRHN1$LBD$protein,$50nM$PGC1α$ coNactivator$ peptide$ and$ a$ concentration$ titration$ of$ Whitby$compound$ 5A$ is$ incubated$ with$ the$ nickel$ chelate$ coated$ acceptor$beads$ in$ triplicate$wells$ per$ peptide$ concentration$ on$ 384$well$ plate.$Compound$concentrations$ranged$from$25µM$to$0.4nM.$Following$a$30$minute$ incubation$ the$ streptavidin$ donor$ beads$ were$ added$ and$ the$reaction$ further$ incubated$ for$ 1$ hour$ prior$ to$ reading$ the$ plate.$Statistical$ reliability$ of$ each$ experiment$was$ assessed$ using$ a$ Z$ score$and$accepted$if$>0.45.$The$plate$results$are$analysed$via$Prism$software.$The$ mean$ values$ of$ the$ alpha$ signal$ are$ shown,$ corrected$ for$background$signal$and$the$error$bars$represent$the$SEM.$Results$show$agonism$ with$ 5A$ and$ an$ EC50$ 221nM.$ (B)$ The$ af\inity$ of$ SRC$ 2$ coNactivator$ peptide$ with$ 50nM$ of$ his$ tagged$ LRHN1$ LBD$ protein$ is$assessed$ plus$ and$ minus$ 5uM$ compound$ 5A.$ SRCN2$ peptide$ titration$(ranging$ from$ 100µM$ to$ 1.6nM$ over$ 10$ data$ points$ as$ before)$ was$added$ in$ triplicate$ to$ 384$ well$ plate$ to$ 50nM$ his$ tagged$ LRHN1$ LBD$respectively$with$nickel$chelate$acceptor$beads$and$either$compound$5A$or$ DMSO$ control.$ Following$ a$ 30$ minute$ incubation$ the$ streptavidin$donor$ beads$ were$ added$ to$ a$ total$ volume$ of$ 25µl$ and$ the$ reaction$further$ incubated$ for$ 1$ hour$ prior$ to$ reading$ the$ plate.$ Statistical$reliability$of$each$experiment$was$assessed$using$a$Z$score$and$accepted$if$>0.45.$The$plate$results$were$analysed$via$Prism$software$as$above.$$
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Figure'3.53'Alpha' Screen'assay' for'determining' effects' of' soluble'
compounds' (1µM)' on' interaction' of' LRH;1' LBD' with' PGC1α' co;















































































































































































































Figure' 3.54' Alpha' Screen' assay' for' determining' effects' of' poorly'
soluble'compounds'(10µM)' 'on'interaction'of'the'LRH;1'LBD'with'





























Figure' 3.55' Alpha' Screen' assay' for' determining' effects' of' poorly'
soluble'compounds'(1µM)'on'interaction'of'LRH;1'LBD'with'PGC1α'










































































































































































































































Figure' 3.56' Alpha' Screen' assay' for' determining' non' speci`ic'
binding' inhibition:'effects'of' the'22'compounds'previously'shown'




























































































































Figure' 3.58' JR' 430' has' weak' antagonism' to' LRH;1' and' shows'



































































































































































































































































Figure' 3.60' Alpha' Screen' assay' for' determining' the' effects' of'
compounds' on' interaction' of' the' LRH;1' LBD' with' the' PGC1α' co;










































































Figure' 3.61' Alpha' Screen' assay' for' determining' the' effects' of'
compounds' on' interaction' of' the' LRH;1' LBD' with' the' PGC1α' co;






















































breast&cancer&!Gene! expression!microarray! analysis! showed! that! the! overall! number! of! estrogen!regulated! genes!was! lower! in!MLET5! than! in!MCF7! cells.! Increased! expression! of!ERα,!PgR!and!GREB1!mRNA!levels!was!evident!in!the!absence!of!estrogen,!reflecting!the!estrogen! independence!of!MLET5!cell! growth.!A!number!of! the!genes! that!are!estrogenIregulated! in! MCF7! cells! showed! altered! expression! in! MLET5! cells,!consistent!with! gain! of! estrogenIindependent! expression.! Examples! include! CD36!(mildly! estrogen! repressed),! TM4SF1! (estrogen! repressed),! IGFL1! (estrogen!repressed)! and! Calb2! (estrogen! stimulated)! and! these! were! the! top! four! ranking!differentially!regulated!genes.!It!would!be!interesting!to!look!further!at!these!genes!as!per!the!data!discussed!in!section!3.1.3!which!suggests!they!could!be!useful!as!part!of!a!genetic!signature!of!endocrine!resistance,!or!novel!therapeutic!targets!in!breast!cancer!(TM4SF1).!Estrogen!independence!in!the!expression!of!ERα!target!genes!has!been!described! for! longIterm!estrogenIdeprived! (LTED)!MCF7! cells,! developed!by!Dr!LIA!Martin!and!Prof!M!Dowsett!(Chan!et!al.,!2002).!LTED!cells!were!generated!by!continuous!culturing!and!passaging!of!MCF7!cells!in!estrogenIfree!media.!The!LTED!cells! go! through! three! stages:! initially! no! growth! (quiescence)! for! 15! weeks,!followed! by! growth! in! keeping! with! increasing! estrogen! sensitivity!(hypersensitivity),! then! growth! independent! of! estrogen! at! 50! weeks!(independence).! ERα! expression! is! elevated! in! the! estrogen! hypersensitive! and!independent!stages,!as! is!also!observed! in!MLET5!cells.!Note! that!MLET5!cells!are!clonal,!whereas! the!LTED!phenotype! is!reflective!of! the!culture!and!may!therefore!represent!a!mixed!cell!population.!In!LTED!cells,!no!significant!changes!were!seen!in!cofactor!protein!levels!(SMRT,!TIFI1,!RIP140),!but!elevated!ERK1/ERK2!activity!led!to! increased! ERBB2! expression! and! the! LTED! cells!were! sensitive! to! the! tyrosine!
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kinase!inhibitor!ZD1839!and!the!MEK!inhibitor!U0126!(Martin!et!al.,!2003;!Martin!et!al.,! 2005).! LTED! cells! have! increased! sensitivity! to! growth! suppression! by! ICI!182,780! (Martin! et! al.,! 2005),! indicative! of! a! requirement! for! ERα.! By! contrast,!MLET5! cells! grow! in! the! presence! of! tamoxifen! or! ICI! 182,780,! although! their!growth! is! slowed! compared! with! culturing! in! the! presence! of! estrogen! or! in! the!absence!of!ligand,!implying!some!estrogen!dependence.!LTED!cells!generated!in!the!Santen!lab!also!showed!emergence!of!increase!in!sensitivity!to!low!levels!of!estrogen!(Song!et!al.,!2002),!however,!in!this!model!there!was!no!change!in!the!transcription!of!ERα! target! gene! regulation,! although! there!was! an! increase! in! activation!of! the!MAPK/mTOR/PI3K! pathways! (Santen! et! al.,! 2008;! Song! et! al.,! 2002;! Yue! et! al.,!2003).!In!MLET5!cells,!other!work!from!our!laboratory!did!not!provide!evidence!for!changes! in! EGFR! or!HER2.!However,! there!was! an! increase! in! PIAKT! activity! and!MLET5! cells! were! 5! times! more! sensitive! than! MCF7! to! the! PI3K! inhibitor,!LY294002!(Tolhurst!et!al.,!2010).!The!activation!of!AKT!by!growth!factors!occurs!in!a!PI3K!dependant!way!(Franke!et!al.,!1995).!Once!activated!AKT!then!activates!ERα!by! phosphorylation! at! SerI167! or! regulates! apoptosis! pathways.! Kirkegaard! et$ al!have!reported!that!the!AKT/mTOR/PI3K!pathway!is!associated!with!a!greater!risk!of! relapse! and! death! in! patients! with! ERα! breast! cancer! treated! with! tamoxifen!(Kirkegaard! et! al.,! 2005).! A! recent! study! looked! at! ERα! positive! primary! breast!cancer! samples! and! subsequent!metastatic! samples.! It! assessed! the! expression! of!downstream!activated!proteins!in!the!AKT/mTOR/PI3K!pathway!(pImTOR,!pI4EBP!and!pIp70S6K)!by!immunohistochemistry!and!showed!a!45%!increase!in!pImTOR!in!metastatic! samples! compared!with!primary! tumour! in!patients!previously! treated!with! endocrine! therapy! (n=34)! versus! patients! who! did! not! receive! adjuvant!endocrine! treatment! (n=37).! A! multivariate! analysis! confirmed! a! significant!increase!in!all!three!proteins!in!patients!previously!treated!with!adjuvant!endocrine!therapy! (Beelen!et!al.,! 2014).!Preclinical! studies!using! low!dose!everolimus! (RADI001),! an! mTOR! inhibitor,! and! letrozole! or! fulvestrant! reversed! AKTImediated!endocrine!resistance!(Beeram!et!al.,!2007).!!!
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In! a! clinical! setting! there! have! been! a! number! of! completed! trials! looking! at! the!combination! of! an!mTOR! inhibitor! with! endocrine! therapy! with! some! conflicting!results,! suggesting! that! patient! selection! remains! key.! HORIZON! was! a! negative!phase!III!trial!evaluating!temsirolimus!and!letrozole!in!a!first!line!metastatic!setting,!in!patients!who!had!not!previously!received!an!aromatase!inhibitor!(patients!could!have! received! an! aromatase! inhibitor! adjuvantly! if! it! was! greater! than! twelve!months!prior).!Hence!this!trial!had!very!low!numbers!of!patients!who!had!received!adjuvant!endocrine! treatment! (43%! in! the! combination!arm!and!40%! in! letrozole!only! arm)! (Baselga! et! al.,! 2012;!Wolff! et! al.,! 2013),!which!may! explain! the! lack! of!improvement! in! PFS.! Conversely! BOLEROI2,! a! positive! phase! III! trial,! looked! at!everolimus!and!exemestane! in!metastatic,!ERα!positive!patients!who!had!relapsed!following! treatment!with! a! nonIsteroidal! aromatase! inhibitor.! This! trial! showed! a!significant! improvement! in! PFS! (10.6! months! versus! 4.1! months)! and! a! recent!updated! analysis! confirmed! an! ongoing! improvement! in! PFS! although! the! overall!survival!data!are!not!yet!ready!(Baselga!et!al.,!2012).!Similarly!TAMRAD,!a!phase!II!clinical! trial! in! patients! with! metastatic! breast! cancer! who! had! previously! been!treated!with!an!aromatase! inhibitor,! looked!at!everolimus!and!tamoxifen,!showing!an! improved! clinical! benefit! rate! (61! versus! 42%)! and! a! 55%! decreased! risk! of!death! in! combination! treatment.! In! this! trial,! an! unplanned! analysis! suggested!patients!with!acquired!resistance!(>6!month!response!to!an!aromatase!inhibitor!in!the!metastatic! setting! or! greater! than! 6!months! following! completion! of! adjuvant!treatment! with! an! aromatase! inhibitor)! to! endocrine! therapy! obtained! a! greater!benefit! (Bachelot! et! al.,! 2012).! In! contrast! to! HORIZON,! both! BOLEROI2! and!TAMRAD! are! assumed! to! have! a! greater! proportion! of! patients! with! endocrine!resistance!based!on!the!outcomes!in!the!control!groups!(lack!of!response!in!the!first!line! setting! to! endocrine! therapy! and! PFS! <6! months)(Paplomata! and! O'Regan,!2014).!!PI3K! inhibitors! are! under! evaluation! in! clinical! trials,! for! example! PXI866,! which!demonstrates!good!tolerability!and!stable!disease!in!phase!I!studies!alone!(Hong!et!al.,! 2012)! and! also! in! combination! with! docetaxel! (Bowles! et! al.,! 2013).! Similar!
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results!have!been!seen!with!BGT226!a!dual!PI3K!and!mTOR!inhibitor!(Markman!et!al.,!2012).!There!are!various!ongoing!phase!I!studies!looking!at!the!combination!of!a!pan! PI3K! inhibitor! and! a! dual! PI3K! and! mTOR! inhibitor! with! letrozole! and! a!selective!class!1!PI3K!inhibitor!with!Fulvestrant!(GDCI0942).!!BKM120! is!a!pan!PI3K! inhibitor!which! is!well! tolerated!on! its!own! (Bendell!et!al.,!2012;!Maira!et!al.,!2012)!and!in!combination!with!trastuzumab!(Saura!et!al.,!2014).!This!drug!is!currently!undergoing!assessment!within!BELLEI2,!BELLEI3!and!BELLEI4! clinical! trials.! BELLEI2! addresses! the! role! of! BKM120! with! Fulvestrant! after!progression! with! an! AI! in! patients! with! HER2! negative! breast! cancer.! BELLEI3!addresses! the! role! of! BKM120! in! patients!with!HER2! negative! breast! cancer!who!have!had!prior!treatment!with!an!mTOR!inhibitor!and!BELLEI4!addresses!the!use!of!BKM120!in!combination!with!paclitaxel.!!!Appropriate!patient!selection!remains!a!key!question!and!selecting!patients!who!are!less!likely!to!respond!to!AKT/PI3K/mTOR!inhibitors!by!analysis!for!PI3K!mutations!has!been!proposed!(Vasudevan!et!al.,!2009),!but!this!still!requires!clinical!validation.!!
4.1.2&ProQsurvival&pathways&are&upregulated&in&MLET5&cells&One!of!the!most!significantly!altered!cellular!pathways!identified!from!comparison!of! the! MCF7! and! MLET5! microarray! datasets! was! apoptosis.! Examination! of! the!differentially! regulated! genes! in! this! pathway! showed! that! expression! of! proIapoptotic! genes! (including! BIK)! was! reduced! and! expression! of! antiIapoptotic!genes,! in! particular! BCL2,! was! increased! in! MLET5! cells.! RealItime! RTIPCR! and!Western! blotting! confirmed! these! findings,! and! MLET5! cells! were! shown! to! be!resistant! to! the! apoptosis! inducing! agent,! etoposide.! Interestingly,! many! of! the!differentially!regulated!apoptosis!associated!genes!demonstrate!estrogenIregulation!in! MCFI7! cells,! where! estrogen! treatment! represses! expression! of! proIapoptotic!genes,! whilst! stimulating! expression! of! antiIapoptotic! genes.! The! best! studied! of!these!genes! is!BCL2,!estrogen!stimulation!of!which! is!well!known!(Su!et!al.,!2014;!Teixeira!et!al.,!1995).!Interestingly,!BCL2!expression!was!also!elevated!in!LTED!cells,!
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whilst!expression!of!BIK!and!BID!was!reduced!in!LTED!cells,!as!it!is!in!MLET5!cells.!These!results! indicate!that!escape!from!the!growth!arrest!engendered!by!estrogen!withdrawal! requires! activation! of! proIsurvival! pathways! and! highlights! survival!pathways! as! potential! therapeutic! targets! in! the! treatment! of! endocrine! resistant!breast! cancer.! Methods! that! have! been! investigated! as! means! of! targeting! BCl2!include! the!development!of!antisense!BCL2!and!BH3!mimetics! i.e.! small!molecules!that!mimic!the!actions!of!proIapoptotic!BH3Ionly!proteins!(Souers!et!al.,!2013).!Anti!sense!BCL2! increased! the! sensitivity! of!MCF7! cells! to! doxorubicin! (Teixeira! et! al.,!1995).! Two! BH3! mimetics,! ABTI737! and! the! platelet! sparing! ABTI199! and!tamoxifen!were! tested!alone!and! in!combination! in! four!patient!derived!xenograft!models,! three!ERIpositive!and!one!ERInegative.!Of! the!ERIpositive!xenografts,! two!showed!a!partial!response!and!one!an!almost!complete!response,!but!there!was!no!response!in!the!ERInegative!xenograft.!The!effect!of!the!combination!of!BH3!mimetic!and!tamoxifen!was!greater!than!tamoxifen!alone,!measured!by!reduction!in!tumour!volume!and! survival.! Following!on! from! this,!pAKT!expression!was!measured!and!found! to! be! much! higher! in! the! two! partial! response! xenografts,! as! might! be!predicted!as!AKT!modulates!the!expression!of!phophorylated!BAD!and!suppreses!its!proIapoptotic! function! (Vaillant! et! al.,! 2013).! This! causative! finding! was! then!confirmed! by! the! dual! treatment! with! ABTI737! and! a! dual! PI3K/mTOR! inhibitor!resulting! in! a! superior! response! to! both! single! and! dual! therapies! (Vaillant! et! al.,!2013).! BCL2! as! a! potential! therapeutic! target! has! recently! moved! into! phase! 1!clincal!trials!with!BH3!mimetic!ABTI199!in!patients!with!NHL!and!CLL!(Vaillant!et!al.,!2013).!!!!This!indicates!that!treatment!of!endocrine!resistant!disease!is!likely!to!involve!the!targeting! of! several! pathways! to! gain! control! of! growth! and! prevent! alternative!growth!(escape)!pathways!being!activated.!MLET5!cells,!featuring!AKT!upregulation!and! upregulation! of! BCL2,! may! provide! an! important! model! cell! line! for!investigating!the!action!of!drugs!targeting!PI3K!and!apoptosis!pathways.!!!!
!!
240!
4.1.3&Future&Directions&The! studies! described! in! this! thesis! provide! evidence! for! the! importance! of! the!PI3K/AKT! and! BCL2! family! in! endocrine! resistance! and! potential! therapeutic!approaches! targeting! these!pathways.!As!described!above,! there! is!much!evidence!linking!these!pathways!to!ERαIpositive!breast!cancer!progression!and!resistance!to!endocrine!therapies.!A!number!of!other!genes!whose!expression!is!greatly!changed!in! MLET5! cells! may! have! potential! as! biomarkers! and/or! therapeutic! targets,! as!discussed! in! section!3.1.3.!Whilst! I! extended! some!of! our! findings! to!MCFI7!LTED!cells! from! the! Martin! and! Dowsett! laboratory,! it! is! important! also! to! extend! to!further! MCF7! derived! models! of! endocrine! resistance,! including! lines! generated!following! culturing! in! the! presence! of! antiIestrogens! (Brunner! et! al.,! 1997;!Lykkesfeldt!et!al.,!1994).!It!is!clearly!also!important!to!extend!beyond!MCF7!cells!to!resistance!models! generated! from! other! ERαIpositive! breast! cancer! cell! lines,! e.g.!T47D,! ZRI75I1.! Finally,! recent! advances! allow! indefinite! maintenance! of! patient!biopsies,! usually! by! passaging! in! mice,! the! soIcalled! patient! derived! xenografts!(PDX).! PDX! from! endocrine! resistant! breast! cancer! have! been! generated! and!characterised! (Li! et! al.,! 2013).! PDX! could! provide! important! new! models! for!determining! the! importance! of! the! genes! and! pathways! identified! here.! Finally,!immunohistochemical!staining!of!large!tissue!microarrays!(TMAs)!(Abd!ElIRehim!et!al.,! 2005)! would! provide! further! opportunities! for! validation! of! the! differentially!regulated!genes!identified!here,!should!appropriate!antibodies!be!available.!!!As! mentioned! above,! MLET5! cells! are! characterised! by! ligandIindependent!regulation!of!many!ERα! target!genes.!MLET5!cells! therefore!provide!an! important!resource! for! investigating! changes! in! ERα! activity! that! may! be! involved! in!development!of!endocrine!resistance.!!Unlike!many!other!LTED!models,!MLET5!cells!are! clonal! and! thus! provide! a! valuable! model! for! studying! ERα! interaction! with!transcriptional! coIregulators! and! ERα! recruitment! to! gene! regulatory! regions!globally,! for! example! with! ChIPIseq! using! antibodies! for! ERα.! The! potential!significance!of! such! studies! for!understanding!ERα!action! in!breast! cancer! cells! is!highlighted!by!the!finding!that!the!key!ERα!coactivator!AIB1!is!frequently!amplified!
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and/or!overIexpressed!in!breast!cancer!cells,!whilst!the!related!coIactivator!SRCI1!has!been!linked!to!the!agonist!activity!of!tamoxifen!(Anzick!et!al.,!1997;!Burandt!et!al.,!2013;!Harigopal!et!al.,!2009;!TorresIArzayus!et!al.,!2004;!TorresIArzayus!et!al.,!2010;!Zwart!et!al.,!2011).!The!coIrepressors!NCoR!and!SMRT!are!frequently!downIregulated!in!breast!cancer!(Ciriello!et!al.,!2013;!Smith!et!al.,!2012)!and!mutations!in!NCoR!(NCoR1)!have!been!identified!in!breast!cancer!(Stephens!et!al.,!2012).!These!changes! are! likely! to! impact! on! regulation! of! gene! expression! by! ERα,! so!understanding!the!molecular!mechanisms!by!which!ERα!activity!might!be!altered!in!endocrine!resistance!is!important!for!understanding!breast!cancer!progression.!!!!
4.2&Evaluation&of&LRHQ1&target&gene&expression&in&breast&cancer&cells&Studies! comparing!MCF7! and!MLET5! are! helping! to! identify! potential! biomarkers!and! therapeutic! targets.!One!of! the!ERα! target!genes! thus! identified! is! the!nuclear!receptor! LRHI1.! LRHI1! is! potentially! of! great! interest! given! its! role! in! regulating!aromatase!expression!in!breast!cancer!associated!stroma!(Clyne!et!al.,!2004;!Clyne!et!al.,!2002).!Our!previous!studies!demonstrated! that!LRHI1! is!a!direct!ERα!target!gene,! with! ERα! binding! to! a! region! 10kb! upstream! of! the! LRHI1! gene! promoter!(Thiruchelvam!et!al.,!2011).!LRHI1!was!down!regulated!in!MCF7!cells!using!a!pool!of!four! small! interfering! RNAs.! This! resulted! in! an! inhibition! of! MCFI7! growth,!confirmed! in!LRHI1!positive!ZRI75I1!and!T47D!cell! lines.!Growth!effects!of!LRHI1!were! then! confirmed! using! the,! previously! described,! published! synthetic! LRHI1!activating! compounds! 5A,! 5L! and! 5B!with! stimulation! of! growth! effects! in! LRHI1!positive!cell!lines!and!again!no!effect!in!LRHI1!negative!(specifically!BT474!which!is!ERα!positive! but! LRHI1!negative).! These! compounds! stimulated! the! activity! of! an!LRHI1! responsive! reporter! gene! and! in! MCF7! cells,! stimulated! the! expression! of!ERα.!!!This!work!confirmed!the!importance!of!LRHI1!for!growth!in!breast!cancer!cells!and!its! role! in! regulating! ERα! expression! by! direct! recruitment! to! the! ERα! gene!promoter.! These! studies! further! highlight! LRHI1! as! a! potentially! significant! new!therapeutic! target! and! prompted! us! to! perform! gene! expression! microarray!
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analysis,! in! order! to! identify! LRHI1! target! genes! in! breast! cancer,!with! a! view! to!elucidating! the! potential!mechanisms! of! LRHI1! function! in! breast! cancer! cells.! As!there! were! no! suitable! LRHI1! agonists! and/or! antagonists,! LRHI1! target! gene!identification! was! undertaken! following! siRNAImediated! LRHI1! knockdown.! As!some! siRNAs! have! offItarget! effects,!we! used! two! independent! siRNA! in! the! gene!expression! microarray! analysis.! Note! that! the! synthetic! LRHI1! agonists,! whilst!stimulating!LRHI1!activity,!only! increase! its!activity!marginally,! thus!bringing! into!question!the!possibility!of!obtaining!robust!microarray!data,!so!the!siRNA!approach!was!followed.!!Evidence! for! the! importance! of! LRHI1! in! the! estrogen! driven! development! and!progression!of!breast!cancer!is!seen!in!the!analysis!of!LRHI1!siRNA!microarray!with!37%! of! the! genes!whose! expression!was! upI! or! downIregulated! following! LRHI1!siRNA! treatment,! being! known! ERα! target! genes.! Pathway! enrichment! analysis!confirmed!these!findings!and!‘Response!to!estrogen’!pathway!was!the!top!hit,!with!wellIrecognised!estrogen!regulated!genes!included!in!this!list!(GATA3,!BCL2,!SOCS2,!CYP1A1!and!CYP1B1)!and! importantly!ERα.!The!regulation!of!ERα!and!ERα!target!genes!by!LRHI1!has!been!published!both!by!this!laboratory!and!others!(Chand!et!al.,!2012;!Lai!et!al.,!2013;!Thiruchelvam!et!al.,!2011).!As!mentioned!in!section!3.2.1!the!cooperativity! between! LRHI1,! ERα! and! GATA3!may! provide! a! further!mechanism!whereby!other!genes!important!in!breast!cancer!are!regulated.!!!MCF7!cell!do!not!express!aromatase!and!therefore!direct!delineation!of!the!role!of!LRHI1!in!the!regulation!of!aromatase!(CYP19)!is!not!advanced!by!this!experiment.!However! as! previously!mentioned,! CYP1A1! and! CYP1B1! are! both! involved! in! the!catabolism!of! estrogens,! therefore! LRHI1! inhibition! of! these! genes!might! increase!estrogen! levels! and! strengthen! the! evidence! for! the! role! of! LRHI1! in! increasing!estrogen! bioavailability.! Remarkably,! expression! of! GPER,! an! estrogen! binding!protein!that!mediates!the!nonIgenomic!effects!of!estrogen,!was!reduced!upon!LRHI1!knockdown.! This! finding! adds! yet! another! facet! to! the! regulation! of! estrogen!signalling! in! breast! cancer! cells! by! LRHI1.! By! upregulating! GPER,! LRHI1! may!
!!
243!
promote! the! nonIgenomic! actions! of! estrogen,! in! addition! to! regulating! estrogen!biosynthesis! and! ERα! expression.! A! further! surprise! finding! regarding! LRHI1!function!in!breast!cancer!cells!is!that!obtained!in!our!laboratory!recently!using!ChIPIseq! for! LRHI1! (Lai! et! al.,! 2013).! Global! identification! of! LRHI1! binding! regions! in!MCF7!cells!using!ChIPIseq!for!LRHI1!demonstrated!that!a!large!proportion!of!LRHI1!binding!sites!are!coincident!with!ERα!binding!regions.!Importantly,!LRHI1!promotes!the!recruitment!of!ERα!to!coincident!binding!sites.!!!Together,!these!findings!demonstrate!a!central!role!for!LRHI1!in!estrogen!signaling!in!breast! cancer! cells,!which! together!with! its!other!defined! role! in! local! estrogen!biosynthesis,!makes!LRHI1!an!important!new!therapeutic!target!in!breast!cancer.!!!
4.3&Development&of&Small&Molecule&Inhibitors&of&LRHQ1&! !As! described! in! section! 1.3.5! the! first! synthetic! LRHI1! ligands,! published! by!Professor! Whitby’s! group,! were! agonists! based! on! a! cisIbicyclo(3.3.0)octI2Iene!skeleton! (Whitby! et! al.,! 2006).! A! second! series,! by! the! same! group,! has! been!published,!with! improved! stability! and! specificity! but! less! potency! (Whitby! et! al.,!2011).! The! discovery! by! Professor! Ortlund’s! group,! during! crystallographic!examination,! that! phospholipids! are! present! in! the! LRHI1! LBD! has! led! to! the!discovery!that!medium!chain!phosphatidylcholines!act!as!LRHI1!agonists,!DLPC!and!DUPC,!with!increased!binding!of!coactivators!and!inhibition!of!interaction!of!LRHI1!with!SHP!and!the!corepressor!SMRT!(Lee!et!al.,!2011;!Musille!et!al.,!2012;!Ortlund!et!al.,! 2005).! These! compounds! are! interesting! as! they! bind! superficially,! near! the!mouth!of!the!LBP,!leaving!a!deeper!unoccupied!pocket!(Musille!et!al.,!2012).!!To!design!an!antagonist!for!LRHI1,!some!assumptions!have!been!made!with!regard!to!its!potential!similarity!to!other!nuclear!receptors!for!which!antagonists!have!been!successfully!discovered!and!designed,!such!as!ERα.!!The!similarities!that!have!been!assumed! relate! to! the! structural! changes! of! a! nuclear! receptor! in! the! activated!format,!i.e.!for!ERα!on!binding!of!an!antagonist!the!adjustment!in!the!positioning!of!
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H12,!to!change!the!AF2!topology!and!allow!the!recruitment!of!coIrepressors!rather!than!coIactivators.!!!!With! regards! to! this! thesis! we! targeted! the! LBD,! beginning! with! the! published!agonist!compound!5L!and!using!computational!identification!(Cresset!and!SHoP)!of!compounds!with!similar!3Dand/or!electrophysiological!characteristics,!to!search!for!potential! antagonists.! Using! this! approach,! a! number! of! compounds! with! agonist!activity!greater!than!compound!5L!were!identified!in!both!the!cell!based!and!in$vitro!assays.! However,! these! compounds! were! unselective,! with! off! target! cell! toxicity.!The!poor!selectivity,!shown!by!the!activation!of!ERα!by!these!compounds,!indicates!that!they!are!either!promiscuous!or!activation!is!due!to!off!target!effects,!perhaps!via!modulation!of! protein! kinase!pathways!or! chromatin! remodelling! enzymes.!To! go!from!these!to!viable!selective!antagonists!would!likely!mean!a!considerable!amount!of!chemistry!redesign!perhaps!achievable!only!by!screening!libraries!of!compounds.!Two!potential!antagonists!were!identified!but!these!did!not!block!the!activation!of!LRHI1! by! 5A,! indicating! that! any! inhibitory! activity!may! be! indirect! or! that! these!compounds! have! only! a! very! weak! affinity! for! LRHI1.! That! very! few! potential!antagonists!were! identified! using! this! technique! perhaps! indicates! that!modelling!using!LRHI1!agonists,!as!a!starting!structure!may!not!be!appropriate.!!!The! most! promising! results! from! this! thesis! relate! to! the! nuclear! receptor!modulator!extension!work.!This!technique!also!targeted!the!LBD,!using!the!nuclear!receptor! modulators! raloxifene! and! tamoxifen! as! templates! initially! for! two!dimensional! virtual! HTS! of! the! Chem!Navigator! library! (50+!million! compounds),!followed!by!three!dimensional!docking!based!screening!of! the!delivered!hits!using!the!LRHI1!LBD!with!bound!phospholipid!(PDB!code!1YUC).!Two!potential!scaffolds!for! the! development! of! LRHI1! antagonists! were! identified,! a! Raloxifene! analogue!and! a! Tamoxifen! analogue,! although! both! had! poor! potency! and! solubility,! and!molecular! weights! above! 700! and! will! therefore! require! significant! modification.!The! Raloxifene! analogue! (JR430)! has! been! chosen! for! further! chemistry! design!based!on!LRHI1!docking!analysis!suggesting!that!the!CI7!arm!of!the!benzothiophene!
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scaffold! is! a! key! feature! as! it! is! directed! towards! H12.! Certainly! compounds! that!moved!away!from!this!feature!had!little!activity!(JR505!and!JR530).!Future!work!will!aim!to!develop!analogues!with!modifications!of!this!arm!to!improve!potency.!Ideally!to!enable!the!most!effective!analogues!to!be!developed!this!structure!would!be!coIcrystallised!with! the!LRHI1!LBD!as! this!would! allow! ‘intelligent!design’! of! further!compounds!by!defining!the!key!interactions!between!the!LRHI1!LBD!and!compound.!!
4.4&LRH1:&Future&direction&The! limitations! of! the! screening!methods! that! I! have! employed!within! this! thesis!relate!to!throughput!and!specificity.!In!future,!using!an!in$vitro!binding!assay!as!the!first! step! in! the! screening! cascade! would! allow! a! more! rapid! throughput! of!compounds!and!could!be!used! initially! to! screen! for!both!potential!LRHI1!activity!and!specificity!by!developing!the!same!assay!for!a!range!of!nuclear!receptors.!The!in$
vitro! binding! assay! I! have! set! up! and! validated! could! certainly! be! used! for! such!screening! efforts.! Confirmation! of! the! functional! effects! on! full! length! LRHI1! and!other! nuclear! receptors! could! then! be! assessed! in! cell! based! assays.! ! This! would!then!be! followed!by! growth! and!proliferation! assays! in! appropriate!breast! cancer!cell!lines.!!Work!published!by!Professor!Fletterick’s!group!at!the!University!of!California!in!San!Francisco! highlights! potential! drawbacks! in! our! initial! approaches! for! identifying!LRHI1! antagonists.! This! group,! in! a! similar! manner! to! us,! used! the! structural!conformation! of! the! LRHI1! LBD! from! the! known! agonist! bound! conformation! but!with! predicted! adjustments! based! on! ERα! bound! to! tamoxifen! (PDB! code! 3ERT))!(Benod!et!al.,!2013).!The!adjustments! looked!at! the!way! in!which!ERα!antagonists!have! a! hydrophobic! core! with! a! polar! side! chain! protruding! out! of! the! pocket,!preventing! H12! from! allowing! the! recruitment! and! docking! of! coIactivators.! As!there! have! been!many!different! positions! of!H12! seen! in!ERα! this!meant! that! the!actual!position!of!H12!was!unknown!in!LRHI1!and!H12!was!therefore!removed!from!their!model.!They!then!used!a!flexible!ligandIsampling!algorithm!that!superimposes!
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atoms!of! a! docked!molecule! onto! spheres!matching! a! defined!binding! site.! In! this!case! there! were! 50! matching! spheres! which! mimicked! the! inside! of! the! LRHI1!binding! pocket! and! subsequently! were! readjusted! to! increase! sampling! at! the!opening! in! the!receptor’s!molecule!surface!created!by!deletion!of!H12.!This!model!was! screened! using! an! online! database! (ZINC)! (Irwin! and! Shoichet,! 2005)! but! an!additional!filtering!step!was!added!at!this!point!to!improve!the!‘druggability’!of!any!compounds! selected! by! also! screening! out! compounds! using! molecular! weight!(<400),!a!logP!(an!octanolIwater!partition!coefficient)!<4!and!less!than!10!rotatable!bonds.!!!Additionally,! the! type! of! compound! library! used! for! the! initial! identification! of!potential! compounds! to! take! forward! into! in$ vitro! assay! testing!might! need! to! be!considered!with!the!potential!advantages!offered!by!compound!fragment! libraries.!Lipinski’s!rule!of!five!has!been!the!basic!guide!to!predicting!the!potential!suitability!of!new!drugs!based!on!their!pharmacokinetic!properties!and!states!that!four!out!of!the!five!rules!should!be!adhered!to,!to!ensure!success!of!a!compound!in!a!biological!system.!The!five!rules!are:!no!more!than!five!hydrogen!bond!donors,!not!more!than!10!hydrogen!bonds!acceptors,!a!molecular!mass!of!less!than!500!daltons!and!a!logP!not!greater!than!5!(Lipinski!et!al.,!2001).!Maintaining!these!properties!during! lead!optimisation! is! challenging! if! the! starting!molecular!weight!of! a! lead!compound! is!already! 700.! Hence,! fragment! libraries! use! a! modified! rule! of! three:! a! logP! not!greater!than!3,!a!molecular!mass!less!than!300!daltons,!not!more!than!3!hydrogen!bond! acceptors,! not! more! than! 3! hydrogen! bond! donors! and! not! more! than! 3!rotatable!bonds!(Congreve!et!al.,!2003).!!It!would!be!important!in!the!future,!in!view!of!the!drive!to!find!LRHI1!inhibitors,!to!further!predict!and!assess!what!the!downstream!impact!of!LRHI1!inhibition!would!be,! for! example! on! reversal! cholesterol! and! bile! acid!metabolism.!As! described! in!section! 1.3,! we! might! predict! that! lowering! LRHI1! systemically! could! result! in!hypercholesterolaemia,! requiring! additional! therapy! with! HMGICoA! reductase!inhibitors!(Statins).!LRHI1!alone!promotes!bile!acid!production!by!the!induction!of!
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CYP7A1! and! Cyp8B1,! however! increased! levels! of! bile! acids! initiate! a! regulatory!feedback!mechanism!to!activate!FXR,!which!in!turn!induces!SHP,!SHP!then!inhibits!LRHI1! (Goodwin! et! al.,! 2000;! Lu! et! al.,! 2000).! With! further! regard! towards! the!potential!problems!associated!with!decreasing!LRHI1!levels!systemically,!its!role!in!diabetes! has! been! of! interest.! LRHI1! has! previously! been! found! to! be! protective!against! diabetes! and! the! discovery! that! the! LRHI1! agonist,! DLPC! (dilauroyl!phosphatidylcholine),! decreases! hepatic! steatosis! and! improves! glucose!homeostasis! in! two! independent! mice! models! of! insulin! resistance,! (specifically!lowering!serum!glucose!levels!and!hepatic!triglycerides),!whilst!increasing!bile!acid!levels! has! compounded! this! and! led! to! the! pilot! human! clinical! study! in! USA! to!explore!the!effects!of!DLPC!in!patients!with!preItype!2!diabetes!mellitus!(Lee!et!al.,!2011;! MelladoIGil! et! al.,! 2012).! The! full! impact! of! lowering! LRHI1! levels! has! not!been! fully!revealed!and! in! fact!a!recently!published!study! looking!at!heterozygous!LRHI1!knockout!mice!found!that!they!are!prone!to!obesity!but!without!any!objective!worsening! of! glucose! and! lipid! metabolism! (Hattori! et! al.,! 2014)! indicating! the!presence!of!compensatory!pathways.!!!In!view!of!the!role!of!LRHI1!in!ERα!and!aromatase!regulation,!LRHI1!antagonism!in!breast! cancer!may! be! seen! in! combination!with! existing! endocrine! treatments! or!indeed! in! combination! with! alternative! pathway! antagonism! i.e.! Akt/PI3K/mTOR!inhibitors! as! is! currently! under! investigation!within! the!BELLE! clinical! trials.! The!challenge,! as! always! will! be! to! select! out! appropriate! groups! of! breast! cancer!patients!who!are!likely!to!benefit!most!from!LRHI1!inhibition!and!to!this!end,!there!is! a! need! for! robust! biomarkers! of! LRHI1! activity.! Identifying! LRHI1! target! genes!using! microarray! analysis,! as! described! in! this! thesis,! will! surely! aid! biomarker!development.!!
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5.&Conclusions&!The!MLET5!microarray!analysis!has!confirmed!the!functionality!of!ERα!in!MLET5!by!the!presence!of!ERα!and!associated!estrogen!regulated!genes.!It!has!also!confirmed!the! estrogen! independence! of! this! clonal! cell! line! and! highlights! the! potential! of!MLET5!as!a!model!of!endocrine!resistant!breast!cancer.!I!have!shown!that!one!of!the!mechanisms! of! resistance! in!MLET5! involves! an! upIregulation! of! the! proIsurvival!pathway!involving!BCL2!family!members,!suggesting!that!targeting!this!pathway,!in!addition!to!endocrine!treatment,!may!provide!an!important!strategy!for!overcoming!endocrine! resistance.! Future! studies! should! focus! on! confirming! these! findings! in!alternative!cell! lines!of!endocrine!resistance!with!a!view!to! investigating!potential!new!therapeutic!targets!or!biomarkers.!!LRHI1! is! a! direct! ERα! target! gene! important! for! the! growth!of! breast! cancer,! and!work!from!this!laboratory!has!confirmed!that!LRHI1!itself!can!directly!regulate!ERα!and!ERα!regulated!genes.!Identification!of!LRHI1!target!genes!in!breast!cancer!cells!has! confirmed! the! importance! of! LRHI1! in! estrogen! driven! development! and!progression! of! breast! cancer.! The! coIoperativity! between! LRHI1,! ERα! and! other!genes!such!as!GATA3!may!provide!a!key!mechanism!for!regulating!the!expression!of!genes!required!for!breast!cancer!progression.!GPER!has!been!shown!to!be!an!LRHI1!regulated! gene! and! further! investigation! of! the! potential! nonIgenomic! effects! of!GPER!on!estrogen!regulation!are!required.!Similarly,!there!will!be!ongoing!analysis!for!appropriate!biomarkers!that!could!be!used!during!future!drug!discovery.!!The!evidence!from!other!groups!showing!that!LRHI1!drives!estrogen!biosynthesis!in!breast!cancer!associated!stroma,!together!with!the!demonstration!here!that!LRHI1!is! directly! involved! in! regulation! of! the! ERα! transcriptome! in! breast! cancer! cells,!together!with!the!identification!of!GPER,!which!has!been!implicated!in!nonIgenomic!actions!of!estrogen,!provide!compelling!evidence!for!exploration!of!LRHI1!inhibitors!as!breast!cancer!therapeutics.!The!studies!described!in!this!thesis!demonstrate!that!
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it!should!be!possible!to!develop!LRHI1!selective!small!molecule!inhibitors.!However,!it! is! also! clear! that! successful! identification! of! molecules! for! development! as!therapeutics,! or! even! LRHI1! selective! tool! molecules,! require! the! use! of!sophisticated! approaches,! ideally! utilizing! highIthroughput! screening! of! large!compound! libraries! and/or! fragment! libraries,! couple! with! coIcrystallisation!studies,!prior!to!any!focused!chemistry!approaches.!!!
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